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Introduction 13
People have always been searching for methods to stay young and live longer. For 
example, in the European middle ages alchemists were looking for the “potion of life”. 
This elixir, also known as the elixir of immortality and sometimes equated with the 
philosopher’s stone, is a legendary potion, or drink, that grants the drinker eternal life 
or eternal youth. So far no elixir has been found. The same holds for the fountain of 
youth, a legendary spring that reputedly restores the youth of anyone who drinks of its 
waters. Despite all these efforts it was not until the beginning of the twentieth century 
that a non-invasive way to prolong life-, and healthspan was found: dietary restriction.
DiETARy REsTRiCTion
Dietary restriction (DR), a reduction in daily energy intake without causing malnutrition, 
is able to extend lifespan. This was first reported by C.M. McCay in 19351. He divided 
his rats into three groups based on their nutritional regimen: ad libitum (unrestricted) 
diet, 30% restriction of caloric intake starting from the time of weaning and starting 
2 weeks after weaning. Rats on 30% DR lived twice as long when compared to the 
ad libitum fed group. Hereafter, the life-extending action was found to occur in both 
genders of many different rat and mouse strains, as well as in non-mammalian species 
such as fish, flies, and water fleas2-7. Recently, it was reported that DR is also able to 
increase the lifespan of non-human primates8, suggesting that DR could also work in 
humans. Although studies investigating the effect of DR in humans on lifespan are lack-
ing there are reports which imply that DR might work in humans. Epidemiological data 
showed that people living on the Island of Okinawa (Japan), which were not exposed 
to the westernisation of their diet and adhered to a relatively calorie-restricted diet, 
had a higher centenarian rate compared to the people on the “mainland” of Japan9. 
Furthermore, during the first mission in Biosphere 2 (a 12700 m2 artificial, materially-
closed ecological system) the eight humans were capable of producing only 83% of the 
calorie intake of a normal human diet, leading tot calorie restriction. Medical markers 
indicated that their health during this fase of the the experiment was excellent and 
it was concluded that non-obese humans on a low-calorie, nutrient-dense diet show 
physiologic, hematologic, hormonal, and biochemical changes resembling those of 
rodents and monkeys on such diets10. In addition, the CALERIE trial (a randomized 
controlled trial were participants were randomized to 6 months of a control diet or 
25% calorie restriction) reports a reduced risk for cardiovascular events in healthy non-
obese individuals11, and improved insulin sensitivity in non-obese humans adhering to 
a DR diet12.
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14 Chapter 1
ThE EffECT of DiETARy REsTRiCTion on AGinG AnD oxiDATivE sTREss
Aging can be defined as the process of growing old or maturing. One of the most sup-
ported theories about why we age is the free radical theory of Harman13. He postulated 
that aging and the degenerative diseases associated with it are due to the deleterious 
effects of free radicals on cell constituents and connective tissues. Although it has 
been shown that DR delays the aging process and extends lifespan, the mechanisms 
underlying this effect have not been elucidated. Rubner et al.14 were the first to suggest 
that metabolic rate (i.e. energy metabolism per unit of body mass) is negatively cor-
related with the length of life. With the subsequent discovery that energy metabolism 
generates reactive oxygen species that cause molecular oxidative damage, a potential 
biochemical mechanism emerged that linked DR to oxidative damage and aging. DR 
is indeed able to attenuate the age-associated increase in lipid peroxidation15, the ac-
cumulation of oxidized proteins16 and the accumulation of oxidative damage to DNA17. 
Furthermore, long-term DR lowers steady-state levels of oxidative stress, decreases 
mitochondrial electron and proton leak in mammalian cells and attenuates damage 
resulting from intracellular oxidative stress18-21. The concept that DR, as a relatively non-
invasive method, is able to reduce and/or protect against oxidative stress is interesting 
from a clinical perspective. DR can be performed by means of different regimens such 
as calorie restriction (CR; reduced daily calorie intake), fasting (no food intake), and 
alternate day fasting (ADF). In addition, DR can be divided into long-term (months-
years) or short-term (days-weeks) interventions. Long-term interventions are however 
not amendable in the clinical setting. Therefore, this thesis focuses on short-term DR.
oxiDATivE sTREss in ThE CliniCAl siTuATion
ischemia and reperfusion injury
Chapter 2 offers a review of the literature on the protective effects of short-term DR 
against clinically relevant forms of oxidative stress such as ischemia-reperfusion (I/R) 
injury. Ischemia is a deprivation of sufficient blood supply, accompanied by the lack of 
oxygen, which is an essential source for cellular energy metabolism, resulting in dam-
age or dysfunction of tissue. Reperfusion injury refers to the additional damage caused 
when blood supply is restored after a period of ischemia. Many complex mechanisms 
are involved in the injury caused by I/R, including an inflammatory response and 
oxidative damage through the induction of oxidative stress. I/R injury is unavoidable 
in case of liver transplantation and is commonly induced during major liver resections 
when vascular occlusion techniques, such as the Pringle maneuver, are used to control 
bloodloss22. Renal transplantation is considered the treatment of choice for people 
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Introduction 15
with end-stage renal disease. I/R injury negatively influences the outcome after kidney 
transplantation23,24. Delayed graft function is primarily a consequence of I/R injury and 
contributes to the loss of kidney grafts25. The development of a protective non-invasive 
strategy against I/R injury is therefore warranted to improve clinical outcome after 
kidney transplantation as well as liver surgery and transplantation. In previous studies 
we have demonstrated that dietary restriction protects against I/R injury26. Both 3 days 
of fasting and 2 weeks of reduced (30%) caloric intake prior to renal I/R resulted in 
significant protection against I/R injury in mice. In chapter 3 we aimed to extend these 
observations and elucidate the mechanisms of protection by short-term fasting against 
hepatic I/R injury.
In chapters 4 and 5 we aimed to identify the factor(s) responsible for the beneficial 
effect of short-term DR on I/R injury. During short-term stress responses, activation of 
the hypothalamic-pituitary-adrenal axis stimulates the release of glucocorticoids from 
the adrenal gland. Glucocorticoids are important mediators in these stress response 
pathways27 and essential in limiting and resolving inflammation28. I/R injury induces 
inflammation, which is responsible for many of its detrimental consequences29. Fasting 
acts as an acute stressor and increases levels of corticosterone in rodents30. We there-
fore tested the hypothesis that the protection against I/R injury imposed by fasting is 
mediated by increased systemic levels of corticosterone in chapter 4. Fasting also leads 
to an increase in serum levels of ghrelin31. The complete structure of ghrelin has been 
identified as an [O-n-octanoyl-Ser 3]-peptide. The n-octanoyl moiety is essential for the 
activity of ghrelin32. Acylated ghrelin is the endogenous ligand for the growth hormone 
secretagogue receptor31. Interestingly, ghrelin has been shown to reduce ischemia-
related problems after skin flap transfer33 and to protect against renal I/R injury34. The 
influence of ghrelin levels on renal I/R injury was examined in chapter 5.
Postoperative inflammation
Surgical procedures induce hematogenic tumor cell dissemination into the blood-
stream as reflected by increased circulating tumor cells (CTC) present during surgical 
procedures35. The importance of CTC is underlined by an increased hepatic metastasis 
rate in CTC-positive patients, when compared to CTC-negative patients36. Almost every 
surgical trauma causes oxidative stress37,38 and provokes an acute phase reaction. This 
response is characterized by increased levels of pro-inflammatory cytokines such as 
interleukin-6 and tumor necrosis facto alpha (TNF-α), increased levels of C-reactive 
protein and leukocytosis39,40. Surgery also decreases the number of circulating B- and 
T-cells, which may lead to a temporary impairment of cellular immunity41,42. These 
changes in the immune system are thought to play an important role in enhancing the 
metastatic potential of pre-existing or intraoperatively spilled CTC. The inflammatory 
reaction with elevated levels of local and systemic proinflammatory cytokines results 
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16 Chapter 1
in the up-regulation of adhesion molecules, such as E-selectin which may promote out-
growth of metastases by facilitating tumor cell adhesion to the endothelium of several 
organs such as the liver. Secondly, the induction of a pronounced immunosuppressive 
period after major surgery may impair the innate effector cell function of Kupffer cells 
and natural killer cells, which have an important role in the eradication of tumor cells 
retained in the liver vasculature. Impairment of their activity may result in an increased 
risk of the development of hepatic metastases35,43,44.
The perioperative period may provide a window of opportunity in which the adhe-
sion and outgrowth of CTC in the liver can be reduced, leading to less metastatic 
lesions and possibly lower patient morbidity and mortality rates. DR is associated with 
extended longevity1 and reduced cancer incidence8,45-48. Short-term preoperative DR 
for one week reduces angiogenesis and growth in a mouse brain tumor model49. In 
addition, we reported that short-term DR prior to both renal and hepatic I/R injury 
reduces the expression of pro-inflammatory cytokines and adhesion molecules50. In 
chapter 6 we used a murine model to determine the effect of short-term preoperative 
DR on tumor cell adhesion and hepatic tumor load after inoculation with tumor cells.
fEAsiBiliTy of PREoPERATivE DiETARy REsTRiCTion in ThE CliniCAl 
sETTinG
The experimental studies show that the beneficial effects of DR are induced rapidly and 
can be tapped for clinically relevant benefits such as protection against I/R injury. The 
maximum protection against renal I/R injury in the mouse was induced by both three 
days of preoperative water-only fasting and two weeks of preoperative reduced (30%) 
caloric intake. Preoperative DR may therefore be a non-invasive way to reduce I/R 
injury following organ transplantation25. Unfortunately, preoperative fasting is currently 
considered an unwanted necessity as it reduces patient well-being and induces periph-
eral insulin resistance51,52. The concept of reducing I/R injury by slightly longer periods 
of preoperative fasting or preoperative dietary restriction is novel and so far no clinical 
studies have been conducted. It is known that humans in general have difficulties to 
adhere to prescribed diets and it is unknown if people are able to adhere to a diet in 
preparation for surgery, which causes distress itself. We therefore describe in chapter 7 
a pilot study where we investigated whether a relatively mild preoperative DR regimen 
was feasible in the clinical setting and explored the effects of preoperative DR in live 
kidney donors on both the donor and recipient. We studied live kidney donors, who are 
a healthy, relatively homogenous patient group undergoing a standardised operation, 
rendering them a suitable study population and designed a DR regimen involving three 
preoperative days of 30% DR and one day of fasting. To assess the effect of preoperative 
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Introduction 17
DR on renal transplant function, we measured graft function on the first postoperative 
day by means of renographs and during the first month by serum creatinine levels 
in the recipient. In chapter 8 we focussed on the effect of preoperative DR on the 
postoperative acute phase response. We hypothesized that short-term DR reduces the 
postoperative acute phase response in humans. This theory was based on the results of 
our experimental studies where short-term DR reduces the inflammatory response after 
surgically induced acute oxidative stress50, and on others who found reduced serum 
cytokine levels after surgery53,54. Furthermore, TNF-α levels are lower and well-being 
is improved in asthma patients after short-term DR55, supporting the use of DR in the 
clinical situation. In chapter 9 the results of the studies performed in this thesis are 
summarized and discussed.
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ABsTRACT
Preoperative fasting was introduced in the 19th century to reduce the risk of aspiration 
pneumonia while under general anesthesia. During the last decades, the value of pre-
operative fasting has been questioned and more liberal guidelines have been proposed, 
such as the use of preoperative carbohydrate-rich drinks. Here we review both old and 
new evidence supporting the view that slightly longer periods than overnight fasting 
are beneficial for an entirely different purpose: protection against certain types of stress, 
such as ischemia-reperfusion injury. We provide a framework to explain these benefits 
as well as future applications and alternatives to induce the protection afforded by 
nutritional interventions.
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inTRoDuCTion
Perioperative nutrition is a recurrent issue in experimental as well as clinical research 
related to the safety of anesthesia on the one hand, and the metabolic response to 
surgical trauma on the other hand. Hiram Studley (1936) was the first to report a nega-
tive correlation between (excessive) preoperative weight loss and surgical outcome 
following major abdominal or thoracic surgery1. Although it is difficult to draw firm 
conclusions from this study, since there was no control group that failed to lose weight 
or actually gained weight prior to surgery, in the clinical setting malnutrition has been 
proved to indeed be a risk factor for surgical complications2-4.
The appreciation that a large portion of hospitalized patients suffers from under-
nutrition has further fuelled the attention for pre- and postoperative feeding. Pre- and 
postoperative nutritional support may not only reduce the complications of surgery, as 
shown in a randomized clinical trial by Beattie et al.5, but may also speed up postopera-
tive recovery6-8.
As early as in 1858 John Snow wrote that the best time for an operation is before 
breakfast (thus after a night of fasting) arguing that “the possibility of vomiting consti-
tutes an unpleasantness and inconvenience which is desirable to avoid”9. Anesthesia 
relaxes the gag reflex, and increases the chance for either pulmonary aspiration or 
aspiration pneumonia. To reduce the risk of pulmonary aspiration, patients in the end 
18th and early 19th century were mainly allowed only a cup of tea up to a few hours 
before surgery9. With little evidence to prove its usefulness, this practice has evolved to 
become the accepted “nil by mouth from midnight” regimen, which has been widely 
used in the 20th century. During the last decades, the value of preoperative fasting has 
been questioned, and it was recently shown that the intake of clear fluids up to two 
hours before surgery did not increase the gastric residual volume or risk of aspiration as 
compared to overnight fasting10. Nowadays, a six hour fast from solid foods and a two 
hour fast from clear liquids prior to surgery is accepted as safe for healthy individuals11.
Along with the increasing understanding that patients require an optimal nutritional 
status before surgery, it was shown that surgery induces resistance to the actions of 
insulin, which may be ameliorated by the preoperative administration of carbohydrates. 
Randomized studies, where glucose was administered either as an infusion or as a 
carbohydrate-rich drink taken two to three hours before surgery, were found to reduce 
the postoperative insulin resistance and increase the patients subjective well-being 
before and after surgery12-17.
Although the literature is replete with studies showing the adverse effects of the 
fasted state for surgical patients18-20, there are a number of older studies as well as 
emerging new data in the field indicating that different types of DR (dietary restric-
tion, defined as reduced food intake without malnutrition) in well-nourished patients 
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may in fact be beneficial as a way of protecting against acute organ stress. DR can 
be performed by means of different regimens such as CR (calorie restriction, reduced 
daily calorie intake), fasting (no food intake) and ADF (alternate day fasting), which 
are associated in experimental literature with lifespan extension and increased stress 
resistance in a wide range of organisms21-24. In this review we provide an overview of 
the studies lending support to the beneficial effects of DR in the context of increased 
resistance to surgical stress in the liver. More generally we will provide a perspective 
that attempts to explain how various types of dietary restriction, including CR, fasting 
and ADF, upregulate endogenous cell resistance mechanisms and how these benefits 
may be further explored in liver transplantation and surgery.
fAsTinG PRoTECTs AGAinsT hEPATiC isChEMiA-REPERfusion injuRy
Ischemia-reperfusion injury is unavoidable during liver transplantation and is com-
monly induced during liver resections when vascular occlusion techniques, such as 
the Pringle maneuver, are used. The effects of fasting on ischemia-reperfusion injury 
were investigated in the nineties, since it was suggested that donor nutritional status 
may affect the outcome after liver transplantation and that starvation of donors, due to 
prolonged stay in the intensive care unit, may adversely affect the transplanted liver25.
Aiming to investigate the effects of duration of donor fasting on the outcome after 
orthotopic liver transplantation (OLT) in a rat model, Sumimoto et al.26 found to their 
surprise that livers from fasted donors were more viable than livers from fed donors. 
After 45 minutes of warm ischemia 50% of the recipients survived when the liver was 
obtained from a fed donor, whereas 80% survived when the liver was obtained from 
a three-day-fasted donor. Increasing the warm ischemia time to 60 minutes resulted in 
100% mortality in the fed donor group. In contrast, if the donor was fasted for three 
days, 89% of the transplanted animals survived for seven days. Livers that were cold-
stored for 30 hours were 50% viable, and fasting for one to three days did not affect this 
outcome. However, if the donor was fasted for four days, 100% survival was obtained. 
After 44 hours cold preservation, only 29% of the recipients survived for seven days. If 
the donor was fasted for four days, survival increased to 83%. In addition, liver func-
tion, bile production, and serum transaminases were better in livers from the fasted 
donors than from the surviving fed rats.
The glycogen content of the liver has been studied as a possible factor determin-
ing the outcome after OLT. As glycogen provides energy to maintain cellular function, 
glycogen was expected to reduce ischemic preservation injury. The results of these 
experiments are somewhat paradoxical, since both fasting (glycogen depletion), but 
also feeding plus oral glucose supplementation (glycogen restoration) are beneficial 
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for the survival after transplantation of cold stored liver grafts. Glucose supplementa-
tion in rats, prior to harvesting the liver, could result in newly synthesized glycogen, 
which could lead to reduced hepatocellular damage27. Since this study also found that 
fasting, and fasting plus oral glucose supplementation had similar beneficial effects, 
an alternative explanation is that glucose supplemented rats obtain their calories from 
glucose and consume less chow, and thus are restricted in calorie intake from food. 
However, Sumimoto et al.28 reported that, in a rat model, four days of donor fasting 
resulted in the highest survival rate of the recipient, while the fasted group with glucose 
supplementation had high glycogen levels, but the worst survival rates.
Cold storage induces microvascular injury to the sinusoidal lining cells and this 
relates directly to graft viability. Six hours after transplantation the livers from fed 
rats showed significantly more apoptosis of the sinusoidal lining cells compared to 
the livers from the fasted group and electron micrographs showed sinusoidal spaces 
filled with more cell debris as well as inflammatory cells and Kupffer cells in the fed 
group29. The decrease of apoptotic sinusoidal lining cells observed after fasting may be 
related to the protection of the liver graft from reperfusion injury afforded by fasting, 
and partially explain the survival benefit of fasted livers.
In 1995, Sankary et al.30 showed that recipient survival after OLT in a rat model after 
twelve hours of cold ischemia was significantly higher using donors that were fasted 
for 48 hours compared to ad libitum fed donors. In addition, they showed that fasting 
was associated with significantly lower tumor necrosis factor alpha serum levels after 
transplantation, which suggested a lower Kupffer cell activation.
When cells are exposed to stress, the expression of heat shock proteins (HSP’s) is 
transcriptionally upregulated31. HSP’s are cytoprotective molecular chaperones that 
aid in protein folding, refolding and degradation. In 1998, Takahashi et al.32 showed 
that HSP-60 and HSP-70 were upregulated in livers from fasted rats after 72 hours of 
cold storage. These fasted livers were significantly more viable than normal fed livers 
after cold storage. Recent data suggest that HSP-70 is hepato-protective during hepatic 
ischemia-reperfusion injury, which suggests that upregulation of HSP’s is (partially) 
responsible for the protective effect of fasting33.
Using a similar model as above, Uchida et al.34, showed in 2000 that four days of 
fasting significantly increased the levels of hemoxygenase in the liver after 24 hours 
of cold storage. As hemeoxygenase-1 is an inducible stress protein which confers 
cytoprotection against oxidative stress in vitro and in vivo, and upregulation of heme-
oxygenase-1 has been shown to confer protection against hepatic cold preservation 
injury, it is likely also involved in the protective effect of fasting35. In contrast, fasting 
for 36 hours in male rats reduced the levels of catalase and copper, zinc-superoxide 
dismutase (anti oxidant enzymes) while the activity of glutathione peroxidase remained 
the same36 (Table 1).
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The effect of donor fasting was also studied in a large animal model. Donor pigs 
were divided into three groups: group one was fasted for seven days and received 
intravenous administration of saline; group two was fed ad libitum, and group three 
Table 1: Studies reporting beneficial effects of donor fasting prior to orthotopic liver transplantation.
First 
author
Year Animal Model Intervention Outcome compared to ad libitum 
fed control group
Sumi-
moto, R
1993 Rat, 
Brown 
Norway
OLT1:
-  warm 
ischemia 
(45/60 min1)
-  cold ischemia 
(30/44 hours)
24, 48, 72, and 96 
hours water only 
fasting
-  Fasting induced higher recipient 
survival rates after cold and 
warm ischemia and lower ALT1 
and AST1 serum levels
Sun, X 2001 Rat, 
Wistar
OLT:
-  cold ischemia 
(24 hours)
96 hours water only 
fasting
-  Fasting induced higher 14 days 
survival rates in the recipient 
(0% vs. 90%)
-  Fasting reduced the number of 
apoptotic SLC1 compared to the 
ad libitum fed donors
-  Fasting reduced the LDH1 
serum levels six hours after 
transplantation
Sankary, H 1995 Rat, 
Lewis
OLT:
-  cold ischemia 
(8, 12 hours)
48 hours water only 
fasting
-  Fasting resulted in significantly 
higher recipient survival rates 
after 12 hours ischemia (0% vs. 
83%)
-  Fasting resulted in a significant 
decrease of peripheral blood 
TNF1- α levels after reperfusion
Takahashi, 
Y
1998 Rat, 
Brown 
Norway
OLT:
-  cold ischemia 
(48, 60, 72, 
96 hours)
24, 48, 72, and 96 
hours water only 
fasting
-  96 h fasting resulted in 
significantly higher recipient 
survival rates after 48 and 72 
hours ischemia.
-  HSP1-60 and HSP-70 showed an 
increased expression after four 
days of fasting
Uchida, Y 2000 Rat, 
Lewis
OLT:
-  cold ischemia 
(24 hours
48 hours water only 
fasting
-  Fasting induced higher 7 days 
survival rates in the recipient 
(0% vs. 87.5%)
-  Fasting induced expression of 
HO1-1 in Kupffer cells
-  Tissue GSH content was less 
reduced in livers from fasted 
donors
Sumi-
moto, R
1996 Rat, 
Brown 
Norway
OLT:
-  cold ischemia 
(30-44 hours)
96 hours water only 
fasting: with and 
without oral glucose 
water suppletion
-  Fasting induced higher 
recipient survival rates after 
cold ischemia, while glucose 
suppletion lowered survival
1 Orthotopic liver transplantation (OLT), minutes (min), Aspartate amino transferase (AST), Alanine amino 
transferase (ALT), Sinusoidal lining cells (SLC), Lactate dehydrogenase (LDH), Tumor necrosis factor (TNF), 
Heat shock protein (HSP), Heme-oxygenase (HO)
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was fasted for seven days, but given 20% glucose intravenously. The mean survival time 
after OLT in the last group (group three) was 37.2 days, significantly longer than 5.8 
+/- 0.7, and 9.8 +/- 2.0 days in groups one and two, respectively37. In another study 
five days of fasting resulted in deteriorated adenosine triphosphate synthesis and less 
sinusoidal lining cell viability when compared to one day of fasting. The survival in the 
one day fasted group was 75% (1/4, death due to technical error) in contrast to 25% in 
the five day fasted group38. Both studies indicate that extended periods of fasting in pigs 
do not protect against ischemia-reperfusion injury in an OLT model.
Several studies used isolated perfusion models of the liver to examine the effect of 
nutritional interventions on ischemia-reperfusion injury after cold and/or warm storage. 
Results of these studies differ from those of the orthotopic transplant models. Using 
isolated liver perfusion, fasted livers release more transaminases in the perfusate than 
livers of fed animals39-42. These studies suggest that isolated liver perfusion is not a 
suitable model to reveal the beneficial effects of fasting observed in in-vivo studies.
The previous results were obtained using animals with healthy livers. Fatty livers are 
known to be more sensitive to the deleterious effects of ischemia-reperfusion injury, 
and livers with more than 60% steatosis are currently regarded as unsuitable for trans-
plantation43. Since the incidence of obesity and the concomitant incidence of steatosis 
is rapidly increasing44,45 this leads to the loss of potential donors. In 1999 Caraceni et 
al.46 used fed and fasted rats with normal or fatty livers, induced by a choline deficient 
diet, who underwent one hour of warm hepatic ischemia followed by reperfusion. 
Whereas survival was similar in fasted and fed rats with normal livers (90% vs. 100%), 
18 hours of water only fasting dramatically reduced the survival in rats with fatty livers 
(14% vs. 64%). The duration of the fasting period could be a determining factor.
In rats with steatosis, induced by feeding a choline deficient diet for 28 days, two 
or four days of fasting had no effect on the severity of steatosis, but afforded a time 
dependent increase in the protection against warm and cold preservation injury and 
ischemia-reperfusion injury47.
In summary, fasting for one to four days protects livers from cold preservation injury 
and results in higher survival rates after OLT in animal studies. Proposed mechanisms 
include an upregulation of cytoprotective molecules such as HSP’s and heme oxy-
genase-1. The depletion or augmentation of donor glycogen stores did not affect the 
outcome. The beneficial effects of preoperative fasting were not found when isolated 
liver perfusion models were used.
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A fRAMEwoRk To unDERsTAnD ThE BEnEfiCiAl EffECT of fAsTinG
Why did the former studies, showing beneficial effects of fasting, with their enormous 
potential to influence preoperative nutritional care, have so little measurable impact 
in the past decade and a half since they were first published? First, these studies were 
published at a time when a shift in preoperative nutritional care was underway, namely 
replacing strict preoperative overnight fasting guidelines with more liberal ones, and 
later with liquid carbohydrate-rich beverages specifically to avoid the catabolic state 
associated with fasting and to improve subjective perioperative well-being12-17. Second, 
a number of prior and subsequent studies demonstrated detrimental effects of fast-
ing and/or malnutrition in various different experimental systems (e.g. isolated liver 
perfusion), leaving the overall picture cloudy and controversial14,48,49. Finally, these 
studies lacked a mechanistic framework in which to understand the results and make 
predictions on what would and wouldn’t work and why, which is essential in order to 
have an impact on clinical practice. In this section we aim to provide a framework to 
understand these results.
The effects of long-term DR regimens have been widely studied and provide mecha-
nistic insights with which the effect of DR on acute stress resistance may be explained. 
DR is the most robust, non-invasive intervention that increases lifespan and reduces 
the rate of aging50. This life-extending action has been found to occur in both genders 
of many different rat and mouse strains, as well as in hamsters and non-mammalian 
species such as fish, flies, and water fleas50-55. Long-term DR lowers steady-state levels 
of oxidative stress, decreases mitochondrial electron and proton leak in mammalian 
cells, attenuates damage resulting from intracellular oxidative stress23,56-58, reduces the 
susceptibility to chronic diseases, and retards age-associated functional decline22,59. 
DR also augments antioxidant defence systems, and increases stress resistance to both 
oxidative and non-oxidative challenges in models of extended longevity. Hormesis is a 
common biological phenomenon in which exposure to a low intensity stressor induces 
a general adaptive response that has net beneficial effects on the cellular and/or organ-
ismal level, including protection against subsequent, higher dose exposures as well 
as to different types of stress60-62. DR has been proposed to act as a mild stressor that 
extends longevity through hormetic mechanisms63,64. Interestingly, ischemic precondi-
tioning, a procedure used to protect against ischemic insult that entails brief period(s) 
of ischemia prior to a longer ischemia time, is also thought to function via hormesis65.
DR may be performed by various regimens, namely: calorie restriction, fasting and 
alternate day fasting. CR (calorie restriction) refers to an intervention in which the total 
daily calories provided to an animal or organism is limited to a certain percentage of 
the animals’ normal daily intake. ADF (alternate day fasting) regimens involve a “feast 
day” on which food is consumed ad libitum that alternates with a “fast day” on which 
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food is withheld. A key difference in the ADF approach is that overall calorie intake 
needs not to be limited. The alternating days of fasting are sufficient to act as a low dose 
stressor inducing a hormetic response66, which can also extend lifespan and protect 
multiple organ systems against diseases in rodents67,68. All regimens can be applied for 
longer (lifetime–years) or shorter (months-days) time periods (Figure 1). Although long-
term regimens induce many beneficial effects, four weeks of CR is able to induce many 
of the genomic expression changes seen after long-term CR. Short-term CR induced all 
of the changes seen after long-term CR on xenobiotic metabolism and stress response/
chaperone protein gene expression. It also reproduced 67% of the effects of long-term 
CR on inflammatory response gene expression. These results suggest that the effects 
seen after long-term CR are induced rapidly, and that short- and long-term CR may act 
via a common protective mechanism69.
Although the mechanisms responsible for the upregulation of defence systems dur-
ing both long-term and short-term DR are not well understood, we are now able to 
see a mechanistic framework to explain the early studies on nutritional interventions 
in liver donors. The data and insights discussed below reveal new areas of applications 
that may therapeutically benefit from the changes triggered by the low-grade stress 
induced by DR as predicted by the hormesis hypothesis.
DIETARY RESTRICTION 
With reduction in energy intake 
Long-term 
calorie 
restriction 
Short-term 
calorie 
restriction 
Several 
days 
fasting 
Increased stress resistance  
Without reduction in energy intake 
Alternate 
day  
fasting 
figure 1: Overview of various forms of dietary restriction which are capable of inducing increased stress 
resistance. Calorie restriction refers to an intervention in which the total daily calories provided to an 
animal or organism is limited to a certain percentage of the animals ad libitum daily intake. Alternate 
day fasting regimens involve a “feast day” on which food is consumed ad libitum that alternates with a 
“fast day” on which food is withheld.
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PRoTECTion By shoRT-TERM DiETARy REsTRiCTion ExTEnDs To oThER 
oRGAns, AnD is noT liMiTED To isChEMiA-REPERfusion injuRy
Studies have been reported in which DR is used in the context of enhanced stress 
resistance to prevent or reduce injury in clinically relevant situations, such as ischemia-
reperfusion injury. As described below, different organ systems such as brain, heart, 
liver, and retina were shown to enjoy protection by various forms of clinically ap-
plicable DR regimens.
Broad protection against ischemia-reperfusion injury
DR has recently been shown to facilitate the functional recovery of ischemically dam-
aged neurons in the brain. The performance of DR rats in spatial tasks after an ischemic 
insult, such as the radial arm maze, was significantly better than that of ad libitum 
fed rats70. Furthermore, DR prior to cerebral ischemia-reperfusion resulted in a highly 
significant decrease in infarct volume when compared with the ad libitum fed group. 
Immunoblot analysis showed that levels of HSP-70 were greatly increased in neuronal 
tissue of DR mice compared with ad libitum fed controls71. In the heart, DR attenuated 
the postischemic inflammatory response of rats subjected to fifteen minutes of partial 
cardiac ischemia-reperfusion injury compared to ad libitum fed animals. This was 
shown by a reduced activation of nuclear factor kappa beta and faster return to baseline 
of antioxidant enzymes72. Similar benefits were found in the retina of rats subjected to 
DR. DR was neuroprotective in the retina following ischemia, and this was associated 
with increased levels of HSP-7073.
Unfortunately, the onset of heart attack and cerebral ischemia is unpredictable, and 
thus not readily amenable to planned nutritional interventions. However, Plunet et 
al.74 showed that DR may also be effective when applied after the injury. After surgical 
induction of cervical spinal cord injury, rats that were on DR showed a 50% reduction 
in lesion volume and improved regeneration and behavioral recovery.
DR protects the liver against various toxic insults
DR for three weeks protects rats against a lethal dose of the hepatotoxic compound TA 
(thioacetamide). DR rats showed 70% survival compared with 10% in ad libitum fed 
rats. Paradoxically, DR and ad libitum fed animals showed similar hepatocellular injury, 
and the survival benefit was due to stimulation of tissue repair in the DR group resulting 
in arrest of progressive injury and enhanced regeneration75. Expression of hepatocyte 
growth factor was consistently higher in the livers of DR rats after the administration 
of TA. Epidermal growth factor receptor expression was higher in DR rats before TA 
administration and remained higher until 48 hours after TA intoxication. DR induced a 
2-fold increase in hepatic inducible nitric oxide synthase activity, which is consistent 
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with early cell division in DR rats after TA challenge. These data suggest that the aug-
mented liver tissue repair after TA-induced hepatotoxicity in DR rats is due to faster and 
higher expression of growth stimulatory cytokines and growth factors75. Protection from 
acetaminophen hepatotoxicity has been found in mice that had been exposed to DR for 
eight months, as shown by negligible increases of serum alanine amino transferase and 
lactate dehydrogenase in the DR group and high levels of alanine amino transferase 
and lactate dehydrogenase in the ad libitum controls76.
DisCussion AnD fuTuRE PERsPECTivEs
Although animal studies suggest potential uses for DR in the clinic, there are several 
drawbacks that need attention. Randomized clinical trials have shown that preoperative 
carbohydrate-rich drinks contribute to better insulin sensitivity and increased patient 
well-being. However, clinical studies on the effects of preoperative DR are currently 
lacking. Recently, a study was published in which human subjects adhered to a DR diet 
for three months, which led to a significant increase in verbal memory scores compared 
to the ad libitum group77. In addition, the CALERIE trial reports a reduced risk for car-
diovascular events in healthy non-obese individuals78, and improved insulin sensitivity 
in non-obese humans adhering to a DR diet79. Furthermore, overweight patients with 
asthma subjected to DR revealed improved well-being and reduced levels of circulat-
ing tumor necrosis factor alpha, brain-derived neurotrophic factor, and ceramides80. 
These studies indicate that DR in humans is feasible and capable to exert beneficial 
effects. However, more clinical studies are needed to develop DR regimens (length, 
reduction, and timing) for different pathological conditions.
Secondly, animal studies have shown that DR protects organs against various forms 
of stress. It is not known whether surgical patients benefit more from preoperative feed-
ing or from the beneficial effects of DR on an organ specific level. Recently it was 
shown that two days of fasting is able to confer protection against the adverse side 
effects of a high dose of the chemotherapeutic agent etoposide in mice81,82. Etoposide 
displays a generalized toxicity profile ranging from myelosuppression to liver and neu-
rological damage. This suggests that DR acts on an organismal rather than on a single 
organ-specific level.
Thirdly, protein restriction without a reduction in calories has been shown to in-
crease maximum longevity in rats and mice as well83. Although the magnitude of these 
increases is around 30–40% of that of DR, neither carbohydrate84 nor lipid restric-
tion85,86 exerted these effects. Restriction of proteins could therefore be another way 
to induce the effects seen after DR. These data also show that the beneficial effects of 
preoperative carbohydrate-rich drinks and DR may not be mutually exclusive.
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Finally, the use of DR mimetics may be a way to overcome the problems associated 
with DR in surgical patients. A DR mimetic can be loosely defined as any pharmaco-
logical intervention that produces beneficial effects of DR without causing or requiring 
a significant reduction in calorie intake. One compound that has received consider-
able attention as DR mimetic is resveratrol, a naturally-occurring polyphenol found in 
red wine. Resveratrol induces genomic changes which resemble many of the genetic 
alterations induced by DR87 and, at doses that can be readily achieved in humans, 
mimics aspects of DR, including an increased resistance to oxidative stress88,89. In 
addition, resveratrol treatment decreases liver injury induced by ischemia-reperfusion 
injury by significantly increasing glutathione reductase, Cu/Zn-superoxide dismutase, 
and catalase activities90.
ConClusions
Together these results support an emerging view that the increased resistance to stress, 
that is associated with longevity in animals on long-term DR, may be tapped for short-
term benefits. These range from neuroprotection and resistance to the adverse effects 
of chemotherapy, to protection against preservation- and ischemia-reperfusion injury 
in organ allografts, cardiothoracic surgery, and liver resection. Although these data 
are robust and convincing, more research is needed to identify the appropriate diet 
for each condition. The notion that protein restriction, and not DR per se can induce 
similar effects, may offer new avenues to combine preoperative nutrition (carbohydrate 
rich beverages) with restriction of proteins and thereby protect the target organ with-
out compromising patient well-being. Furthermore, new drugs are able to mimic the 
protective effects of DR and must be studied more extensively in relation to ischemia-
reperfusion injury of the liver.
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ABsTRACT
Background: We have shown that brief periods of fasting induce functional changes 
similar to long-term dietary restriction in mice, including protection from ischemia- 
reperfusion (I/R) injury. Here, we investigated the mechanisms of protection induced by 
fasting, and determined its effect on liver regeneration following partial hepatectomy.
Methods: Partial hepatic ischemia (75 minutes) was induced in ad libitum fed and 
one, two and three days fasted mice. In following experiments we performed a 35% 
hepatectomy in ad libitum fed and 3 day fasted mice.
Results: Preoperative fasting for two and three days significantly decreased hepatocel-
lular I/R injury. Hepatic gene expression of heme oxygenase-1 (HO-1), superoxide 
dismutase-2 (SOD2), glutathione peroxidase-1 (Gpx1), and glutathione reductase 
(GSR) was significantly upregulated in three day fasted mice prior to I/R injury and six 
hours hereafter. Furthermore, after reperfusion p-selectin and interleukin-6 (IL-6) were 
significantly down-regulated, and superoxide radical generation and neutrophil influx 
were significantly attenuated in the fasted mice. Preoperative fasting did not affect he-
patocyte proliferation 48 hours and liver weight 5 days following a partial hepatectomy. 
Hepatic gene expression of tumor necrosis factor-alpha (TNF-α), IL-6, and transforming 
growth factor-beta 1 (TGF-β1) were significantly up-regulated in three days fasted mice 
at baseline and following resection.
Conclusions: Upregulation of the stress response gene HO-1 and the mitochondrial an-
tioxidant enzymes SOD2, Gpx1, and GSR at baseline, and a better response following 
reperfusion, likely underlie the protection induced by short-term fasting against hepatic 
I/R injury. Because fasting does not affect liver regeneration after partial hepatectomy, 
it may be a promising new strategy to protect the liver against I/R injury in the clinical 
situation.
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inTRoDuCTion
Temporary occlusion of hepatic in-flow (Pringle maneuver) and hepatic in- and out-
flow (total hepatic vascular occlusion) are routinely used techniques during extended 
liver surgeries such as hepatic resection, and liver transplantation1-2. These prolonged 
interruptions of hepatic blood flow result in ischemia-reperfusion (I/R) injury. Hepatic 
I/R injury is characterized by progressive hepatocellular injury and hepatocyte loss. It is 
considered to be a risk factor for potentially lethal primary-, or delayed non-functioning 
of the liver3-4, as well as a risk factor for distant organ damage such as kidney, heart and 
lung5-6. To reduce the negative consequences of hepatic I/R injury during liver surgery 
and liver transplantation, development of a protective strategy against I/R is warranted.
Dietary restriction (DR), defined as reduced food intake without causing malnutri-
tion, has been reported to extend lifespan in several organisms, including non-human 
primates7. DR is associated not only with extended longevity, but also with prolonged 
health span8-9, and improved resistance against various stressors10-12. We have recently 
shown that the beneficial effects of DR can be induced rapidly. Both three days of 
fasting and one month of 30% DR were able to confer protection against hepatic I/R 
injury13.
Although previous studies have shown similar beneficial effects of fasting against 
hepatic I/R injury in liver transplant models14, the mechanisms responsible for this 
protective effect remained unknown and no connection with DR was made. As these 
results ran against their gut feeling and studies in an isolated rat liver perfusion models 
later opposed these findings15, the issue remained mired in controversy to this day.
In the present study, we aimed to elucidate the mechanisms of protection induced 
by short-term fasting against hepatic I/R injury. Because in the clinic postoperative 
outcome is determined by the severity of I/R injury and the regenerative capacity of 
the liver, we also investigated the effects of short-term fasting on liver regeneration after 
partial hepatectomy. Here, we show that upregulation of the mitochondrial antioxidant 
enzymes SOD2, Gpx1, and GSR and the stress response gene HO-1 likely underlie 
the protection against hepatic I/R injury by fasting, and that short-term fasting does not 
affect liver regeneration.
MATERiAls AnD METhoDs
Animals
C57BL/6 male mice (~25 grams) were obtained from Harlan, Horst, the Netherlands. 
All mice had free access to water and chow (Special Diet Services, Witham, United 
Kingdom), unless mentioned otherwise. The one, two or thee day water-only fasting 
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regimen was applied by transferring mice to clean cages without food at 17:00 hours 
(n = 3-4 animals per cage). No mortality occurs during these fasting regimens. The 
experimental protocol was approved by the Animal Experiments Committee under the 
Dutch National Experiments on Animals Act and complied with the 1986 directive 
86/609/EC of the Council of Europe.
surgical procedures
All operations were performed between 9:00 and 13:00 hours. Mice were anesthetized 
by isoflurane/N2/O2 inhalation, and placed on a heating plate to maintain body tem-
perature. Partial (~70%) hepatic I/R injury was induced by occluding the blood flow 
to the left lateral and median liver lobes with an atraumatic microvascular clamp for 
75 minutes. After clamp removal, restoration of blood flow in the ischemic liver lobes 
was observed. For partial (~35%) hepatectomy (PH) the left liver lobe was resected. 
All mice received 0.5 mL of phosphate buffered saline subcutaneously postoperatively 
after which they were placed under a heating lamp to recover from anesthesia. After 
surgery all animals had free access to food and water.
hepatocellular injury
Mice were anesthetized, and blood was drawn by retro-orbital puncture before surgery 
(baseline; t = 0 hours) and at six and twenty-four hours post-reperfusion. Sera were 
analyzed for alanine aminotransferase (sALAT) at the central clinical chemical labora-
tory of the Erasmus University Medical Center. The percentage of necrosis (0, 0-25, 
25-50, 50-75, 75-100 or 100%) was scored by two independent observers blinded to 
the treatment on 3 µm thick H&E stained liver sections at a magnification of 100x in 
five microscopic fields per section.
immunohistochemistry
Frozen (5 µm) and paraffin embedded (3 µm) liver sections were stained with mono-
clonal antibodies against neutrophils or proliferating cell nuclear antigen (PCNA), and 
visualized based on alkaline phosphatase- and HRP-conjugated secondary antibodies, 
respectively. In five microscopic fields per section the number of neutrophils or PCNA 
positive cells was counted by two independent observers blinded to the treatment at 
magnifications of 200-400x.
superoxide radical production
Superoxide radical production in the liver was measured as described earlier16, using 
10 µM dihydroethidium. At least 300 nuclei per section were counted in 2-3 consecu-
tive sections by an independent observer blinded to the treatment.
12
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
Fasting protects against hepatic ischemia and reperfusion injury 47
liver weight/total body weight ratio
Wet liver weights and total body weights of fed and three day fasted mice were deter-
mined at baseline and five days after PH. This was also measured from three day fasted 
mice who were refed for five days without undergoing any surgery. Liver weight/total 
body weight (LW/TBW) ratio was calculated as follows: wet liver weight divided by 
total body weight.
Quantitative RT-PCR
Total RNA was extracted from frozen liver tissue using Trizol reagent (Invitrogen, Breda, 
the Netherlands), purified by a DNase treatment (RQ1 RNase-Free DNase; Promega 
Benelux B.V., Leiden, the Netherlands), and reverse transcribed to cDNA using random 
hexamer primers, and Superscript II RT (both from Invitrogen, Breda, the Netherlands) 
according to manufactures instructions. Quantitative real-time PCR was performed 
using a MyiQ Single-color Real-Time PCR Detection System with SYBR Green incor-
poration (both from Bio-Rad Laboratories B.V., Veenendaal, the Netherlands). Primer 
sequences are available upon request. Relative expression was calculated using the 
equation 2-(ΔCt sample – ΔCt control). Each sample was tested at least in duplicate.
statistical analysis
Data were expressed as mean ± standard error of the mean (SEM). Differences in groups 
were analyzed by Mann-Whitney U tests using SPSS (version 15). Differences were 
considered significant at P values less than 0.05.
REsulTs
short-term fasting protects against hepatic i/R injury
At baseline there were no significant differences in sALAT levels between the fed 
and fasted mice. However, six hours after reperfusion sALAT levels were significantly 
lower in two (P=0.004) and three (P=0.004) day fasted mice when compared to the 
ad libitum fed mice (Figure 1A). At twenty-four hours post-reperfusion sALAT levels 
remained significantly lower in two (P=0.03) and three (P=0.02) days fasted mice when 
compared to the control group. Twenty-four hours after I/R ijnury histological examina-
tion of livers from preoperative fed mice shows large areas of necrosis (69% ± 6 of the 
examined area). This was significantly lower in two (25% ± 0, P=0.01) and three (28% 
± 6, P=0.001) day fasted mice (Figure 1B).
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short-term fasting reduces the inflammatory response after hepatic i/R
Development of hepatic I/R injury is a biphasic inflammatory process. In the first phase 
reactive oxygen species are generated, while the second phase is characterized by 
the release of pro-inflammatory cytokines such as interleukin-6 (IL-6), the expression 
of adhesion molecules such as p-selectin, and infiltration of neutrophils17. We inves-
tigated the effect of three days of preoperative fasting on the inflammatory response 
after hepatic I/R. Six hours post-reperfusion significantly less superoxide radicals were 
produced in livers from preoperative fasted animals compared to the control group 
(644 ± 41 vs. 1453 ± 235, P=0.02) (Figure 2A). Hepatic mRNA expression levels for 
IL-6 were low and comparable in both groups at baseline (2.7±1.3 vs. 1.1±0.2 in fed 
livers, P=NS). In contrast, p-selectin expression at baseline was significantly higher in 
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figure 1: Hepatocellular injury. (A) Following reperfusion, serum alanine aminotransferases (sALAT) 
concentrations were significantly lower in two and three day preoperative fasted mice (n = 5-8 per group 
per time point). (B) Twenty-four hours post-reperfusion, livers from preoperative fasted mice contained 
significantly less hemorrhagic necrosis (n = 3-11 per group). Data are expressed as the mean±SEM. 
*P<0.05; **P<0.01 vs. preoperative fed mice.
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livers from fasted animals (4.2±1.4 vs. 0.7±0.1 in fed livers, P=0.03). Six hours after I/R 
injury both inflammatory markers were significantly lower in livers from preoperative 
fasted animals (p-selectin P=0.03; IL-6 P=0.02) when compared to the fed group. At 
twenty-four hours post-reperfusion this difference remained significant for p-selectin 
(P=0.03), but not for IL-6 (Figure 2B). Significantly less neutrophils were present in 
livers from preoperative fasted animals (P=0.02) at twenty-four hours post-reperfusion 
(Figure 2C).
fasting up-regulates mitochondrial antioxidant enzymes and the stress response 
gene ho-1
In response to hepatic I/R, heat shock proteins (Hsp), and antioxidants are produced 
which mitigate hepatocellular injury18-19. We investigated the effect of three days of 
fasting on Hsp70 and heme oxygenase-1 (HO-1) gene expression, and on the mito-
chondrial antioxidant enzyme activities of superoxide dismutase 2 (SOD2), glutathione 
peroxidase 1 (Gpx1), glutathione reductase (GSR), and superoxide dismutase 1 (SOD1). 
At baseline, HO-1 expression was eight times higher in livers from fasted mice (8.8±2.2 
vs. 1.1±0.2 in fed mice, P=0.01). Six hours after reperfusion, HO-1 expression signifi-
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figure 2: Inflammatory response. (A) Six hours post-reperfusion significantly less superoxide radical 
production was detected in livers from preoperative fasted mice (n = 4-8 per group per time point). (B) 
Following reperfusion, hepatic mRNA expression levels of p-selectin and interleukin-6 (IL-6) were sig-
nificantly reduced in livers from preoperative fasted mice. Data was normalized for beta-2-microglobulin 
and expressed relative to preoperative fed mice at t = 0h (n = 3-5 per group per time point). (C) Lower 
numbers of neutrophils were detected in livers from preoperative fasted mice post-reperfusion (n = 3-6 
per group per time point). Data are expressed as the mean±SEM. *P<0.05 vs. preoperative fed mice.
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cantly increased in livers from both groups versus their baseline values (preoperative 
fasted: 23.3 fold increase, P=0.01; preoperative fed: 15.0 fold increase, P=0.02), with 
significantly higher levels in livers from preoperative fasted animals when compared 
with preoperative fed animals (203.8±51.9 vs. 16.5±2.1 in fed, P=0.02) (Figure 3A). 
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figure 3: Hepatic gene expression of the stress response genes HO-1, and Hsp70, and the mitochon-
drial antioxidant enzymes SOD2, Gpx1, GSR, and SOD1. (A) Heme oxygenase-1 (HO-1) levels were 
significantly up-regulated at baseline, with a maximum expression six hours post-reperfusion in livers 
from preoperative fasted mice. (B) Heat shock protein 70 (Hsp70) levels peaked six hours post-reperfusion 
in both groups before returning to baseline values. (C) Superoxide dismutase 2 (SOD2) expression was 
significantly up-regulated in livers from preoperative fasted mice at baseline, and peaked to significantly 
higher levels six hours after reperfusion. (D) A significant increase in glutathione peroxidase 1 (Gpx1) 
expression levels was found in preoperative fasted mice at baseline, which remained significantly el-
evated six hours post-reperfusion. (E) At baseline, and six hours post-reperfusion, glutathione reductase 
(GSR) expression was significantly up-regulated in livers from preoperative fasted mice. (F) Six hours after 
reperfusion superoxide dismutase 1 (SOD1) peaked in livers from preoperative fasted mice. Data was 
normalized for beta-2-microglobulin and expressed relative to preoperative fed mice at t = 0h (n = 3-5 per 
group per time point). Data are expressed as the mean±SEM. **P<0.01, *P<0.05 vs. preoperative fed mice.
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Twenty-four hours post-reperfusion HO-1 expression remained elevated in livers from 
preoperative fed mice, while it returned to baseline in preoperative fasted animals. No 
significant difference in Hsp70 expression was found at baseline, or at six hours post-
reperfusion, when Hsp70 expression peaked in both groups before returning to baseline 
values at twenty-four hours post-reperfusion (Figure 3B). In livers from three day fasted 
animals expression levels of SOD2, Gpx1, and GSR were significantly upregulated at 
baseline (SOD2: 2.7±0.2 vs. 1.0±0.1, P=0.01; Gpx1: 1.4±0.1 vs. 1.0±0.0, P=0.03; 
GSR: 3.9±0.8 vs. 1.0±0.1 in fed livers, P=0.01) (Figure 3C-E). In the preoperative fasted 
group, SOD2 expression increased 4.2 times (5.9±1.9 vs. 1.4±0.1 in preoperative 
fed livers, P=0.03), Gpx1 2.5 times (1.5±0.5 vs. 0.6±0.0 in preoperative fed livers, 
P=0.03), GSR 5.0 times (13.4±4.8 vs. 2.7±0.0 in preoperative fed livers, P=0.03), and 
SOD1 3.6 times (4.0±0.6 vs. 1.1±0.2 in preoperative fed livers, P=0.02) at six hours 
post-reperfusion (Figure 3F). Twenty-four hours post-reperfusion SOD2 (4.4±1.5), 
Gpx1 (0.8±0.1), GSR (8.9±3.1), and SOD1 (2.0±0.2) expression levels decreased in 
livers from preoperative fasted animals compared with six hours post-reperfusion. In 
livers from preoperative fed animals no significant changes in expression levels were 
observed as compared with preoperative fed animals at six hours post-reperfusion.
fasting does not affect liver regeneration after partial hepatectomy
An important determinant of postoperative liver function is the capacity of the liver to 
regenerate. To investigate liver regeneration we determined LW/TBW ratios. At baseline, 
liver weight (P=0.05), total body weight (P=0.05) and LW/TBW ratios (P=0.05) were 
significantly lower in three day fasted mice when compared to fed mice (Figure 4A, 4B). 
Preoperative fed mice did not eat much during the first days after PH, while preopera-
tive fasted mice started eating rapidly. In the fed group, liver weight on post-resection 
day five was significantly lower (P=0.03) when compared to their baseline value. In 
contrast, livers from preoperative fasted mice were significantly heavier five days after 
PH when compared to baseline (P=0.03). Liver weight of fasted mice after five days of 
refeeding, without any intervention, was also significantly (P=0.03) higher when com-
pared to baseline (Figure 4C). LW/TBW ratios on post-resection day five of preoperative 
fasted animals were significantly higher than preoperative fed animals (0.06±0.00 vs. 
0.04±0.00, P=0.01) (Figure 4D). However, after correction for the increase in liver 
weight due to the “fasting and refeeding effect” no difference in liver weight, expressed 
as a percentage of the liver without PH, was observed (Figure 4E). We next investigated 
hepatocyte proliferation by PCNA staining (Figure 4F). At baseline, a significant reduc-
tion in the number of PCNA positive cells was found in livers from three day fasted 
animals (0±0 vs. 4±2 in fed animals, P=0.01). In a time course following PH, PCNA 
positive cells peaked at forty-eight hours without a significant difference between both 
groups (35±14 vs. 27±5 in preoperative fed animals).
12
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
52 Chapter 3
fasting differentially affected cytokine and growth factor expression after Ph
Because liver regeneration is initiated by the expression of genes involved in hepatic 
growth and proliferation, such as tumor necrosis factor-alpha (TNF-α)20 and IL-621, 
we investigated the effects of preoperative fasting on these markers using qRT-PCR. 
TNF-α expression was significantly increased in livers from preoperative fasted animals 
at twenty-four hours post-resection (8.6±2.1 vs. 0.4±0.1 at baseline, P=0.03) and 
returned towards baseline values at forty-eight hours post-resection (Figure 5A). TNF-α 
expression in livers from preoperative fed animals remained unaffected. Before PH, 
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figure 4: Liver regeneration. (A) At baseline, liver and total body weight were significantly decreased 
in three day fasted mice (n = 3 per group). (B) Liver weight/total body weight ratio was significantly 
decreased in three day fasted mice at baseline (n = 3 per group). (C) Bodyweight of the mice five days 
after PH, and the control group (Fasted – 5 days refeeding). Livers from preoperative fasted mice with 
and without partial hepatectomy (PH) were significantly heavier on postoperative day five (n = 4-5 per 
group). (D) On post-resection day five, liver weight/total body weight ratios were significantly increased 
in preoperative fasted mice with and without PH (n = 4-5 per group). (E) Relative liver weight on 
postoperative day five was expressed as a percentage of the weight at baseline (ad libitum fed group) 
or as a percentage of the liver weight after three days of fasting and five days of refeeding without 
liver resection (fasted group), to compensate for the increase in liver weight by fasting and refeeding. 
No significant change in relative liver weight was observed between both groups (n = 3-5 per group). 
(F) Hepatocyte proliferation assessed by proliferating cell nuclear antigen (PCNA) staining peaked at 
forty-eight hours in both groups (n = 4-5 per group). Data are expressed as the mean±SEM. *P<0.05 vs. 
preoperative fed mice.
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figure 5: Growth factor kinetics after PH. (A) Hepatic mRNA expression levels of tumor necrosis factor-
alpha (TNF-α) peaked twenty-four hours post-resection in livers from preoperative fasted mice (n = 
4-5 per group per time point). (B) Interleukin-6 (IL-6) levels were already significantly up-regulated at 
baseline and remained so until twenty-four hours after partial hepatectomy (PH). (C) In livers from pre-
operative fasted mice transforming growth factor-beta1 (TGF-β1) expression was up-regulated at base-
line, and peaked at twenty-four hours post-resection. Data was normalized for beta-2-microglobulin 
and expressed relative to preoperative fed mice at t = 0h (n = 4-5 per group per time point). Data are 
expressed as the mean±SEM. *P<0.05; **P <0.01 vs. preoperative fed mice.
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IL-6 expression was significantly up-regulated in livers from preoperative fasted animals 
(4.7±2.0 vs. 1.2±0.4 in fed animals, P=0.04) and remained significantly higher until 
twenty-four hours post-resection. In livers from preoperative fed mice IL-6 expression 
remained unaffected (Figure 5B). TGF-β1 is one of the factors involved in the termina-
tion response of liver regeneration22. Before PH, expression levels were significantly 
up-regulated in fasted livers (1.8±0.4 vs. 1.0±0.1 in fed livers, P=0.02) (Figure 5C). 
After PH, significantly higher expression levels were found in livers from preoperative 
fasted animals (24h: 3.0 times higher, P=0.009; 48h: 2.8 times higher vs. preoperative 
fed animals, P=0.03).
DisCussion
Long-term DR is associated with extended longevity and improved stress resistance in 
multiple experimental models. We recently showed that the beneficial effects of DR 
can be induced rapidly. Short-term DR as well as brief periods of preoperative fasting 
induced many of the transcriptional changes observed after long-term DR, and both 
protected against I/R injury13. The objective of the present study was to elucidate the 
mechanisms of protection induced by fasting. In addition, we investigated the effect of 
preoperative fasting on liver regeneration after partial hepatectomy. Both two- and three 
days of preoperative fasting offered significant protection against hepatic I/R injury. 
Moreover, we showed that the beneficial effects of three days of preoperative fasting 
were likely achieved by higher expression levels of genes encoding for mitochondrial 
matrix residing antioxidant defense enzymes SOD2, Gpx1, and GSR, and the stress 
response gene HO-1 at baseline, and a more expeditious and pronounced response 
post-reperfusion.
Consistent with previous studies23-25, we found that hepatic I/R resulted in increased 
superoxide radical formation, up-regulation of p-selectin and IL-6 mRNA expression 
levels, and increased neutrophil infiltration. Although at baseline these markers were 
slightly elevated in livers from preoperative fasted mice, after I/R injury they were 
significantly lower.
HO-1 overexpression at baseline and after reperfusion is a critical factor in protec-
tion against hepatic I/R injury. Up-regulation of HO-1 expression after hepatic I/R has 
been shown to reduce graft injury in human liver transplant patients26. In addition, 
pharmacologically induced baseline HO-1 overexpression decreased I/R mediated 
hepatocellular injury in several animal models. For example, pretreatment with the 
HO-1 inducer cobalt protoporphyrin reduced hepatocellular injury after reperfusion 
in rat and mouse models27-29. In contrast, inhibition of HO-1 expression in the liver at 
baseline and post-reperfusion, results in higher sALAT levels, more hepatocellular ne-
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crosis and apoptosis, higher neutrophil numbers and an increase in pro-inflammatory 
cytokine synthesis28. Our finding that three days of preoperative fasting induced HO-1 
and strongly increased its expression after reperfusion suggests that HO-1 plays an 
important role in the beneficial effects of preoperative fasting.
Mitochondria are considered a major intracellular source of reactive oxygen species 
generation during hepatic I/R injury30. To minimize oxidative stress, these organelles 
contain a variety of antioxidant enzymes. Overexpression of these enzymes protects 
I/R injury prone organs such as the liver and the heart31-32. We demonstrate that three 
days of preoperative fasting significantly increases the baseline expression of these 
mitochondrial antioxidants SOD2, Gpx1 and GSR, and following I/R injury. These data 
suggest that protection against hepatic I/R injury by short-term fasting is in part medi-
ated by increased resistance against mitochondrial oxidative stress.
Because in the clinic I/R injury occurs in situations when the liver needs to regener-
ate to maintain function, we investigated the effects of short-term preoperative fasting 
on liver regeneration. As hepatic ischemia impairs liver regeneration following partial 
hepatectomy33, we chose to study a partial hepatectomy per se without concomitant 
hepatic ischemia. Although the combination is often encountered in the clinical setting.
In accordance with previous observations34-35 we found a decrease in liver weight 
after three days of fasting. Furthermore, if animals are refed after a period of fasting the 
liver increases in weight to weights more than their normal value36-38. Therefore, it is 
not surprising that livers from preoperative fasted mice gained more weight than that 
those from preoperative fed mice after a PH. However, if we correct the liver weight 
for this “fasting-refeeding effect” the liver weight was similar in preoperative fed and 
fasted animals five days after PH. If we take into account the unaffected PCNA rate 
and the LW/TBW ration, our data suggest that preoperative fasting does not affect liver 
regeneration following hepatectomy. However, we must take into account that our 
model consists of a 30% PH, this induces a relatively minor regenerative response. 
Future experiments will be conducted in a 70% PH model.
In the scarcity of nutrients during the fasting period, cellular signaling shifts towards 
a survival mediated response, and represses proliferation39. We found that three days 
of fasting up-regulates baseline expression of the regeneration termination cytokine 
TGF-β1, and down-regulates the hepatic regeneration cytokine TNF-α. In contrast, 
IL-6 expression was increased in fasted livers at baseline. IL-6 has a role in both liver 
regeneration and inflammation40. Studies have shown that glycogen depletion results 
in hepatic injury41-42. The slight increase in IL-6, and p-selectin expression at baseline 
after three days of fasting, points towards the induction of a low grade inflammatory 
response by fasting. It is possible that this low grade inflammatory response contributes 
to the induction of cytoprotective and antioxidant genes, and preconditions the liver to 
a stronger response following injury.
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Following partial hepatectomy, TNF-α, IL-6, and TGF-β1 showed a stronger and 
more expeditious response in livers of fasted mice. This suggests that to compensate for 
the hepatic injury caused by fasting at baseline, higher TNF-α and IL-6 levels facilitates 
an enhanced regenerative response. This is followed by an increase in TGF-β1 expres-
sion to terminate this enhanced regeneration response. The net result is a proliferative 
response that is similar to that in livers from preoperative fed animals.
In conclusion, this study shows that preoperative fasting ameliorates hepatic I/R 
injury via up-regulation of baseline levels of the mitochondrial antioxidant enzymes 
and the stress response gene HO-1, and a more expeditious and pronounced response 
of these genes following I/R injury. The baseline up-regulation of these genes, as well 
as TNF-α and TGF-β1 suggest that preoperative fasting acts as a low-level stressor, pre-
conditioning the liver for other types of stress such as partial hepatectomy and hepatic 
I/R injury. Because preoperative fasting does not significantly affect liver regeneration in 
our model it could be a promising new non-invasive strategy to protect the liver against 
the detrimental effects of hepatic I/R injury during liver transplantation and major liver 
resection.
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ABsTRACT
Background: Three days of fasting protects mice against lethal renal ischemia-reperfu-
sion (I/R) injury. We hypothesize that the protection imposed by fasting is mediated by 
increased levels of corticosterone, induced by the stress of food deprivation.
Methods: C57BL/6 mice were fasted for one, two or three days after which serum 
corticosterone levels were determined. Mice underwent a bilateral adrenalectomy 
(ADX) or sham procedure and ten days later they were fasted prior to renal I/R injury. 
Furthermore, another group of mice was given a corticosterone receptor antagonist or 
a vehiculum while fasting prior to I/R injury. Bilateral renal I/R injury was induced by 
clamping the artery and vein of the left and right kidney simultaneously for 37 minutes. 
Survival and kidney function were determined.
Results: Fasting significantly increased corticosterone levels. Only 8% of the ADX mice 
which were fasted prior to I/R injury survived, whereas all sham-ADX operated mice 
survived I/R injury after fasting. After ADX and fasting, 70% of the mice subjected to 
sham-I/R succumbed to the surgical procedure. After fasting with concomitant block-
ade of the glucocorticoid receptor all animals survived renal I/R.
Conclusions: Three days of fasting protects against I/R injury and increases serum cor-
ticosterone levels. ADX renders mice incapable of withstanding subsequent abdominal 
surgery. Glucocorticoid receptor blockade does not interfere with the protective effects 
of fasting. Thus, the protection against renal I/R injury induced by preoperative fasting 
is mediated by corticosterone-independent mechanisms.
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inTRoDuCTion
Renal transplantation is considered the treatment of choice for people with end-stage 
renal disease. One of the factors negatively influencing the outcome after kidney trans-
plantation is ischemia-reperfusion (I/R) injury1,2. Delayed graft function is primarily a 
consequence of I/R injury and contributes to the loss of kidney grafts3. We have previ-
ously shown that dietary restriction protects against I/R injury4. Both 3 days of fasting 
and 2 weeks of reduced (30%) caloric intake prior to renal I/R resulted in protection 
against I/R injury in mice. Dietary restriction increased baseline levels of cytoprotective 
and antioxidant genes and resulted in a more expeditious and pronounced response 
of these genes to I/R injury4,5. The mechanism by which dietary restriction induces this 
protection remains elusive.
During short-term stress responses, activation of the hypothalamic-pituitary-adrenal 
axis stimulates the release of glucocorticoids from the adrenal gland. Glucocorticoids 
are one of the main mediators in these stress response pathways6 and are essential in 
limiting and resolving inflammation7. I/R injury induces inflammation, which is re-
sponsible for its detrimental consequences8. Prolonged fasting acts as an acute stressor 
and increases levels of corticosterone in rodents9. We hypothesized that the protec-
tion against I/R injury imposed by fasting is mediated by increased systemic levels of 
corticosterone. We quantified serum corticosterone levels after three days of fasting 
and subjected mice to a bilateral adrenalectomy (ADX) and treatment with the gluco-
corticoid receptor antagonist Mifepristone during fasting. The effect of glucocorticoid 
receptor blockade on the increased expression of cytoprotective and antioxidant genes 
induced by fasting was determined to investigate the relationship between fasting, 
corticosterone, and the expression profile of these genes.
MATERiAls AnD METhoDs
Animals
Male C57BL/6 mice with an average weight of 25 g were purchased from Harlan (Horst, 
The Netherlands). All mice were maintained under standard conditions with a 12 hour 
light/dark cycle and were allowed food and water ad libitum. The experimental pro-
tocol was approved by the Animal Experiments Committee under the Dutch National 
Experiments on Animals Act and complied with the 1986 directive 86/609/EC of the 
Council of Europe.
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fasting protocol
Mice in the fed group were allowed unrestricted access to food. Mice in the fasting 
groups were transferred to a clean cage at 5:00 pm and withheld food for 3 days. All 
animals were given continuous access to water or 0.9% NaCl (discussed next).
Bilateral adrenalectomy
Mice were anaesthetized by isoflurane inhalation (5% isoflurane initially and then 
2% with oxygen for maintenance). Body temperature was maintained by placing the 
animals on heating pads until recovery from anesthesia. A small incision (0.5 cm) was 
made in the left and right flanks after which the adrenal glands were identified. Dia-
thermy coagulation was performed to remove the adrenal glands from the surrounding 
tissue. Wounds were closed in two layers using 5/0 Safil (B.Braun Medical B.V., Oss, 
The Netherlands) sutures. Sham animals underwent the same procedure without re-
moval of the adrenal glands. After surgery, 0.5 mL phosphate-buffered saline (PBS) was 
administered subcutaneously for maintenance of the fluid balance. Postoperatively, all 
animals were given access to 0.9% NaCl to ensure adequate salt balance. The experi-
ments were resumed following a recovery period of 10 days. Corticosterone levels were 
determined as described below to confirm complete removal of the glands.
Bilateral renal i/R injury
All surgical procedures were conducted between 9.00 and 12.00 hours. Mice were 
anaesthetized by isoflurane inhalation (5% isoflurane initially and then 2% isoflurane 
with a 1:1 air:oxygen mixture for maintenance of anaesthesia). Body temperature was 
maintained by placing the animals on heating pads until recovery from anesthesia. Fol-
lowing a midline abdominal incision, the renal artery and vein of both the left and right 
kidney were occluded simultaneously, by using atraumatic microvascular clamps, for 
37 minutes. In a previous study we showed that this ischemic time induces a mortality 
rate of 40%4. After macroscopic confirmation of ischemia (purple color), the incision 
was covered with PBS-soaked gauze and the animal was covered with an aluminum 
foil blanket to maintain body temperature. Following release of the vascular clamp, 
restoration of blood-flow was confirmed by the kidney returning to normal color. The 
abdominal wound was closed in two layers using 5/0 Safil sutures. Directly after clos-
ing the abdomen 0.5 mL of PBS at body temperature was injected subcutaneously for 
maintenance of fluid balance.
Glucocorticoid receptor blockage
Mifepristone is a potent glucocorticoid type II receptor antagonist that also blocks the 
progesterone receptor, albeit to a much lesser extent. Mifepristone (RU-38486, Sigma-
Aldrich, St. Louis, MO) was dissolved in dimethyl sulfoxide (DMSO) (Sigma-Aldrich) 
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to a final concentration of 500 mg/mL. This stock solution was diluted 850- or 85-
fold with PBS before intraperitoneal injection yielding a final DMSO concentration 
of 0.12% or 1.16%, respectively, to minimize the effect of DMSO on I/R injury10. As 
these treatments differ in final DMSO concentration, we used two vehicle solutions 
containing either 0.12% or 1.16% DMSO to correct for this difference.
serum measurements
Blood samples were obtained under anesthesia by retro-orbital venous plexus puncture 
(during the experiments) or heart puncture (at the end of the experiment). Serum urea 
levels were determined using a QuantiChrom assay kit, DIUR-500 (Gentaur, Brussels, 
Belgium). Serum corticosterone was determined using a corticosterone ELISA kit (Sigma 
Aldrich) according to the manufacturer’s protocol. Corticosterone serum levels were 
determined from blood samples obtained between 9:00 and 10:00 am.
influence of fasting and ADx on corticosterone levels
Animals were fed ad libitum or fasted for one, two, or three days (n = 6/group), after 
which they were scarified by exsanguination under anesthesia. Furthermore, blood 
samples were obtained from ADX and sham(ADX)-operated mice (n = 6/group) after a 
3-day fast. Determination of corticosterone levels was performed to confirm complete 
removal of the adrenal glands (Figure 1A).
survival following renal i/R injury after ADx and subsequent fasting
ADX mice (n = 13) or sham (ADX)-operated mice (n = 8) underwent three days of 
fasting and subsequent renal I/R. Animals were observed twice a day for one week to 
monitor survival. In addition, survival was assessed in fasted ADX mice that had been 
subjected to a sham I/R procedure (n = 8) (Figure 1B)
survival following renal i/R injury after mifepristone treatment
To asses the effect of glucocorticoid receptor blockade on renal I/R injury after a three 
day fast several experiments were performed. First, either the vehicle (PBS containing 
0.12% DMSO, n = 6) or mifepristone (10 mg/kg, n = 6) was injected intraperitoneally 
(i.p.) 30 minutes prior to I/R after 3 days of fasting. Next, vehicle (n=6) or mifepristone 
(n=6) were administered once daily at 17.00 during the 3-day fast before renal I/R was 
applied. Finally, either vehicle (PBS containing 1.16% DMSO) (n = 8) or mifepristone 
in a ten times higher dose (100 mg/kg, n = 8) was injected daily i.p. during the 3-day 
fast before renal I/R was applied. To investigate the effects of mifepristone on renal 
I/R without preoperative fasting, vehicle (n = 6) or mifepristone (100 mg/kg, n = 6) 
was administered daily i.p. to ad libitum fed control mice (no ADX) during three days 
preceding I/R injury (Figure 1C). Mifepristone was administered in dosages that have 
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been reported to effectively block all glucocorticoid receptors11,12. Serum corticosterone 
levels increase after administration of mifepristone11 due to feedback inhibition of the 
pituitary gland. Therefore, increased corticosterone levels were used to indirectly assess 
blockade of the glucocorticoid receptors by mifepristone.
I/R
I/R
SHAM I/R
B: Survival after adrenalectomy, fasting and renal I/R injury
ADX group (n = 13)
SHAM ADX group (n = 8)
SHAM I/R group (n = 8)
Recovery 3 day fast
ADX   
SHAM ADX
ADX
D: Effect of mifepristone or vehiculum on fasting induced gene expression patterns
(Fast, n = 6) MP 3x100 mg/vehiculum
3 day fast
PCR * * *
C: Effect of mifepristone or vehiculum and fasting on renal I/R injury
(Fast, n = 6)    MP 1x10 mg or vehiculum
(Fast, n = 6)    MP 3x10 mg or vehiculum
(Fast, n = 8)1   MP 3x100 mg or vehiculum
(Control, n = 6)MP 3x100 mg or vehiculum
3 day fast
I/R
I/R
I/R
I/R
Control
*
* * *
* * *
* * *
SHAM ADX
A: Determination of corticosterone levels after fasting
Control  (n = 6)
1 day fast (n = 6)
2 day fast (n = 6)
3 day fast (n = 6)
3 day fast (n = 6)
3 day fast (n = 6)
Recovery
ADX   
3 day fast
figure 1: (A) Corticosterone levels were determined in control animals and in animals after 1, 2, or 
3 days of fasting. Furthermore, corticosterone levels were determined in animals after ADX or sham-
ADX and subsequent fasting. (B) Animals were subjected to either a bilateral adrenalectomy or a sham 
procedure. After a recovery period of ten days, animals in all groups were fasted for 3 days followed by 
either bilateral renal ischemia and reperfusion injury or a sham procedure. Survival was monitored fol-
lowing this second operation. (C) All animals were subjected to three days of fasting while mifepristone 
or the vehiculum was administered, except for the last group which was fed ad libitum. The asterisk (*) 
indicates administration of mifepristone or the vehiculum. Next, all groups were subjected to renal I/R 
injury and survival was monitored.1 Renal function was measured in this group. MP = Mifepristone. (D) 
During the 3-day fast, either vehicle or mifepristone was injected daily i.p. The effect of mifepristone 
treatment on the expression of anti-oxidant genes in the liver was assessed after the 3-day fast.
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Quantitative real-time PCR
During the 3-day fast, either vehicle (PBS containing 1.16% DMSO, n = 6) or mifepris-
tone 100 mg/kg i.p. (n = 6) was injected daily i.p. (Figure 1D). Since the most robust 
upregulation of cytoprotective and antioxidant genes upon fasting was observed in the 
liver; we investigated the effect of mifepristone treatment on the expression of these 
genes in the liver. Livers were harvested and snap frozen in liquid nitrogen after the 
3-day fast. For gene expression analysis, total RNA was extracted from frozen liver 
tissue using Trizol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufac-
turer’s instructions. To prevent contamination by genomic DNA, the isolated RNA was 
purified by a DNase treatment (RQ1 Rnase-Free Dnase; Promega, Madison, WI, USA). 
Two µg of total RNA was reverse transcribed to cDNA using random hexamer primers 
(Invitrogen), and Superscript II RT (Invitrogen) according to manufacturer’s instruc-
tions. Quantitative real-time PCR was performed using a MyiQ Single-color Real-Time 
PCR Detection System (Bio-Rad Laboratories, Herculus, CA, USA) in combination 
with SYBR Green as DNA probe (Bio-Rad Laboratories). The following primers were 
used: B2m, forward 5‘-TCACTGACCGGCCTGTATGC-3,’ reverse 5‘-GAGGCGGGTG-
GAACTGTGTT-3,’ Hsp32/HO-1, forward 5’-GAAGGCTTTAAGCTGGTGATGG-3,’ 
reverse 5‘-CTTCGGTGCAGCTCCTCAGG-3,’ SOD2, forward 5’-TCTGGCGGGA-
GATGTTACAA-3,’ reverse 5‘-GGGCTCAGGTTTGTCCAGAAAAT-3,’ GSR, forward 
5’-CCGCCTGAACACCATCTAT-3,’ reverse 5’-TTCCCATTGACTTCCACCG-3,’. Relative 
mRNA expressions were calculated using the equation 2−(ΔCt, sample − ΔCt, control). Each sample 
was assayed in duplicate.
statistical analysis
Categorical data are presented as number (percentage) and continuous variables as 
mean ± SEM (normal distribution, assessed visually and by means of Shapiro-Wilks 
test) or median ± interquartile distance (no normal distribution). Means between two 
groups were compared using either the non-parametric Mann-Whitney U test or the 
t-test for parametric data. Survival curves were compared using a log-rank (Mantel-Cox) 
test. P-values of <0.05 were considered significant. All analyses were performed using 
Statistical Package for the Social Sciences 15.0 (SPSS, Chicago, IL).
REsulTs
fasting induces increased levels of corticosterone
Baseline corticosterone levels were 298±40 nmol/L. One, 2, and 3 days of fasting sig-
nificantly increased corticosterone levels compared with baseline to 1135±163 nmol/L 
(p = 0.0022), 1253±234 nmol/L (p = 0.0022), and 1287±167 nmol/L (p = 0.0022), 
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respectively (Figure 2A). ADX in combination with 3 days of fasting led to significantly 
reduced corticosterone values of 2.6±0.3 nmol/L, when compared to the sham(ADX)-
operated group, who had corticosterone levels of 1186±150 nmol/L (p=0.0022) after a 
3-day fasting period (Figure 2B).
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figure 2: (A) Animals were fasted for 0, 1, 2, or 3 days after which the serum corticosterone levels were 
determined. Data are presented as mean±SEM. An asterisk (*) designates a statistically significant dif-
ference between the indicated groups (p = 0.0022 for all comparisons). Ns. = not statistically different. 
(B) ADX-FAST animals underwent an adrenalectomy 10 days prior to fasting and subsequent I/R. Sham 
(ADX)-FAST animals served as a control group. Animals in this group underwent a sham adrenalectomy 
10 days prior to fasting. Data are presented as mean±SEM. An asterisk (*) designates a statistically 
significant difference between the indicated groups (p = 0.0022).
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ADx abolishes the protective effect of fasting on renal i/R injury
Mice recovered rapidly from the ADX as reflected by their return to preoperative weight 
on postoperative day 2. When ADX mice were subjected to a 3-day fast followed by 
renal I/R injury only 8% of the animals survived (Figure 3A). In contrast, survival of 
sham(ADX)-operated mice after fasting and subsequent I/R was 100% (p < 0.0001). 
To determine whether the high mortality rate was due to I/R injury or the absence of 
adrenal glands, the survival of ADX mice subjected to a sham I/R procedure after 3 days 
of fasting was assessed (Figure 3B). The 7-day survival in this group was 30%, similar 
to the ADX mice that had undergone renal I/R (p = 0.501), indicating that mice are not 
able to withstand abdominal surgery after bilateral adrenalectomy.
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figure 3: (A) Survival of adrenalectomized (ADX) mice vs. sham(ADX) mice after a 3-day fast and sub-
sequent renal I/R injury. Survival in the sham-operated group is 100% vs. 8% in the adrenalectomized 
group (p < 0.0001). (B) Survival of adrenalectomized mice after a 3-day fast and subsequent sham I/R 
injury. Survival in the sham-operated group is 30%. This is not statistically different from the survival of 
the ADX group in figure 3A (p = 0.5010).
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Glucocorticoid receptor blockade does not affect the benefits of fasting on renal 
i/R injury
To asses the effect of glucocorticoid receptor blockade on renal I/R injury after and 
during a three day fast several experiments were performed. In the first experiment 
mice received either 10 mg/kg mifepristone or vehicle after 3 days of fasting and 30 
minutes prior to renal I/R injury. In both groups survival was 100%. Subsequently, 
we increased the frequency of mifepristone administration to once daily during the 
3-day fast preceding I/R injury. All animals survived the experiment. When a tenfold 
higher mifepristone dosage (100 mg/kg) was given, again all animals in the control 
and mifepristone groups survived I/R after the 3-day fast. Following the high dose of 
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figure 4: Kidney function after renal I/R injury as indicated by serum urea values. Mifepristone treat-
ment was given once daily (100mg/kg) during the 3-day fast preceding I/R. The control group received 
a vehicle. There were no statistically significant differences between both groups.
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mifepristone, kidney function assessed by serum urea concentrations before and 24 
and 48 hours after I/R, showed no differences between the two groups (Figure 4). To 
rule out that mifepristone or the vehicle interfered with the renal I/R injury model, the 
three day treatment as described above was applied to ad libitum fed control mice (no 
ADX, only I/R injury). The survival of mifepristone and vehicle-treated mice (Figure 5A) 
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figure 5: (A) Survival of mifepristone-treated and vehicle-treated control animals after renal I/R injury.
Mifepristone (100mg/kg) was administered once daily, starting 3 days prior to I/R. Vehicle (PBS containing 
1.16% DMSO) was administered to the control group. There was no significant difference in survival. Survival 
was similar to that observed in control mice without treatment[4] (data not shown).
(B) Corticosterone levels of mifepristone-treated and control animals after a three day fast. Mifepristone (MP) 
(100mg/kg) was administered once daily during the three day fast (n = 4). Vehicle (PBS containing 1.16% 
DMSO) was administered to the control group, during the three day fast (n = 4). After the three day fast 
corticosterone levels were measured and expressed as a percentage of the control group. Corticosterone levels 
were significantly (p=0.0268) higher in the mifepristone treated group, when compared to the control group. 
This indicates blockade of the glucocorticoid receptor.
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figure 6: Hepatic mRNA expression levels of hemoxygenase-1(A), glutathione reductase (B), and su-
peroxide dismutase-2 (C). Mifepristone treatment was given once daily (100mg/kg) during a 3-day fast 
after which the livers were harvested (n=6). The control group (n=6) received a vehicle. There were no 
statistically significant differences in mRNA expression between both groups.
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was similar to the survival of untreated (no mifepristone or vehicle), ad libitum fed 
mice4. To confirm effective glucocorticoid receptor blockade by mifepristone serum 
levels of corticosterone were measured. Corticosterone levels were significantly in-
creased (p<0.05) in mifepristone-treated animals, confirming adequate blockade of the 
glucocorticoid receptors during fasting and subsequent I/R (Figure 5B).
The effect of mifepristone on fasting-induced upregulation of cytoprotective 
genes.
We have previously shown that 3 days of fasting led to significantly higher baseline ex-
pression levels of antioxidant defense genes in the liver4. Here, we determined mRNA 
expression levels of hepatic tissue after 3 days of fasting with or without mifepristone 
treatment (three days, 100mg/kg/day). No significant differences were observed in 
mRNA expression levels of hemoxygenase-1, glutathione reductase, and superoxide 
dismutase, suggesting that corticosterone receptor inhibitor treatment did not interfere 
with the induction of cytoprotective and antioxidant genes by fasting (Figure 6).
DisCussion
Renal ischemia and reperfusion injury (I/R) negatively influences the outcome of kidney 
transplantation. Strategies to reduce I/R injury are important to improve patient survival 
as well as graft function and survival, as I/R is one of the main factors contributing 
to graft loss3. We have recently reported that fasting is able to protect both kidney 
and liver against I/R injury4. Current experiments were designed to investigate whether 
the protection afforded by fasting against I/R injury is mediated by increased levels 
of corticosterone. Fasting led to significantly higher levels of corticosterone when 
compared to ad libitum feeding9. Bilateral ADX was performed to investigate the effect 
of corticosterone on renal I/R injury. After ADX, mice exhibited higher mortality rates 
after I/R compared with control mice. However, survival after laparotomy in ADX mice 
without I/R injury resulted in similar mortality rates. These experiments did not address 
our hypothesis that the protection afforded by fasting is due to increased corticosterone 
levels.
Mifepristone, a glucocorticoid receptor antagonist, blocks the downstream signaling 
of the glucocorticoid receptor. The use of mifepristone therefore enables controlled 
studies on the effects of corticosterone on renal I/R injury without bilateral ADX. Gluco-
corticoid receptor blockade 30 minutes prior to I/R injury did not abolish the protective 
effects of fasting on renal I/R injury. This suggests that either glucocorticoid receptor 
blockade does not interfere with the protective effects of fasting or that fasting induces 
its protection during the three days fast. The latter is supported by elevated levels of cor-
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ticosterone already after one day of fasting. Therefore, mifepristone was administered 
daily during the 3-day fast. However, this regime did not affect the protective effect of 
fasting on renal I/R injury. Finally, a higher dosage of mifepristone was used based on 
previous studies13. Again, this regime did not abolish the protection afforded by fasting 
on renal I/R injury. Survival rates and kidney function were similar in both the treatment 
and the control group. We therefore conclude that fasting-induced protection against 
renal I/R injury is mediated by corticosterone/glucocorticoid receptor-independent 
pathways. This is partially in line with earlier reports indicating that mice subjected 
to social stress13 or high physiological titers of endogenous glucocorticoids14 exhib-
ited exacerbated ischemic injury. In contrast, a study in rats concluded that bilateral 
ADX prevents renal I/R injury15. However, this protection is probably induced by the 
depletion of mineralocorticoid hormones only, as these rats were supplemented with 
dexamethason, a potent exogenous glucocorticoid agonist. Administration of exog-
enous glucocorticoids is known to protect against cerebral16, cardiac17,18, and renal I/R 
injury19. In addition, clinical studies have shown that donor pre-treatment with steroids 
significantly decreased tissue (liver) and serum expression of proinflammatory cyto-
kines20 after I/R injury. A recent prospective randomized study investigated the effects of 
donor pretreatment with methylprednisolone on organ function and outcome after liver 
transplantation. The use of steroids significantly reduced I/R injury and inflammation 
and improved graft function21. We did not administer exogenous glucocorticoids in 
our model because they are already known to improve I/R injury and because our 
hypothesis predicted the involvement of endogenous steroids.
If increased levels of endogenous corticosteroids do not mediate the protective ef-
fects of fasting, the question remains which mechanisms do contribute to the induced 
protection. In previous experiments we have shown that three days of fasting lead to 
significantly higher expression levels of cytoprotective and antioxidant defense genes 
in the kidney and liver4,22. The strongest response to fasting was observed in the liver; 
therefore we investigated the effect of mifepristone treatment on the expression of these 
cytoprotective and anti-oxidant genes in the liver. The present study demonstrated that 
mifepristone treatment did not interfere with the upregulation of antioxidant defense 
systems. It would be interesting to investigate whether exact mimicking of corticoste-
rone induction by fasting, by corticosteroid administration, would be able to increase 
the expression of cytoprotective genes as well. However, as it is difficult, if not impos-
sible, to duplicate the physiological response to fasting, we have not performed these 
additional experiments. Together, these data support a hypothesis that the up-regulated 
expression of these genes was instrumental in the protection afforded by fasting against 
I/R injury, but that these changes are independent of corticosterone. Future experiments 
are warranted to investigate the relation between these fasting induced changes in gene 
expression patterns and I/R injury.
12
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
Preoperative fasting protects against renal ischemia/reperfusion injury 75
In conclusion, our data demonstrate that fasting increases serum corticosterone 
levels. However, the protective effect of fasting on I/R injury is induced independently 
of corticosterone levels and glucocorticoid receptor availability. The upregulation of 
antioxidant genes is independent of the availability of the glucocorticoid receptor. The 
latter may represent an important clue to elucidate the mechanisms by which fasting 
affords protection against I/R injury.
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ABsTRACT
introduction: One of the factors negatively influencing the outcome after kidney trans-
plantation is ischemia-reperfusion (I/R) injury. Preoperative fasting is able to confer pro-
tection against I/R injury. We hypothesized that the protection imposed by preoperative 
fasting is mediated by increased levels of acylated ghrelin.
Methods: Male C57BL/6 mice, 10-12 weeks old, were fasted for one, two or three days 
after which acylated ghrelin levels were determined. Ad libitum fed mice were injected 
with acylated ghrelin or PBS prior to renal I/R injury. Furthermore, mice were fasted 
for three days during which they were injected with a growth hormone secretagogue 
receptor antagonist, to block the effects of ghrelin, or a vehiculum. Bilateral renal I/R 
injury was induced by clamping the artery and vein of the left and right kidney simul-
taneously for 37 minutes. Kidney function was assessed by means of serum urea values 
determined at 24 and 48 hours after reperfusion.
Results: Fasting significantly increased acylated ghrelin serum levels. Ghrelin supple-
tion in ad libitum fed animals or ghrelin receptor blockade in fasted animals did not 
affect renal function after I/R injury.
Conclusion: Our data suggest that the increased levels of acylated ghrelin induced by 
fasting do not mediate its protection against renal I/R injury.
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inTRoDuCTion
Renal transplantation is considered the treatment of choice for people with end-stage 
renal disease. One of the factors negatively influencing the outcome after kidney trans-
plantation is ischemia-reperfusion (I/R) injury1,2. Delayed graft function is primarily a 
consequence of I/R injury and contributes to the loss of kidney graft3. Currently there 
are no therapies to prevent or treat ischemic injury.
Emerging data suggest that the beneficial effects of long-term dietary restriction (de-
fined as a reduction in energy intake without malnutrition) can be tapped for clinically 
relevant benefits such as protection against hepatic (I/R) injury4 and the toxic side effects 
of chemotherapy5. We have previously shown that dietary restriction protects against 
renal I/R injury6. Three days of fasting prior to renal I/R injury protected against I/R injury 
in mice. Preoperative fasting increased baseline levels of cytoprotective and antioxidant 
genes and resulted in a more expeditious and pronounced response of these genes to 
I/R injury6,7. The mechanism by which dietary restriction induces this protection remains 
elusive. The mechanism by which dietary restriction induces this protection remains 
elusive. Although animal studies suggest that dietary restriction protects against I/R in-
jury, translation of these results to the clinical setting poses a challenge. Patients may not 
respond to dietary restriction similarly as healthy animals or humans. Therefore, future 
research should focus on dietary restriction mimetics or agents that may impinge on 
(some) of the protective pathways induced by dietary restriction. To pharmaceutically 
mimic the effects of dietary restriction, its mechanisms need to be elucidated. In this 
study we sought to determine the role of ghrelin in the protection induced by fasting 
against renal I/R injury in mice. Fasting leads to several hormonal changes, among 
which is an increase in serum levels of ghrelin8. The complete structure of ghrelin has 
been identified as an [O-n-octanoyl-Ser 3]-peptide. The n-octanoyl moiety is essential 
for the activity of ghrelin9. Acylated ghrelin, the endogenous ligand for the growth 
hormone secretagogue receptor (GHSR) has recently been implicated in the control of 
food intake and energy balance8. Interestingly, survival rate after gut I/R injury increased 
significantly if ghrelin was administered just prior to reperfusion. In addition, ghrelin 
treatment reduced serum levels of TNF-α and IL-6, and reduced neutrophil infiltration 
in distant organs10. This suggests that acylated ghrelin is capable of reducing the inflam-
matory response to I/R injury. In addition, ghrelin has been shown to reduce ischemia 
related problems after skin flap transfer11 and to protect against renal I/R injury12. We 
hypothesized that the protection against I/R injury imposed by fasting is mediated by 
increased systemic levels of acylated ghrelin. We quantified serum acylated ghrelin 
levels after one, two and three days of fasting. Furthermore, ad libitum fed mice were 
injected with acylated ghrelin prior to renal I/R injury and fasting mice were treated 
with the competitive GHSR antagonist [D-lys-3]-GHRP-613 prior to renal I/R injury.
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METhoDs AnD MATERiAls
Animals
Male C57BL/6 mice with an average weight of 25 grams were purchased from Harlan 
(Horst, The Netherlands). All mice were maintained under standard conditions with a 
12 h light/dark cycle. Mice in the fed group were allowed unrestricted access to food. 
Mice in the fasting groups were transferred to a clean cage at 5:00 pm and withheld 
food for 1, 2, or 3 days. The experimental protocol was approved by the Animal Experi-
ments Committee under the Dutch National Experiments on Animals Act and complied 
with the 1986 directive 86/609/EC of the Council of Europe.
serum measurements
Blood was obtained under anesthesia (isoflurane inhalation,5% isoflurane initially and 
then 2% isoflurane with a 1:1 air:oxygen mixture for maintenance of anaesthesia) by 
retro-orbital venous plexus puncture (during the experiments) or heart puncture (at the 
end of the experiment). Urea levels were determined in the serum of the animals using a 
QuantiChrom assay kit, DIUR-500 (Gentaur, Brussels, Belgium). Acylated ghrelin levels 
were determined in plasma using an acylated ghrelin ELISA kit (BioVendor, Modrice, 
Czech Republic) according to the manufacturer’s protocol. Acylated ghrelin levels were 
determined from plasma samples obtained between 9:00 and 10:00. After cardiac 
puncture, 400 µL of blood was transferred directly into 1 ml EDTA containing tubes 
(MiniCollect, Greiner Bio-one) pre-filled with p-hydroxymercuribenzoic acid, leading 
to a final concentration of 1 mM. Samples were directly centrifuged (3.500 rpm; 10 
min; 4°C) after which 100 µL of the supernatant was transferred to a separate tube 
containing 10 µL 1NHCl. After centrifugation (3,500 rpm; 5 min; 4°C) the supernatant 
was transferred to another vial and stored at -20°C until assayed.
Bilateral renal i/R injury
Renal I/R procedures were conducted between 9.00 and 12.00 hours. Mice were 
anesthetized with isoflurane inhalation (5% isoflurane initially and then 2% isoflurane 
with a 1:1 air:oxygen mixture for maintenance of anaesthesia). Body temperature was 
maintained by placing the animals on heating pads until recovery from anesthesia. 
Following a midline abdominal incision, the renal artery and vein of both the left and 
right kidney were occluded simultaneously, by using atraumatic microvascular clamps, 
for 37 minutes. Previously we showed that this ischemic time induces a mortality 
rate of 40%6. After macroscopic confirmation of ischemia (purple color), the incision 
was covered with PBS-soaked gauze and the animal was covered with an aluminum 
foil blanket to maintain body temperature. Following release of the vascular clamp, 
restoration of blood-flow was confirmed by the kidney returning to normal color. The 
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abdominal wound was closed in two layers using 5/0 Safil sutures. Postoperatively mice 
received a single subcutaneous injection of 0.5 ml of PBS.
influence of fasting on acylated ghrelin levels
Animals were fed ad libitum (n = 10) or fasted for one (n = 6), two (n = 6), or three days 
(n = 14), after which they were killed by exsanguination under anesthesia. Acylated 
ghrelin levels were measured as described above.
influence of ghrelin administration on kidney function after renal i/R injury
Acylated ghrelin (Polypeptide Group, Strasbourg, France) (100 µg/kg, n = 6) or vehicle 
(phosphate buffered saline, 100uL, n = 6) was injected subcutaneously two times a day 
with 12 hour intervals during the 3-days before renal I/R. Renal function was deter-
mined by measuring serum urea levels at 24 and 48 hours after I/R. The acylated ghrelin 
dosage was based on previous studies showing protection against renal I/R injury12.
influence of GhsR blockage on kidney function after renal i/R injury
GHSR antagonist (200nmol/100µL PBS, [D-Lys-3]-GHRP-6, Bachem, Weil am Rhein, 
Germany, n = 6) or vehicle (phosphate buffered saline, 100µL, n = 6) was administered 
intraperitoneally twice daily with a 12 hour interval during the 3-day fast before renal 
I/R. Renal function was determined by measuring serum urea levels 24 and 48 hours 
after I/R. The GHSR antagonist dosage is based on previous studies showing that an-
tagonism of the ghrelin receptor reduces food intake13.
statistical analysis
Continuous variables are presented as means ± SEM (normal distribution, assessed visu-
ally and by means of Shapiro-Wilks test). One-way ANOVA was used to asses whether 
fasting significantly altered acylated ghrelin levels. Two-way ANOVA was used to asses 
if time or treatment significantly influenced renal function after I/R injury. Thereafter, 
means between the intervention groups and the control group were compared using the 
t-test for parametric data. P-values of <0.05 were considered significant. All analyses 
were performed using Statistical Package for the Social Sciences 15.0 (SPSS, Chicago, IL).
REsulTs
influence of fasting on acylated ghrelin levels
To investigate if fasting influences plasma levels of acylated ghrelin, we measured these 
levels after fasting. Baseline acylated ghrelin levels were 95.51±10.80 pg/ml. One, two, 
and three days of fasting significantly increased acylated ghrelin levels compared with 
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ad libitum fed mice (250.6±45.57 pg/ml (p = 0.0013), 207.4±29.78 pg/ml (p = 0.0075), 
and 303.3±43.30 pg/ml (p = 0.0014), respectively) (Figure 1).
influence of ghrelin administration to ad libitum fed mice on renal function 
after i/R injury
We next determined whether administering acylated ghrelin to ad libitum fed mice 
would protect against renal I/R injury. There was no significant difference in serum urea 
levels between groups at 24 hours after reperfusion (Ghrelin vs. PBS; 40.0±1.1 mmol/
ml vs 40.2 ±1.0 mmol/ml, p = ns). In both groups, serum urea values were increased 
48 hours after reperfusion, when compared to 24 hours after reperfusion. Again no 
statistically significant differences were observed between both groups (Ghrelin vs. 
PBS; 157.5 ± 2.4 mmol/ml vs 151.8 ± 2.4 mmol/ml, p = ns) (Figure 2).
influence of GhsR antagonist administration to fasting mice on renal function 
after i/R injury
As shown previously, three days of fasting protects against renal ischemia and reperfu-
sion injury. Serum urea values at 48 hours after reperfusion were significantly lower 
in fasted mice vs. fed mice (57.4±20.0 mmol/ml vs. 157.5±2.4 mmol/ml, p = 0.008).
Next, we determined whether administration of a GHSR antagonist to fasting mice 
would abolish the protective effect of fasting on renal I/R injury. There was no significant 
difference between groups regarding renal function 24 hours after reperfusion (serum 
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figure 1: Effect of fasting on plasma ghrelin levels. Mice were fasted for one, two, or three days. Control 
mice were allowed unrestricted access to food. One, two, and three days of fasting was associated with 
significantly increased acelyted ghrelin levels as compared with ad libitum fed mice. The bars and error 
bars represent mean ± SEM. One-way ANOVA showed a significant difference between the means (p = 
0.0016) A T-test was used to compare the fasted groups with the control group. (**, p < 0.01 compared 
to ad libitum fed control mice. Ad libitum n =10, one day fasting n = 6, two days fasting n = 6, three 
days fasting n = 14.)
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urea levels in GHSR antagonist treated vs. PBS treated controls; 46.6±11.1 mmol/ml 
vs 25.1±7.5 mmol/ml, p = ns). Serum urea levels at 48 hours after reperfusion were 
comparable to those at 24 hours after reperfusion. Again no statistically significant 
differences were observed between both groups (GHSR antagonist vs. PBS; 57.4±20.0 
mmol/ml vs 29.1±8.7 mmol/ml, p = ns) at 48 hours after reperfusion (Figure 3).
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figure 2: Effect of acylated ghrelin treatment on renal I/R injury. Acylated ghrelin was administered 
subcutaneously twice daily during a 3-days period before renal I/R. Control mice were treated with 
PBS at the same time-points. Serum urea levels were determined at 24 and 48 hours after reperfusion. 
Acylated ghrelin administration did not affect serum urea levels when compared with PBS-treated 
administration. The bars and error bars represent mean ± SEM. Statistical comparisons were made using 
a two-way ANOVA. (ns., not significantly different, n = 6 mice/ group.)
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figure 3: Effect of GHSR antagonist on renal I/R injury. GHSR antagonist was administered intraperi-
toneally twice daily during 3-days before renal I/R. Control mice were treated with PBS at the same 
time-points. Serum urea levels were determined at 24 and 48 hours after reperfusion. GHSR antagonist 
treatment did not affect serum urea levels compared with PBS-treated control mice. The bars and error 
bars represent mean ± SEM. Statistical comparisons were made using a two-way ANOVA. (ns., not 
significantly different, n = 6 mice/ group.)
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DisCussion
Renal ischemia and reperfusion injury (I/R) negatively influences the outcome of kidney 
transplantation. Strategies to reduce I/R injury are important to improve patient survival 
as well as graft outcome, as I/R is one of the main factors contributing to graft loss3. 
Recently we observed that preoperative fasting induces protection against both renal 
and hepatic I/R injury6. In the present study we hypothesized that the protection af-
forded by fasting is mediated by increased levels of acylated ghrelin.
We found that fasting leads to significantly increased serum levels of acylated ghre-
lin, which is in accordance with the literature14. These levels were increased from day 
one, and remained elevated during the three day fast. To mimic increased acylated 
ghrelin levels during fasting, we administered acylated ghrelin twice daily during three 
preoperative days in ad libitum fed mice. However, no effect on renal function after I/R 
injury was detected. It has been shown previously by Takeda et al., that treatment with 
acylated ghrelin improves renal function after I/R injury12. We administered acylated 
ghrelin before the induction of renal I/R, whereas Takeda et al. gave ghrelin both before 
and after I/R, which may explain the observed difference in efficacy.
Acylated ghrelin is the endogenous ligand for the growthhormone secretagogue 
receptor (GHSR)8. A GHSR antagonist [D-lys-3]-GHRP-613 was used to block the recep-
tor mediated effects of elevated ghrelin levels during fasting. Despite using a dosing 
protocol shown to be effective in suppressing the biological activity of ghrelin, no 
difference in postoperative renal function was observed between treated and control 
animals. Furthermore, the protective effect of fasting on kidney function after I/R injury 
was not affected by GHSR antagonist administration.
Limitations of our study are that, we do not know whether our acylated ghrelin 
suppletion schedule exactly mimics the effect of fasting on acylated ghrelin levels. 
Although the dosage we used is based on existing literature, we did not determine 
whether the GHSR antagonist blocked the ghrelin receptor adequately. Furthermore, 
we show that there is no effect on renal function by means of serum urea values, but 
this does not exclude the possibility that other parameters of renal damage, such as 
histology, indicate differences between the groups. However, in previous studies6 we 
found that there is a strong correlation between urea values, histological damage, and 
mortality due to ischemia induced acute kidney injury. Although we cannot exclude 
a protective effect of ghrelin administration on renal I/R injury, our data suggest that 
the increased levels of acylated ghrelin induced by fasting do not mediate protection 
against renal I/R injury. We therefore reject the hypothesis that the protection against 
renal I/R injury afforded by fasting is induced by increased levels of acylated ghrelin.
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ABsTRACT
Background: Inflammatory responses facilitate metastasis by increasing expression of 
adhesion molecules. Dietary restriction (30% reduction in daily calorie intake) reduces 
the expression of adhesion molecules and protects against surgically induced inflam-
mation. DR might therefore beneficially interfere with surgery induced inflammation 
and subsequent adhesion of circulating tumorcells.
Methods: BALB/c mice were subjected to two weeks dietary restriction prior to inocula-
tion with tumor cells. Intrasplenic injection of 5.0x104 c26-colon carcinoma cells was 
followed by splenectomy. Hepatic tumor load was scored after ten days as a percentage 
(tumor surface/total liver surface) on H&E stained sections. Liver mRNA expression of 
adhesion molecules was determined and the effect of serum from dietary restriction 
mice on in vitro tumor growth and adhesion capacity was assessed.
Results: Preoperative dietary restriction significantly reduced mRNA expression levels 
of E-selectin (p=0.0087) and hepatic tumor load(p=0.036). Dietary restriction serum 
did not affect in vitro cell growth, but reduced in vitro adhesion of c26 cells to endo-
thelial cells (p=0.0043).
Conclusions: Preoperative dietary restriction reduces hepatic tumor load after injection 
with tumorcells. Reduced adhesion to endothelial cells and reduced mRNA expression 
of E-selectin suggest that dietary restriction reduces tumor load by lowering the adhe-
sion of circulating tumor cells to hepatic vascular endothelium.
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inTRoDuCTion
Colorectal cancer is the third most common cancer worldwide, with a cumulative life-
time risk of approximately 5% in the United States. Each year approximately 150.000 
patients present with colorectal cancer and over 55.000 deaths are attributed to this 
disease1. In addition, in Europe almost 200.000 new cases of colorectal cancer oc-
cur every year2 and this incidence is estimated to increase with 45% in the next two 
decades3. Surgical resection of the primary tumor remains the treatment of choice. 
Unfortunately, 30% to 50% of all patients undergoing curative resections subsequently 
develop either a local recurrence or distant metastases, predominantly in the liver, 
resulting in increased mortality4. Most recurrences are observed within two years 
after an operation. It is hypothesized that viable circulating tumor cells (CTC) play an 
important role in the pathogenesis of distant metastases. CTC were first detected in 
colorectal cancer patients more than 50 years ago5 and are mainly detected in portal 
blood6. Recently, a meta-analysis showed a significantly increased hepatic metastases 
rate of 21% in CTC positive patients compared with 8% in negative patients which 
emphasizes the influence of CTC on hepatic metastasis formation7. Surgery increases 
the number of CTC due to tumor handling. In addition it enhances the metastatic 
potential of pre-existing or intra-operatively spilled CTC due to several factors. First, 
surgery inevitably leads to tissue trauma which evokes an inflammatory reaction with 
elevated levels of local and systemic proinflammatory cytokines. These cytokines sub-
sequently result in the up-regulation of adhesion molecules, such as E-selectin, on liver 
endothelial cells, which may promote metastases outgrowth by facilitating tumor cell 
adhesion. Secondly, the induction of a pronounced immunosuppressive period after 
major surgery may impair the innate effector cell function of Kupffer cells and natural 
killer cells. These cells have an important role in eradication of tumor cells retained 
in the liver vasculature. Impairment of their activity may result in an increased risk of 
hepatic metastases development8-10.
Several interventions have demonstrated their beneficial effects on perioperative 
tumor metastasis i.e. the “no touch technique”11,12, the use of immunosuppressive drugs 
to blunt the proinflammatory cytokine response13, and blockade of alpha2 integrins 
on tumor cells to reduce adhesion on endothelial cells8. The perioperative period may 
provide a window of opportunity in which the adhesion and outgrowth of circulating 
tumor cells in the liver can be reduced, leading to less metastatic lesions and possibly 
lower patient morbidity and mortality rates.
We investigated the effect of preoperative dietary restriction (DR) on perioperative 
adhesion and outgrowth of CTC. DR, reduced food intake without causing malnutri-
tion, is associated with extended longevity14 and reduced cancer incidence15-19. Short-
term preoperative DR for one week reduces angiogenesis and growth in an mouse 
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brain tumor model20. Recently, we reported that short-term DR prior to both renal and 
hepatic ischemia and reperfusion injury reduces the expression of pro-inflammatory 
cytokines and adhesion molecules21. Here, we used a murine model to determine 
the effect of short-term pre-operative DR on tumor cell adhesion and hepatic tumor 
load after inoculation with tumor cells. We demonstrate that pre-operative DR reduces 
hepatic tumor load. Furthermore, we demonstrate that a two week DR regimen reduces 
the hepatic expression of the endothelial cell specific adhesion molecule, E-selectin. In 
vitro, serum from DR mice was able to reduce the adhesion of tumor cells to endothe-
lial cells. Our results indicate that DR might be a valuable addition to the multimodality 
treatment of patients with colorectal malignancies.
MATERiAls AnD METhoDs
Animals
Male BALB/c mice (+/- 25 gram) were purchased from Charles River (The Netherlands, 
Maastricht). Mice were housed separately under standard laboratory conditions and 
allowed to acclimatize for one week. The experimental protocol was approved by the 
Animal Experiments Committee under the Dutch National Experiments on Animals Act 
and complied with the 1986 directive 86/609/EC of the Council of Europe.
Dietary restriction
After one week of acclimatization, food intake was measured daily during one week. 
Thereafter, mice were randomized to either the control or the experimental group. 
Control mice were fed standard rodent chow (SDS, Hope Farms, Woerden, The Neth-
erlands) ad libitum (= AL group). Experimental mice received only 70% of the daily 
caloric intake by means of standard rodent chow leading dietary restriction (= DR 
group). Mice were subjected to two weeks of DR prior to the surgical intervention. 
Postoperatively, all mice were allowed ad libitum access to food.
Cell culture
The murine colon carcinoma cell line C26 (kindly provided by Dr. R. Schiffelers, 
Utrecht University, The Netherlands) was cultured in Dulbecco’s modified Eagle’s 
medium (DMEM) (Sigma Aldrich, St. Louis, MO, USA) supplemented with 10 percent 
fetal calf serum, penicillin (100 units/ml) and streptomycin (100 units/ml) in a five 
percent carbon dioxide environment. Near confluent cultures were harvested by brief 
trypsinization (0.05 trypsin in 0.02 per cent ethylenediamine tetra-acetic acid (EDTA)). 
For the surgical procedure, cells were harvested and after centrifugation, single-cell 
suspensions were prepared in phosphate buffered saline (PBS) to a final concentration 
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of 5.0 × 104 cells/100 µL or 10.0 x 104 cells/100 µL. Cell viability was determined by 
trypan blue staining, and was always at least 98 percent.
induction of circulating tumor cells
For induction of hepatic tumor growth mice were anaesthetized with isoflurane inhala-
tion. Surgical procedures were performed under aseptic conditions. Body temperature 
was maintained by placing the mice on heating pads. Following a left lateral flank inci-
sion, the spleen was localized and C26 colorectal carcinoma cells were injected into 
the splenic parenchyma (total volume 100µL, n = 6 per group). This experiment was 
divided into two sub-experiments. In sub-experiment 1: 5.0 × 104 cells were injected, 
in sub-experiment 2: 10.0 x 104 cells were injected intra-splenically After 10 minutes, 
the spleen was removed to prevent intrasplenic tumor growth. Single tumor cells 
reach the liver through the portal vein, where a subset grows out to form intrahepatic 
micrometastases. Metastases were allowed to develop for 10 days. Morphological as-
sessment of tumor growth was performed on right lower liver lobes harvested ten days 
after tumor induction.
Determination of hepatic tumor load
Intrahepatic tumor load was scored as the percentage of hepatic tissue that has been 
replaced by tumor cells (hepatic tumor percentage, HTP). Digital images were captured 
from two non-sequential hematoxylin-eosin–stained sections of the right lower liver 
lobe using virtual microscopy (Hamamatsu NanoZoomer). Using specific software 
(NanoZoomer Digital Pathology, NDP) the HTP ratio was determined by two indepen-
dent observers blinded to treatment (Figure 1). We obtained less than 5% intra- and 
interobserver variability. The mean HTP per slide was used to compare the AL-group 
and the CR-group.
serum collection for in vitro assays
Blood was obtained from mice after two weeks DR or AL access to food by means of 
cardiac puncture under general anesthesia. Serum was stored at -80ºC until further 
analysis, without pooling of the serum.
in vitro growth curves
C26 colon carcinoma cells were cultured in DMEM containing 10% foetal calfs serum 
and 200 U/mL penicillin/streptomycin. Cells were suspended in serum free DMEM 
containing in a concentration of 5.25 x104 cells per mL. Subsequently, 10% mouse 
serum obtained from individual AL or DR mice was added to reach a final concen-
tration of 5.0x104 cells. These cells were plated in triplicate on 5 different 96-wells 
plates. Plates were analyzed 6, 24, 48, 72 and 96 hours after seeding. Cell proliferation 
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was determined by a colorimetric assay using tetrazolium salt (XTT, Sigma- Aldrich). 
XTT was dissolved in DMEM until a final concentration of 1.0 mg/ml was obtained. 
N-methyl dibenzopyrazine methyl sulfate (PMS, Sigma-Aldrich) was added to the 
XTT solution to achieve a final concentration of 7.6 µg/ml. Subsequently, 50 µL of the 
XTT-solution was added to the experimental wells followed by one hour incubation at 
37ºC. Absorbance of the samples was measured spectrophotometrically (ELISA plate 
reader, Victor, Perkin Elmer) and cell content was expressed as the optical density at 
wavelength of 490 nanometer.
in vitro adhesion assay
Human umbilical vascular endothelial cells (HUVEC) (kindly provided by dr. A. Seyn-
have, Erasmus University Rotterdam, The Netherlands) at passage 2 were maintained in 
EGM-2-MV Bullet kit medium (Sigma Aldrich). Confluent monolayers were passaged 
by 0.025% trypsin/0.01% EDTA and cells were used up to passage six. C26 colon 
carcinoma cells were cultured as described earlier. To quantify C26 tumor cell adhe-
sion to HUVEC, a standardized cell adhesion assay was used as described previously22. 
a
b
c
figure 1: Histological analysis of tumor load in liver tissue. Hepatic tumor growth was induced in 
BALB/C mice by intrasplenic injection of C26 tumorcells. Histopathologic analyses were performed on 
hematoxylin and eosin-stained liver sections. Digital images of stained sections were captured using a 
virtual microscopy system. Intrahepatic tumor load was determined as the percentage of hepatic tissue 
that has been replaced by tumor cells. (A) Microscopic appearance of a liver section (magnification 2x). 
(B) Manual indication of the total liver section surface using the computerized system. Surface indicated 
in black. (C) Microscopic appearance of C26 tumor areas present in liver tissue using the computerized 
system, tumor indicated (magnification 20x).
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Briefly, endothelial monolayers were established in 96-well microtiter plates (Perkin 
Elmer, Groningen, The Netherlands). Confluent HUVEC were trypsinized and 2×104 
endothelial cells were plated in each well followed by incubation at 37°C, 95% relative 
humidity, 5% CO2. Medium was daily replaced by fresh medium until HUVEC reached 
confluence in 3 to 4 days, confirmed by light microscopy.
To quantify tumor cell adhesion, trypsinized tumor cells (1×106 cells/ml) were 
labeled with calcein-AM (Molecular Probes, The Netherlands, Leiden) and 3×104 c26 
cells were added to the HUVEC monolayer in the presence of 10% mouse serum, 
obtained from individual AL or CR mice. Assays were performed in triplo. Thereafter 
plates were centrifuged for 1 minute at 80 × g in a Heraeus centrifuge and incubated 
at 37°C for 1 hour. After this, wells were washed twice with medium to remove non-
adherent tumor cells. The remaining fluorescence per well was measured on a Perkin 
Elmer plate reader using 485 nm excitation and 530 nm emission filters.
Real time quantitative PCR
RNA was isolated from liver tissue obtained after two weeks of 30% DR or ad libitum 
access to food. For gene expression analysis, total RNA was extracted from frozen liver 
tissue using Trizol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufac-
turer’s instructions. To prevent contamination by genomic DNA the isolated RNA was 
purified by a DNase treatment (RQ1 Rnase-Free Dnase; Promega, Madison, WI, USA). 
Two microgram of total RNA was reverse transcribed to cDNA using random hexamer 
primers (Invitrogen), and Superscript II RT (Invitrogen) according to manufacturers 
instructions.
E-selectin mRNA expression level was determined by real-time quantitative PCR 
(RT-PCR) using an AppliedBiosystems 7700 PCR machine (Foster City, CA, USA) and 
quantified by normalization against ABL as previously23. Each sample was tested in 
duplicate. All values were normalized to the mean relative expression calculated for 
the AL group, which was assigned a value of 1.
statistical analysis
Categorical data are presented as number (percentage) and continuous variables as 
mean ± SEM (normal distribution, assessed visually and by means of Shapiro-Wilks test) 
or median ± interquartile distance (no normal distribution). Means between two groups 
were compared using either the non-parametric Mann-Whitney U test or the t-test for 
parametric data. Mixed models are used to analyse repetitive measurements. P-values 
of <0.05 were considered significant. All analyses were performed using Statistical 
Package for the Social Sciences 15.0 (SPSS, Chicago, IL).
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REsulTs
Dietary restriction
In both groups mean daily food intake was 4.0 gram (95% CI (3.9-4.1)). Dietary restric-
tion was performed by reducing the intake to 70% of the ad libitum intake, which is 
2.8 gram per day/mouse. During dietary restriction, the intake of the control group 
           










  
     

 


 



 

            










     
   
 





 

figure 2: Food intake and bodyweight during the experimental period. Mice were fed ad libitum or 
dietary restricted to 70% of the daily caloric intake during 14 days prior to surgery. After intrasplenic 
injection all mice were allowed to eat ad libitum. (A) Daily food intake was monitored from the onset 
of diet till the mice were sacrificed. In mice randomized to dietary restriction a 70% caloric intake 
was achieved during the dietary period. After surgery caloric intake showed a rapid increase in mice 
subjected to dietary restriction (B) Mean body weight was monitored during the experiment. All mice 
regained their pre-dietary weight within two days after surgery.
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remained constant. Weight loss, an objective measurement of decreased caloric intake, 
was 15.6 ± 3.3% in the intervention group during DR, while the control group gained 
5.0 ± 1.3% bodyweight during the same period (Figure 2A). After intra-splenic tumor 
injection, all mice were allowed to eat ad libitum, resulting in “catch up” intake of the 
DR group (Figure 2B).
hepatic tumor load
We examined whether preoperative dietary restriction affected hepatic tumor load after 
inoculation with CTC. Therefore 5.0 x 104 tumor cells were injected intrasplenically. In 
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figure 3: Effect of caloric restriction on hepatic tumorgrowth. Hepatic tumorgrowth was induced 
in BALB/c mice by intrasplenic injection of tumorcells followed by splenectomy. Mice were fed ad 
libitum or dietary restricted to 70% of the normal daily caloric intake during 14 days prior to surgery. 
Intrahepatic tumor load was determined in liver sections obtained ten days after surgery. (A) Caloric 
restriction was associated with reduced intrahepatic tumor load (HTP) after intrasplenic injection of 5.0 
x 104 tumor cells. (B) Caloric restriction did not reduce intrahepatic tumor load (HTP) after intrasplenic 
injection of 1.0 x 105 tumor cells. (n = 2 sections per mice, 5 mice / group, *, p=0.036). Data are 
presented as median ± interquartile distance.
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mice who underwent DR prior to tumor inoculation hepatic tumor load was significantly 
reduced to 0.11% as compared to 0.62% in the control group (p=0.036) (Figure 3A). 
Next we performed the experiments by injection of a larger tumor volume (1.0 x 105) 
to increase the number of CTC. In both control and DR mice higher tumor loads were 
found (Figure 3B). Although hepatic tumor load in DR mice was consistently lower this 
did not reach statistically significance (p=0.41). Collectively these data suggest that 
preoperative DR is able to reduce hepatic tumor load after inoculation with CTC.
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figure 4: Effect of caloric restriction on in vitro tumor cell growth and adhesion. (A).C26 colon car-
cinoma cells were cultured in medium combined with serum obtained from ad libitum or dietary 
restriction mice. Dietary restriction did not affect in vitro growth of C26 colon carcinoma cells. (B) An 
in vitro adhesion assay we used to determine the effect of serum obtained from dietary restriction mice 
on adhesion of C26 tumor cells to a HUVEC monolayer. Dietary restriction was associated with reduced 
adhesion of C26 tumor cells to HUVECs. (**, p=0.0043).
12
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
Diet restriction reduces tumor adhesion 99
in vitro experiments
To determine the effect of dietary restriction on the in vitro growth rate of C26 colon-
carcinoma cells, we evaluated the effect of serum obtained from ad libitum or DR mice 
on in vitro growth curves of C26 coloncarcinoma cells (Figure 4A). Serum obtained 
from both groups showed no significant differences on the in vitro growth rates of C26 
cells. Next, we evaluated the effect of DR on adhesion of C26 coloncarcinoma cells to 
endothelial cells in vitro. Therefore we determined the effect of serum from either DR 
or AL mice on the capacity of tumor cells to adhere to a HUVEC monolayer. C26 cells 
in the presence of DR serum displayed a significantly (p=0.0043) reduced capacity to 
adhere to HUVEC as compared to C26 cells in the presence of AL serum (Figure 4B).
Real time Quantitative PCR
The endothelial cell specific adhesion molecule E-selectin has an important role in 
the process of tumor cell adhesion to endothelial cells. Therefore, we examined the 
effect of DR on hepatic E-selectin mRNA expression levels. DR resulted in a significant 
(p=0.0087) reduction of E-selectin mRNA expression (Figure 5).
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figure 5: Effect of caloric restriction on hepatic E-selectin mRNA expression. Mice were fed ad libitum 
or dietary restricted to 70% of the normal daily caloric intake during 14 days prior to surgery. Hepatic 
tissue was obtained after 14 days of dietary restriction or ad libitum diet. Relative hepatic E-selectin 
expression level was determined. Dietary restriction was associated with reduced E-selectin expression 
level. (**, p=0.0087)
DisCussion
For most patients with colorectal malignancies surgical resection is the cornerstone of 
any potentially curative treatment. Surgical trauma results in systemic inflammation as 
reflected by cytokine release24,25 and in postoperative cellular immunosuppression26. 
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There is emerging evidence suggesting that these surgery induced processes facilitate 
tumor metastases27. Furthermore, surgical procedures induce hematogenic tumor cell 
dissemination as reflected by increased circulating tumor cells (CTC’s) present during 
surgical procedures9. The importance of CTC is underlined by an increased hepatic 
metastasis rate in CTC positive patients, when compared to CTC negative patients7. 
There are two major schools of thought regarding tumor cell metastasis and extravasa-
tion. One the one hand it is believed that CTC arrest in narrow capillaries due to size 
restriction, on the other hand adhesion of CTC to the microvascular endothelium is 
considered one of the most important steps28. Preventing adhesion of CTC’s to the 
endothelium of distant organs during the perioperative period may be a potential effec-
tive treatment to reduce metastasis rates after curative surgery. In the current study we 
show that preoperative dietary restriction lowers the expression of E-selectin in the liver 
reduces hepatic tumor load after exposure to CTC.
Selectins mediate tethering, rolling and adhesion of several types of cells. E-selectin, 
an endothelial cell specific adhesion molecule, is expressed de novo on endothelial 
cells, such as liver endothelial cells, after transcriptional induction by pro-inflammatory 
cytokines29. These activated endothelial cells express E-selectin, which mediates tumor 
cell adhesion and subsequent liver metastasis29. Here, we demonstrate that dietary 
restriction [DR) reduces mRNA expression of E-selectin and hepatic tumor load. It is 
known that tumor cells trigger the induction of E-selectin expression on endothelial 
cells30. We show that serum obtained from DR mice reduces in vitro adhesion of C26 
coloncarcinoma cells to HUVEC. Although we do not show a direct correlation, it has 
already been demonstrated that E-selectin expression plays an crucial role in the process 
of liver metastasis formation in the murine BALB/c-C26 coloncarcinoma cell model as 
direct blockage of E-selectin was associated with lower numbers of liver metastasis31.
The protective effect of DR on HTP was statistically significant after inoculation with 
5.0 x104cells; while only a trend was observed after injection of 1.0x105 cells. These 
data suggest that if an overwhelming amount of tumor cells has been injected the 
positive effect of DR on CTC adhesion is blunted. However, this situation is unlikely 
to be encountered in the clinical situation as the amount of CTC is much lower (1-10 
CTC per 7.5 mL blood)32 than the supra-physiological amounts of CTC used in our 
model. The model does not fully represent the clinical situation, as a primary tumor is 
absent and the level of (pre-) and post-operative inflammation may be different. But in 
this model, where higher concentrations of CTC than ever encountered in the clinical 
situation are induced, a beneficial effect of DR is observed.
Although a reduced HTP was observed after DR, we cannot rule out that the differ-
ence in postoperative calorie intake contributes to this reduction. However, we assume 
this unlikely as the adhesion assay and hepatic E-selectin mRNA expression level were 
performed with serum samples obtained directly after DR, thus unaffected by postop-
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erative calorie intake. Translation of preoperative DR to the clinical setting also poses a 
challenge. Although in literature periods much longer of than two weeks 30% DR have 
been reported33. We must take into account that several patients suffering from colorec-
tal disease may be malnourished. Interestingly, a diet consisting of protein restriction 
without a reduction in calories has been shown to increase maximum longevity in rats 
and mice as well34. Although the magnitude of these increases is around 30–40% of that 
of DR, neither carbohydrate35 nor lipid restriction36,37 exerted these effects. Restriction 
of proteins could therefore be another way to induce the beneficial effects seen after DR 
and overcome the problem of reducing calorie intake. In addition, the use of DR mimet-
ics may be a way to overcome the problems associated with DR in surgical patients. A 
DR mimetic can be loosely defined as any pharmacological intervention that produces 
beneficial effects of DR without causing or requiring a significant reduction in calorie 
intake. In clinical practice a DR mimetic might be a powerful addition to standard can-
cer treatment. One compound that has received considerable attention as DR mimetic 
is resveratrol, a naturally-occurring polyphenol found in red wine. Resveratrol induces, 
at doses that can be readily achieved in humans, genomic changes which resemble 
many of the genetic alterations induced by DR38. Furthermore, evidence supporting the 
use of resveratrol in the treatment of malignancies is emerging39-41.
The question remains why DR lowers E-selectin expression. We recently reported that 
DR robustly down regulates the production of proinflammatory cytokines and adhesion 
molecules in models of renal and hepatic ischemia-reperfusion injury. In addition DR 
induced the expression of cytoprotective and anti-oxidant genes, leading to a reduced 
formation of reactive oxygen species42. As surgical trauma causes oxidative stress43,44, 
the increased protection against oxidative stress and the subsequently reduced inflam-
matory response, may explain why lower levels of E-selectin are encountered. Micro-
array analyses are currently being performed, aiming to elucidate how DR induces 
this protective response. In addition, future experiments need to identify the optimal 
regimen of DR, in terms of percentage of DR and duration. These should focus on 
combining the beneficial effects of preoperative fasting, which protects against the side 
effects of chemotherapy45,46, with those of DR found in the present study, to a regimen 
that induces the protection against both.
In conclusion our data demonstrate that preoperative DR is able to reduce hepatic 
tumor load ten days after inoculation with CTC. This beneficial effect appears to be 
mediated by reduced vascular E-selectin expression and a subsequent decreased tumor 
cell-endothelial cell adhesion, as lower E-selectin levels were related to less hepatic 
metastasis. This may be a mechanism by which DR inhibits hepatic metastasis. There-
fore, DR may provide a new strategy in the multimodality treatment of patients with 
colorectal cancer.
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ABsTRACT
introduction: Dietary restriction (DR), defined as reduced energy intake without mal-
nutrition, confers protection against renal ischemia and reperfusion injury in animal 
models. This pilot study investigates for the first time the feasibility of preoperative DR 
in the clinical setting.
Methods: Live kidney donors were randomized between preoperative DR or ad libitum 
intake. Seventeen participants were instucted to follow a 30% calorie restricted diet, 
followed by one day of water-only fasting prior to surgery. Thirteen participants were 
allowed to eat ad libitum preoperatively.
Results: 94% of the donors adhered to the diet, 31.4% reduction in caloric intake was 
achieved. Postoperative well-being, appetite and ability to perform daily tasks were not 
different between both groups. There was no difference in post-transplant graft func-
tion of kidneys obtained from DR donors or control donors as determined by serum 
creatinin levels during the first postoperative month and renograms at post-operative 
day one.
Conclusions: This study shows that mild dietary restriction is feasible in the setting 
of live kidney donation. No effect was observed regarding postoperative graft func-
tion. Additional studies are warranted to investigate the appropriate regimen of dietary 
restriction to protecting against ischemia and reperfusion injury, such as increasing the 
magnitude and/or duration of the reduction in daily caloric intake.
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inTRoDuCTion
Life-long daily dietary restriction (DR), defined as a reduction in energy intake without 
malnutrition, is associated with extended longevity1 in multiple organisms including 
yeast, worms, flies, mice2-6 and non-human primates7. Long-term DR is able to attenu-
ate damage resulting from oxidative stress by decreasing mitochondrial electron and 
proton leak and increasing antioxidant defence systems8-11. We have recently shown 
that beneficial effects of long-term DR are induced rapidly and can be tapped for clini-
cally relevant benefits such as protection against ischemia-reperfusion (I/R) injury. After 
one day of water-only fasting protection against renal I/R injury was achieved. The 
maximum protection against renal I/R injury in the mouse was induced by both three 
days of preoperative water-only fasting and two weeks of preoperative reduced (30%) 
caloric intake. In analogy to long-term DR, we found that short-term DR increased 
baseline levels of cytoprotective and antioxidant genes12. Unbiased transcriptional pro-
filing of kidneys from mice subject to short-term DR revealed a significant enrichment 
of the signature genes of long-term DR.
Furthermore, DR has been shown to facilitate the functional recovery of ischemically 
damaged neurons in the brain13 and to result in a highly significant decrease in infarct 
volume when compared with ad libitum fed controls14. In the heart, DR attenuated the 
postischemic inflammatory response15 and similar benefits were found in the retina 
following ischemia16.
We hypothesize that dietary restriction of the donor confers protection to the kidney 
against I/R injury prior to the ischemic insult. Preoperative DR may therefore be a 
non-invasive way to reduce I/R injury following organ transplantation17. Unfortunately, 
preoperative fasting is currently considered an unwanted necessity as it reduces patient 
well-being and induces peripheral insulin resistance18-19. Furthermore, the concept of 
reducing I/R injury by slightly longer periods of preoperative fasting or preoperative 
dietary restriction is novel and so far no clinical studies have been conducted. It is 
known that humans in general have difficulties to adhere to prescribed diets and it is 
unknown if people are able to adhere to a diet in preparation for surgery, which causes 
distress itself. We therefore designed the current pilot study to investigate whether a 
relatively mild preoperative DR regimen is feasible in the clinical setting and carefully 
explored the effects of DR on both the donor and recipient.
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METhoDs
study population
The study population consisted of people participating in a live kidney donation pro-
gram. Donors aged between 18 and 80 years old were eligible for inclusion, provided 
that they had a body mass index above 18.5 kg/m2. All participants were approached 
during their first outpatient visit (five to six months prior to surgery). Approval was 
obtained from the local medical ethics committee and informed consent was obtained. 
The dietician instructed participants to keep a precise weighed food record. Single 
items were recorded in household measurements. Records were kept on two week-
days and one weekend day in one week, approximately four months prior to surgery. 
These data were, if necessary, completed by a diet recall performed by the dietician. 
Hereafter, participants were randomized into either the DR group or the control group. 
This DR regimen is translated from our previous experimental results into a feasible 
regimen for the clinical setting. It is not directly based on existing experimental data. 
The DR group aimed to reduce their calorie intake with 30% (relative to the baseline 
measurements) on day four, three and two before the operation. On the day before 
surgery, these patients were allowed breakfast followed by 24 hours water-only fasting. 
The control group was allowed to eat ad libitum and kept a food record form during 
the four preoperative days. Participants were instructed to record any changes from the 
preoperative prescribed diet.
surgical procedure
All donors were prehydrated with intravenous crystalloids from midnight the day before 
surgery. After endotracheal intubation anaesthesia was carried out according to a pro-
tocol for drugs, ventilation, and fluid regimens. At the end of surgery donors received 
patient controlled analgesia using intravenous morphine.
Data collection
Data were collected prospectively. The following data were obtained from the kidney 
donor: age, sex, body mass index (BMI, weight (kg)/height2 (m2)), cholesterol and fast-
ing blood glucose. Short-term recovery after surgery was measured using the EuroQol20 
questionnaire and visual analogue scores concerning appetite and general well-being. 
Blood was drawn at 20.00 pm the night before surgery (day -1), six hours after surgery 
(day 0) and every morning until discharge. Serum levels of C-reactive protein (CRP), 
leucocytes, insulin, cortisol, urea and creatinine were analysed by the central hospital 
laboratory using standard methods. Insulin levels were measured at 08:00 pm on the 
day before surgery to provide an indirect, objective assessment of compliance with the 
diet. Furthermore, serum albumin levels were determined five to six months and the 
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day before surgery to estimate the effect of DR on the nutritional status. Complications 
were recorded for the first 30 days after the operation and defined as events necessitat-
ing intra-operative or post-operative interventions or prolonged hospital stay.
The following data were collected from the kidney recipient: age, sex, number 
of previous transplantations, kidney replacement therapy, graft survival, urea levels 
and creatinine levels in the first month after surgery. Routinely, all renal transplants 
were evaluated in the first days postoperatively with 99m-technetium mercaptoacetyl 
triglycyne renography. All renographs were analysed by two independent observers, 
blinded to whether the kidney was obtained from a DR or control patient. Peak activity 
(time until maximum acitivity was observed), end activity (amount of activity 20 min-
utes after injection of the tracer as a percentage of peak activity), total activity within 
the first two minutes and a overal grade were noted ranging from zero (no perfusion) to 
five (excellent transplant function).
statistical analysis
Categorical data are presented as numbers (percentage) and continuous variables as 
mean (sd./normal distibution) or median (interquartile distance/no normal distribution). 
Data were tested for normality using the Shapiro-Wilks test and visual assessment. 
Continuous data were compared using either the non-parametric Mann-Whitney test 
or the T-test for parametric data. Dichotomous data were analysed using the chi-square 
test. Related samples were analysed using the Wilcoxon signed rank test. Repeated 
measurements were analysed using mixed model analysis. P-values less than 0.05 were 
considered significant. All the analyses were performed using Statistical Packages for 
Social Sciences 15.0 (SPSS Inc., Chicago, USA). This is a pilot study and therefore no 
powercalculations were made.
REsulTs
study population
Thirty-nine kidney donors were included and underwent randomisation. Figure 1 
shows the flowchart of the study. Eventually, 17 patients were analysed in the dietary 
restriction group and 13 patients in the control group. Baseline characteristics of the 
study population and surgical procedures are presented in Table 1 and Table 2, and 
show that there were no significant differences between both groups.
Dietary intervention
Baseline food record forms were detailed enough to calculate the amount of calories 
consumed. The average baseline intake for the control group was 1863±591 kcal/day, 
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which did not differ significantly from their four-day pre-operative intake (1853±675 
kcal/day). A 31.4% (29.5% - 33.0%) reduction in calorie intake was achieved in the 
intervention group. They consumed 1957±408 kcal/day during the baseline measure-
ments and 1322±251 kcal/day preoperatively. Macronutrient composition of the diets 
(Table 3) did not differ between the two groups. One patient failed to comply with the 
diet, against 94% who adhered rigorously to it. To provide a more objective means of 
Control
n = 13 
Informed consent 
and randomized 
n = 39 
Control
n = 20 
Dietary restriction
n = 19 
Dietary restriction
n = 17 
Surgery cancelled / 
rescheduled  (n =5) 
Withdrew IC (n=2) 
Surgery cancelled / 
rescheduled  (n =1) 
Withdrew IC (n=1) 
figure 1: Flowchart of the study. IC = Informed Consent.
Table 1: Baseline characteristics of the study population. Data are presented as means ± standard devia-
tion, unless stated otherwise.
DR1 (n = 17) Control (n = 13) P-value
Age (Years) 54±9 56±13 0.642
Male : Female ratio (%) 6 (35):11(64) 6 (46):7 (53) 0.711
Height (cm) 171±7.0 166±7.6 0.104
Weight (kg) 74±15 75±13 0.797
BMI (kg/m2) 25.0±4.0 26.7±3.4 0.812
Weight (kg)
 Onset of study 74±15 75±11 0.812
 One day before surgery 74±15 75±12 0.584
Blood glucose2 (mmol/L) 4.7±0.5 4.6±0.6 0.569
Albumin (g/L)
 Onset of study 46.4±3.1 44.2±3.4 0.106
 One day before surgery 46.9±2.0 45.7±2.4 0.199
1 DR = dietary restricted group.
2 Blood obtained after a midnight fast at the outpatient department, several months prior to surgery.
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diet adherence, insulin levels (Figure 2A) were measured. These data show that the 
donors of the DR group had low insulin levels (25.5+/-3.6 pmol/L) on preoperative 
day one (08.00 PM) in contrast with the control group (203.8 +/- 69.0 pmol/L). Serum 
albumin levels were unaffected by the diet (Table 1).
Postoperative CRP and leucocyte responses of live kidney donors
Surgical tissue trauma leads to an inflammatory response characterized by increased 
levels of CRP and leukocytes21-22. We studied whether this response was affected by 
preoperative DR. Baseline values of CRP (DR: 2.17 ± 1.63 mg/L vs. control: 2.5 ± 2.2 
mg/L, P=0.905) did not differ between both groups. CRP levels increased significantly 
after the operation and peaked on postoperative day two. No statistically significant 
Table 2: Baseline characteristics of the surgical procedures. Categorical data are given as number 
(percentage) and continuous variables as means ± standard deviation. Means between the two groups 
are compared using the non-parametric Mann Whitney Test.
DR1 (n = 17) Control (n = 13) P-value
Laparoscopic procedures 17 (100%) 13 (100%) 1.00
Conversion to open approach Never Never 1.00
Skin to skin time (min) 199 ± 57 207 ± 55 0.672
Time until warm ischemia 154 ± 53 156 ± 46 0.813
Warm ischemia (min) 6.0 ± 2.1 6.0 ± 1.8 0.942
Cold ischemia (min) 155 ± 47 158 ± 29 0.346
Second warm ischemia (min) 24 ± 7 25 ± 8 0.860
Total ischemia (min) 185 ± 52 189 ± 32 0.295
Blood loss (ml) 97 ± 91 162 ± 139 0.204
1 DR = dietary restricted group.
Table 3: Macronutrient composition of baseline and preoperative diets. Data are presented as means ± 
standard deviation.
Baseline diet1 Pre-operative diet2
Control (n = 13)
 Protein3 16.7 (3.1)
 Carbohydrates4 48.3 (6.4) 46 (5.0)
 Fat5 32.2 (5.2) 32.1 (5.5)
DR# (n = 17)
 Protein3 17.3 (2.9) 18.0 (3.4)
 Carbohydrates4 49.8 (5.0) 50.3 (5.6)
 Fat5 30.4 (7.0) 31.4 (6.1)
1 Mean values of the three day food record form completed several months prior to the operation.2 Based on 
food record form filled in prior to surgery or the report of adherence to the prescribed diet.3 Energy percentage 
derived from proteins.4 Energy percentage derived from carbohydrates.5 Energy percentage derived from fat. # 
DR = dietary restricted group.
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differences in CRP levels were found between both groups at any of the examined 
time points. The number of leukocytes increased after surgery in both groups. On the 
first postoperative day, the number of leukocytes was significantly (P=0.02) lower, but 
well within the normal range, in the DR group when compared to the control group. 
However, since a mixed model analysis taking into account all time points did not 
show significant differences between both groups, this must be interpreted as a trend 
(Figure 2B).
Postoperative recovery of the donor
By means of visual anlogue scores (VAS), ranging from one to ten, postoperative ap-
petite and general well-being were assessed. There were no significant differences in 
VAS concerning appetite and well-being between the two groups (Figure 3A and 3B). 
Preoperative serum levels of cortisol were measured to provide an indication of the 
stress caused by the diet. In the DR group mean cortisol levels were 206±121 nmol/L 
and in the control group 185±85 nmol/L, this was not statistically different. In addition, 
the ability to perform daily tasks was measured by means of the EuroQol question-
naire. Preoperative DR did not influence the postoperative ability to perform daily tasks 
(Figure 3C). Of the 30 live kidney donors included in the study, 23 (76%) patients had 
a paid job (13 of the DR group vs. 10 in the control group). There was no statistically 
significant difference in the number of days before the participants returned to work 
(DR: 53±28 days vs control: 47±28 days, P= 0.74).
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figure 2: (A) Perioperative insulin levels. These data show that the donors of the DR group had low 
insulin levels (25.5+/- 3.6 pmol/L) on preoperative day one (08.00 PM) in contrast with the control 
group (203.8 +/- 69.0 pmol/L) indicative of a fasted state. There were no statistically significant dif-
ferences postoperatively. Data are presented as means ± standard error of the mean. (B) Perioperative 
number of circulating leukocytes. The mixed model analysis showed no statistically significant differ-
ence (p=0.098) in the number of leucocytes over all the time points measured in de dietary restricted 
group when compared to the ad libitum group. However, on the first postoperative day, the number of 
leucocytes was significantly (p=0.02) lower in the dietary restricted group. Data are presented as means 
± standard error of the mean.
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Complications
Two complications occurred in the DR group. One live kidney donor developed 
postoperative epididymitis, which was treated successfully with antibiotics. One donor 
developed acute tubular necrosis due to a hypotensive period (mean arterial pressure 
50 mm mercury) following induction of anesthesia. This resolved spontaneously within 
days after the operation. In the control group one donor suffered from an iatrogenic 
colon perforation, which was corrected surgically.
Graft function and survival
Thirty patients received a kidney graft from one of the live kidney donors included in 
the study. There are no statistically significant differences between the kidney recipients 
of a “DR graft” or a “control graft” regarding age, sex, number of previous transplanta-
tions and kidney replacement therapy (data not shown). Only one graft was lost within 
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figure 3: Postoperative visual analogue scores of appetite (A) and general well-being (B) and euroQol 
questionnaire scores (C). Higher scores indicate less appetite or decreased well-being. Dietary restric-
tion did not influence postoperative appetite and/or well being scores when compared to the controle 
group. Data are presented as mean, error bars represent standard error of the mean. EuroQol scores 
indicate the ability to perform daily tasks (walking, getting dressed). Higher scores indicate a better 
ability to perform these tasks. Dietary restriction did not influence the postoperative ability to perform 
tasks. Data are presented as means ± standard error of the mean.
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figure 4: Recipient creatinine levels during the first month of follow up.
Serum creatinine levels are shown for the first month after transplantation. There is no significant difference 
between both groups (p=0.601) over all time points measured. Data are presented by means of the 95% 
confidence interval.
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figure 5: Renograph scores of the transplanted kidneys on postoperative day one.
As shown by means of the time needed to achive peak activity (A), the percentage of end activity (B) and the 
total amount of counts during the first two minutes (C), there were no significant differences between both 
groups. The overal score (D) was also not statistically significantly different between both groups. Scoring sys-
tem renographs: Grade 0 = No function, No perfusion, Grade 1 = Very bad (Perfusion present, no extraction), 
Grade 2 = Bad (Perfusion present, no extraction, activity increased > 20 minutes after injection of isotope), 
Grade 3 = Reasonable (Perfusion, extraction and excretion; Peak curve within 10-20 minutes), Grade 4 = 
Good (Perfusion, extraction and excretion; Peak curve within 5-10minutes), Grade 5 = Excellent (Perfusion, 
extraction and excretion; Peak curve within <5 min).
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the first year after transplantation due to acute rejection after ABO incompatible trans-
plantation (DR group). There were no significant differences in one month creatinine 
levels of the kidney recipients (Figure 4). Immediate postoperative graft function was 
measured one day postoperatively using renographs, and showed no significant differ-
ence between kidneys obtained from DR or control donors (Figure 5).
DisCussion
Ischemia-reperfusion (I/R) injury negatively influences the outcome after kidney 
transplantation. Preoperative dietary restriction (DR) confers protection against both 
renal and hepatic ischemia-reperfusion injury (I/R) in mouse models12,23. Thus, DR is a 
potential cost free, non-invasive means to protect kidney grafts against I/R injury. This 
is the first study that investigates the feasibility of preoperative DR in the clinical setting 
in live kidney donors. The results show that modest preoperative DR is feasible in the 
clinical setting and has no measurable effect on postoperative well-being, ability to 
peform daily tasks and complication rates of live kidney donors.
The preoperative diet used in this study is translated, but not directly based on, the 
animal studies performed in our laboratory12 and inspired by existing literature report-
ing that DR is able to induce protection against ischemia and reperfusion injury23. How 
to convert dietary regimens from experimental to clinical studies remains a point of 
discussion. More than 24 hours of fasting is in our opinion not applicable in the clinical 
setting. Patients will become hungry and therefore experience decreased well being in 
advance of surgery. Extending the number of days with dietary restriction provides more 
possibilities for errors (people are less likely to completely adhere to the diet), non-
compliance, and increases the work load of the dietician. Therefore, we have chosen 
to combine 24 hours of fasting with 3 days of 30% calorie restriction. However, as our 
diet failed to demonstrate beneficial effects on postoperative graft function, longer and 
more extensive dietary regimens may be needed. In this case, additional effort of the 
dietician is needed and justified by the goal of the study.
Assessing food intake of individuals is usually based on self-report methods. Validity 
of these methods depends on the accuracy of the participants with recording their 
dietary intake. The gold standard in assessing validity of reported total energy intake 
is through doubly-labeled water studies24. However, because of the high costs of this 
method, it is not widely used. Therefore other methods have been designed to mea-
sure dietary intake, such as dietary records (a complete and accurate list of all foods 
consumed, preferably not influenced by the act of recording, in a time period varying 
from one day to several weeks), diet recall records (a complete recall of all foods and 
drinks ingested on specified days, may be obtained by a trained interviewer) and food-
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frequency questionnaires (reflects food consumption over a designated period of time, 
mainly provides information about food patterns). We used a three-day dietary record 
form, accompanied by a dietary recall history if nessecary. Unfortunately, we were 
not able to determine the amount of underreporting or overreporting, which is a well-
documented phenomenon25. To minimize underreporting and eating bias, participants 
were informed about these features and food record forms were collected prior to 
randomisation. An advantage of our study is the study population. The kidney donors 
were eager to participate and are very committed, which likely benefits the accurate 
reporting of intake and a high compliance (94%) with the diet. Compliance was mea-
sured subjectively and is diffficult to assess with objective measurements. However, the 
low insulin levels on the day before surgery at 08.00 pm in the DR group indicate a 
fasted state, in contrast with the control group where insulin levels were much higher. 
Collaboration between the surgical and dietetic departments, which was crucial to the 
success of the study, created no insurmountable logistical problems.
The concept of preoperative DR goes against this current surgical dogma of preop-
erative carbohydrate loading. Randomized studies, in which glucose was administered 
either as an infusion or as a carbohydrate-rich drink two to three hours before surgery, 
reported an increase in patient well-being before and after surgery26-31. However, our 
diet did not impair postoperative well-being. In addition, postoperative appettite and 
the ability to perform daily tasks were also unaffected by the diet. If anything, DR led to 
an increase in well-being scores after postoperative day two, although this did not reach 
statistical significance. Healthy people undergoing a laparoscopic donor nephrectomy 
have a fast and uneventful recovery, without major complications, which renders it 
difficult to speculate about complications caused or prevented by the diet. Hypoten-
sion after induction of general anaesthesia is a common event which can occur in up 
to 9% of the patients32. We have interpreted the decrease in bloodpressure, which was 
observed in one patient in the DR group, accordingly, and feel that this has contributed 
to postoperative acute tubular necrosis. However, we cannot rule out a relationship 
between DR and postoperative acute tubular necrosis.
The inflammatory response after surgery is partially reflected by increased levels of 
C-reactive protein and leukocytosis21-22. Preoperative dietary restriction did not affect 
perioperative CRP levels. A trend towards a lower number of leukocytes on postopera-
tive day one was observed, however all values were well within the normal range.
To assess the effect of preoperative DR on renal transplant function, we measured 
graft function on the first postoperative day by means of renographs and during the 
first month by serum creatinin levels in the recipient. We acknowledge that this study 
is not sufficiently powered to draw firm conclusions about the relationship between 
preoperative DR and renal transplant function, however, we found no measurable ef-
fect of DR on renal graft function.
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Although this is a pilot study assessing the feasibilty of preoperative DR, the data 
obtained thus far do not indicate protection against renal I/R injury by this relatively 
modest DR regimen. The ability of the diet to induce a protective response may have 
been insufficient. Increasing the length, severity or macronutrient composition of the 
DR regimen are potential avenues to proceed with preoperative DR. Protein restriction 
without a reduction in calories has been shown to increase maximum longevity in 
rats and mice33. Although the magnitude of these increases is around 30–40% of that 
of DR, neither carbohydrate34 nor lipid restriction35-36 exerted these effects. Restriction 
of proteins in combination with calorie restriction could be a more effective way to 
induce the beneficial effects of DR.
Live donor grafts are the grafts least likely to benefit from DR due to the already 
very good results. However the results are not uniformly successful. One of the fac-
tors independently associated with poorer graft survival of kidneys from live donors 
is donor age older than 59 years37. Experimental studies show that older kidneys are 
more susceptible to ischemia and reperfusion injury and that DR protects old kidneys 
against ischemia-reperfusion injury38-39. Therefore DR may protect these older kidneys 
against ischemia and reperfusion injury17. The power to demonstrate a difference in 
renal function between DR and control grafts in our study may have been intrinsically 
limited, since we have included donors from all ages instead of limiting the study to 
“older” donors.However, the beneficial effects of DR may not be limited to transplant 
patients, but could extend to patients at risk for surgically induced I/R injury of the 
kidney, intestine, liver, heart and/or brain.
In summary, we investigated the feasibility of a mild preoperative diet in elective 
surgical patients. Our dietary intervention was logistically possible, well adhered to 
and had no effect on postoperative well-being, appetite and ability to perform daily 
tasks of the live kidney donors. In the recipient, we found no effect on graft function. 
This preoperative diet may set the stage for future work aiming at inducing protection 
against I/R injury by dietary interventions. Increasing the length and/or the severity of 
the DR regimen are potential avenues to proceed in the setting of clinical transplanta-
tion and non-transplant populations.
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ABsTRACT
Background: Lifespan extension is achieved through long-term application of dietary 
restriction (DR) and benefits of short-term dietary restriction on acute stress and inflam-
mation have been observed. So far, the effects of short-term DR in humans are relatively 
unknown. We hypothesized that short-term DR in humans reduces the acute phase 
response following a well defined surgical trauma.
Methods: Thirty live kidney donors were randomised between 30% preoperative di-
etary restriction followed by one day of fasting (n=17) or a four day ad libitum regimen 
(n=13) prior to surgery. Leukocyte subsets and numbers and serum cytokine levels were 
determined. Whole blood was stimulated with Lipopolysaccharide (LPS) and cytokine 
production was determined.
Results: A clear trend towards lower numbers of postoperative circulating leukocytes 
was observed in the DR group. IL-8 serum levels were significantly higher in the DR 
group over the first six postoperative days (p=0.018). After LPS stimulation significantly 
less TNF-α (p=0.001) was produced by blood obtained postoperatively when compared 
to preoperative blood from the DR group. This was not observed in the control group.
Conclusions: A relatively short pre-operative dietary restriction regimen was able to 
modify certain aspects of the postoperative acute phase response. These data warrant 
further studies into the dietary conditions that improve stress resistance in humans. 
(Dutch Trial Registry Number: NTR1875)
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inTRoDuCTion
Dietary restriction (DR), defined as reduced food intake without causing malnutrition, 
is associated with extended longevity1 and improved resistance against various stress-
ors in multiple organisms2,3. Stress resistance is defined as the ability of an organism to 
withstand and/or reduce damage caused by acute or chronic stressors such as surgery, 
ischemia-reperfusion injury and toxic agents. Beneficial effects of DR in non-human 
primates on improved health have been reported4. In humans, effects of DR on longev-
ity are not yet known, but the benefits on general health are clear5-7.
Although lifespan extension is achieved through long-term application of dietary 
restriction, benefits of short-term dietary restriction on acute stress resistance have been 
observed8,9.
The mechanisms leading to the beneficial effects of DR are presently unknown. 
However, several potential mechanisms, such as those leading to increased resistance 
against oxidative damage10-14, have received considerable attention. We have recently 
shown that short-term DR reduces the inflammatory response after surgically induced 
acute oxidative stress15, whereas others have found reduced serum cytokine levels 
after surgery16,17. The effect of short-term DR on acute stress resistance in humans is 
largely unexplored, however tumor necrosis factor alpha (TNF-α) levels are lower 
and well-being is improved in asthma patients after short term DR18. Surgical trauma 
causes oxidative stress19,20 and provokes an acute phase reaction. This response is 
characterized by increased levels of pro-inflammatory cytokines such as interleukin-6 
(IL-6) and TNF-α, increased levels of C-reactive protein (CRP) and leukocytosis21,22. In 
addition, surgery decreases the number of circulating B- and T-cells, which may lead 
to a temporary impairment of cellular immunity23,24. We hypothesized that short-term 
DR increases acute stress resistance in humans and therefore reduces the postoperative 
acute phase response.
METhoDs
study population
Thirty people participating in a live kidney donation program were randomized between 
the diet group and the control group. People aged 18 to 80 years old with a body mass 
index above 18.5 kg/m2 were eligible for inclusion. Approval was obtained from the 
medical ethics committee of the Erasmus MC in Rotterdam. Age, sex, body mass index 
(BMI, weight(kg)/height(m)2), medical history and use of medications were collected. 
Complications were recorded until 30 days postoperatively and defined as events 
necessitating intra-operative or post-operative interventions or prolonged hospital stay.
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nutritional intervention
Our study aimed to reduce pre-operative calorie intake. Based on our previous experi-
ments25 calorie intake was reduced with 30% on day four, three and two prior to surgery 
(relative to the baseline measurement). The day before surgery, patients were allowed 
breakfast followed by 24 hours water-only fasting. Seventeen patients were randomized 
to the intervention group. The control group was allowed to eat ad libitum but fasted 
overnight prior to surgery. They kept a food record form during the four pre-operative 
days to enable calculation of the ingested calories.
surgical procedure
Anaesthesia was carried out according to a protocol for drugs, ventilation, and fluid 
regimens. A laparoscopic nephrectomy was performed in all patients. All operations 
started at 08.00 A.M. Operating time and peroperative complications were recorded.
sample collection
Peripheral venous blood samples were obtained at 08.00 P.M. the evening before sur-
gery, six hours after surgery and at 09.00 A.M. every postoperative day until discharge. 
Samples for cytokine assays were collected in plastic tubes (8.5 mL, BD Biosciences 
Vacutainer® SST II PlusSan Jose, California,USA). Serum levels of CRP (BD Biosci-
ences Vacutainer® SST II Plus) and leukocyte counts (BD Biosciences Vacutainer®) 
were measured routinely and analysed by the central hospital laboratory. Samples for 
immuno-phenotyping were collected at 08.00 P.M. the evening before surgery and at 
09.00 A.M. on postoperative day one. Blood was collected in plastic tubes (BD Biosci-
ences Vacutainer®) with lithium heparin.
Cytokine analysis
Total white blood cell count was measured in all samples. Cytokines (Interleukin (IL)-
1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, TNF-α and interferon-gamma (INF-γ)) 
were measured using commercially available cytometric bead arrays (CBA Human 
Inflammation Kit, BD BiosciencesTM and CBA Human TH1/TH2 Cytokine Kit, BD Bio-
sciencesTM ) according to the manufacturers protocol. These cytokines were measured 
to provide an indication of the acute phase response and the ratio between typical T 
helper cell type-1 (Th1) and T helper-2 (Th2) cytokines. Measurements were performed 
on a FACS Calibur (BD Biosciences) and analysis on FCAP ArrayTM Software (BD Biosci-
ences). Assay sensitivity was five pg/mL for all cytokines.
immuno-phenotyping
Total number of B-cells (CD19+), T-cells (CD3+), CD3+/CD4+ T-cells, CD3+/CD8+ 
T- cells, natural killer cells (CD3-/CD16+/CD56+) and human leucocyte antigen-DR 
12
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
Dietary restriction modifies inflammation 129
(HLA-DR) expression on T-cells (CD3+/HLA-DR+) was determined according to a 
standard diagnostic screening protocol using truecount tubesTM (BD Biosciences).
lPs stimulation tests
For in vitro stimulation, heparinized blood was stimulated with 50 ng/mL LPS (Escherichia 
coli/ 026;B6, Sigma, St. Louis, MO, USA) for 24 h at 37.5°C. Subsequently, plasma was 
stored at −80°C. Levels of TNF-α, IL-1β, IL-10 and IL-6 were determined by means of 
the CBA kit. Due to high levels, IL-8 was determined by enzyme linked immuno sorbent 
assay (ELISA, Invitrogen, Carlsbad, California,USA) according to the manufacturers pro-
tocol. Due to logistical reasons the assays were performed in 9 DR and 8 control patients.
statistical analysis
Categorical data are presented as number (percentage) and continuous variables as 
mean (standard deviation/normal distibution) or median (interquartile distance/no 
normal distribution). Means between two groups were compared using either the non-
parametric Mann-Whitney test or the t-test for parametric data. Dichotomous data were 
analysed using the chi-square test. Related samples were analysed using the Wilcoxon 
signed ranks test. Repeated measurements were analysed using mixed model analysis. 
P-values less than 0.05 were considered significant. All analysis were performed using 
Statistical Package for the Social Sciences 15.0 (SPSS Inc., Chicago, USA).
REsulTs
study population and surgical procedure
Baseline characteristics did not differ significantly between both groups (Table 1). In 
the DR group one patient was treated for epididymitis after surgery and a second had 
acute tubular necrosis due to peroperative hypotension; renal function restored within 
days. In the control group one procedure was complicated by an iatrogenic perforation 
of the colon which was surgically corrected. This patient developed peritonitis and was 
therefore excluded from the study.
nutritional intervention
All patients adhered to the study protocol without reporting adverse events. Baseline en-
ergy intake of the groups was 1863±591 kilocalories (kcal)/day (control) and 1957±408 
kcal/day (DR). Calorie intake in the control group was comparable during the four-day 
pre-operative period (1853±675) kcal/day). In the DR group the preoperative intake 
was reduced with 31.4% (29.5%-33.0%) to 1322±251 kcal/day. Macronutrient com-
position of the diets did not differ between both groups (Table 2).
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C-reactive protein
Baseline values of CRP (DR: 2.17 ± 1.63 mg/L vs. control: 2.5 ± 2.2 mg/L, p=0.905) did 
not differ between both groups. CRP levels peaked on postoperative day two in both 
groups. No statistically significant differences in CRP levels were found between both 
groups at any of the examined time points.
leukocytes
The baseline number of leukocytes (DR: 6.99 ± 1.52 x 109/mL vs. control: 7.35 ± 2.23 
x 109/mL, p=0.616) did not differ between both groups. On the first postoperative day, 
the number of leukocytes in the control group was significantly (p=0.02) higher than 
the DR group. After performing a mixed model analysis, which takes into account 
serial measurements, the overall number of leukocytes was not significantly different 
Table 1: Baseline characteristics of the study population
DR1 (n = 17) Control (n = 13) P-value
Age (Years) 54±9 56±13 0.642
Male : Female ratio (%) 6 (35):11(64) 6 (46):7 (53) 0.711
Height (cm) 171±7.0 166±7.6 0.104
Weight (kg) 74±15 75±13 0.797
BMI (kg/m2) 25.0±4.0 26.7±3.4 0.812
Weight (kg)
 Onset of study 74±15 75±11 0.812
 One day before surgery 74±15 75±12 0.584
Blood glucose2 (mmol/L) 4.7±0.5 4.6±0.6 0.569
1 DR = dietary restricted group.
2 Blood obtained after a midnight fast at the outpatient department, several months prior to surgery.
Table 2: Macronutrient composition of baseline and preoperative diets. Data are presented as means ± 
standard deviation.
Baseline diet1 Pre-operative diet2
Control (n = 13)
 Protein3 16.7 (3.1)
 Carbohydrates4 48.3 (6.4) 46 (5.0)
 Fat5 32.2 (5.2) 32.1 (5.5)
DR# (n = 17)
 Protein3 17.3 (2.9) 18.0 (3.4)
 Carbohydrates4 49.8 (5.0) 50.3 (5.6)
 Fat5 30.4 (7.0) 31.4 (6.1)
1 Mean values of the three day food record form completed several months prior to the operation.2 Based on 
food record form filled in prior to surgery or the report of adherence to the prescribed diet.3 Energy percentage 
derived from proteins.4 Energy percentage derived from carbohydrates.5 Energy percentage derived from fat. # 
DR = dietary restricted group.
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(p=0.098).In addition, the lower leukocyte count in the DR group, which was seen only 
on postoperative day one, was still within the normal range. Altogether, this difference 
must be regarded as a trend (Figure 1).
immuno-phenotyping
On day one before surgery, B-cells (CD19+), T-cells (CD3+), CD3+/CD4+ T-cells, CD3+/
CD8+ T-cells and natural killer cells (CD3-/CD16+/CD56+) did not differ between both 
groups. HLA-DR expression on T-cells (CD3+/HLA-DR+) was also unaffected by dietary 
restriction (Figure 2). Postoperatively, there were no significant differences between 
both groups in absolute lymphocyte numbers. HLA-DR expression on T-lymphocytes 
was also comparable between both groups. The surgical procedure induced a signifi-
cant decrease in absolute numbers of B- and T- lymphocytes. This was unaffected by 
the study diet. However, in the calorie-restricted group the number of natural killer 
cells decreased significantly postoperatively (p<0.001) which was not observed in the 
control group (p=0.08).
Cytokine analysis
IL-1ß, IL-2, IL-4, IL-5, IL-12p70, and TNF-α levels did not exceed the detection limit 
of the test in both groups at any time point measured. Serum levels of IFN-γ, IL-10, 
IL-6 and IL-8 are presented in Figure 3. IFN-γ levels were not affected by the surgi-
cal intervention nor by DR. IL-8 serum levels peaked at 6 hours after surgery in both 
groups, and were significantly higher in the DR group, when compared to the control 
group, over the six perioperative days (p=0.018). When the postoperative IL-8 levels 
were corrected for their preoperative value, no differences with regard to the postop-
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figure 1: Number of leukocytes on preoperative and postoperative days for both the dietary restricted 
and control group. Data are presented as mean, the error bars represent the standard error of the mean. 
An asterix (*) indicates a significant difference (p=0.02).
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figure 2: Immuno-phenotyping for both the dietary restricted and control group. Data are presented 
as means, the error bars represent the standard error of the mean. An asterix (*) indicates a significant 
difference between the pre- and postoperative values. No statistically significant differences were found 
between the number of cells between the two groups, both pre- and postoperatively.
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erative response were observed (data not shown). This indicates that the diet induced 
significantly higher IL-8 levels pre-operatively, but did not affect the magnitude of the 
postoperative response. IL-6 levels increased after surgery during the first postoperative 
day in both groups, after which they returned to normal on postoperative day four.IL-10 
levels showed a similar pattern. No significant differences between both groups were 
observed. The ratios between pro-inflammatory and anti-inflammatory cytokines (IL-6/
IL-10 and IL8/IL-10) did not differ significantly between both groups (data not shown).
lPs stimulation tests
In 17 patients (9 DR vs. 8 controls) LPS stimulation tests on whole blood samples, 
obtained before and after surgery, were performed (Figure 4). There were no significant 
differences between the two patient groups in cytokine levels in unstimulated samples 
(data not shown). Cytokine levels in the unstimulated preoperative samples were not 
statistically different from the unstimulated postoperative values in both groups (data 
not shown). After stimulation with LPS, cytokine levels increased significantly in all 
samples tested. No statistically significant differences between both experimental 
groups were found, although we observed a consistent trend in the DR group, where all 
cytokine levels tended to be lower after stimulation. In the DR group TNF-α levels were 
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figure 3: Perioperative cytokine levels for both the dietary restricted and control group. There are no 
significant differences in the levels of IFN-γ, IL-6 and IL-10. The levels of IL-8 are significantly higher in 
the DR group, when compared to the control group (p=0.018).
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figure 4: Whole blood stimulation with LPS of pre- and postoperative samples of both the dietary re-
stricted and control group. Lines represent the cytokine response after stimulation with LPS of individual 
patients before and after surgery. All cytokine values are expressed as: picogram/1*106 white blood 
cells. Tumor necrosis factor alpha production upon LPS stimulation is significantly reduced postopera-
tively in the DR group (p=0.001).
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significantly lower after stimulation (p=0.001) in samples obtained postoperatively 
when compared to preoperative stimulated samples.
DisCussion
We hypothesized that short term DR is able to improve acute stress resistance in hu-
mans, and reduce the acute phase response after surgical trauma. We designed a DR 
regimen involving three preoperative days of 30% DR and one day of fasting. In the DR 
group we observed a trend towards lower numbers of postoperative leucocytes while 
IL-8 serum levels were significantly higher. In postoperative whole blood samples from 
the DR group, TNF-α levels were significantly lower after stimulation with LPS when 
compared to preoperative samples, which was not the case in the control group.
The preoperative diet we applied in this study is based on our previous studies25 
and reports that DR is able to improve resistance to acute stressors such as ischemia 
and reperfusion injury of the liver9, and the toxic side effects of chemotherapy8. We 
studied live kidney donors, who are a healthy, homogenous patient group undergoing 
a standardised operation, rendering them a suitable study population.
Leukocyte numbers are known to increase after surgical trauma and peak on the 
first postoperative day24. Conventional (open) surgery causes more surgical stress than 
laparoscopic procedures, and induces higher leukocyte peak values24. The peak in total 
leukocytes on postoperative day one was significantly lower in the DR group when 
compared to the control group. However, as the mixed model analysis over all time-
points was not significantly different between both groups, this can only be interpreted 
as a trend. If anything, DR did not lead to increased numbers of leukocytes. As differ-
ences in T-cell, B-cell or NK-cell number could not have accounted for this increase it 
should be due to increased levels of other cell types, most likely granulocytes.
In accordance with previous reports26-29, serum levels of IL-1β, IL-2, IL-4, IL-5, IL-
12p70 and TNF-α were undetectable during to pre- and postoperative period. IFN-γ 
levels were unaffected by the operation26,29, whereas IL-10 levels increased shortly after 
surgery26. IL-6 serum levels are often reported as markers of surgical trauma30,31. IL-6 
levels in our study are similar to those previously reported after laparoscopic surgery, 
and lower when compared to major open surgery26.
We hypothesized that the acute phase response, as measured by increases in IL-6 
and CRP serum levels, would be attenuated in the DR group as the magnitude of 
the acute-phase response is directly proportional to the degree of surgical stress30,31. 
Laparoscopic donor nephrectomy in this study was followed by a fast and unevent-
ful recovery, without major complications in both groups. The relatively mild surgical 
trauma induced by laparoscopic nephrectomy was reflected by low levels of both CRP 
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and IL-6 and were therefore unlikely to be influenced by DR. This raises the question if 
live kidney donors are a suitable study population to test our hypothesis, as the surgical 
trauma is relatively mild. Preoperative dietary modifications might therefore be more 
beneficial in patient populations undergoing more extensive surgery.
IL-8 levels were significantly higher in the DR group, both pre- and postoperatively. 
These increased levels were not correlated with infectious complications after surgery, 
as has been reported before32. In obese men following DR for eight weeks, circulating 
IL-8 levels also increased with 30%33. A slight increase in IL-8 may desensitize against 
the proinflammatory effects of subsequent high IL-8 levels34. Mice over producing IL-8 
exhibit decreased exudation of neutrophils into body cavities in response to acute 
inflammatory stimuli35. We therefore speculate that the preoperative rise in IL-8 levels 
by DR reduces its subsequent pro-inflammatory effect in the postoperative period. This 
is partially supported by our finding of a trend towards lower numbers of postoperative 
peripheral leukocytes in the DR group.
In line with previous reports23,36, a decrease in the number of B- and T-lymphocytes 
following surgery was observed, which was similar in both groups. Although the num-
ber of NK cells was significantly reduced in the DR group, the absolute mean numbers 
were 0.14 *109 cells/L (DR) and 0.15 *109 cells/L (control). This is very unlikely to have 
a clinically relevant impact, as the values are well within the normal range.
In contrast to the relatively mild acute phase response induced by laparoscopic ne-
phrectomy, LPS is a major stimulus to the immune system. Stimulation of preoperative 
whole blood samples showed that dietary restriction itself did not influence the reactiv-
ity to LPS. In postoperative samples, TNF-α levels were significantly lower after LPS 
stimulation in the DR group, when compared to the stimulated preoperative samples. 
Since TNF-α is important in the acute phase response, this observation supports our 
hypothesis that DR attenuates the postoperative inflammatory response. And although 
not significant, there was a clear trend towards a lower production of all other cytokines 
after LPS stimulation in de DR group.
Although several parameters of the acute phase response were blunted by preopera-
tive DR, we are not able to draw firm conclusions with regard to the clinical conse-
quences. As mentioned before, live kidney donors undergo a relatively mild surgical 
procedure, with a very low complication rate, which makes it difficult to speculate 
about the clinical implications of our findings. Furthermore, the immunological pa-
rameters were obtained over a relatively short perioperative period. This prevents the 
detection of changes occurring at later time points. Anesthesia is known to influence 
postoperative immune function up to several days after surgery37. The anesthetic regi-
men in our study was rigorously adhered to and similar in both groups. Therefore, the 
differences between the immunologic parameters are very likely to be caused by the 
preoperative dietary intervention. Differences in postoperative food intake may influ-
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ence the measured indices. We have registered the patients’ postoperative appetite 
using a visual analogue score (data not shown) and found no significant differences. 
It is therefore unlikely that differences in postoperative calorie intake influenced the 
outcome. Finally, since the kinetics of onset of the beneficial effects induced by DR are 
not know in humans, the length and severity of our dietary intervention may have been 
insufficient to induce the maximal beneficial response.
The possible relevance for the clinical situation warrants further investigation as 
preoperative DR may activate protective mechanisms that induce increased resistance 
to the post surgical inflammatory response. Human studies on stress resistance and 
nutrition are sparse, and our study provides important information that corroborates 
with experimental evidence that calorie restriction is able to blunt the inflammatory 
response.
In summary, we hypothesized that short-term DR increases acute stress resistance 
in humans and reduces the acute phase response following surgical trauma. We found 
evidence to suggest that a relatively short nutritional intervention was able to induce 
beneficial changes in the acute phase response after a mild surgical intervention. We 
feel that our data warrant more clinical studies to define the relevant dietary conditions 
and patient populations which might benefit from them. Furthermore, other parameters, 
which provide additional insight into whether the post-operative stress response was 
ameliorated, need to be investigated.
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suMMARy AnD DisCussion
In the beginning of the twentieth century a non-invasive way to prolong the life- and 
health span of various animal species, including non-human primates, was found: 
dietary restriction (DR). DR may be performed by various regimens such as calorie 
restriction (CR), fasting, and alternate day fasting (ADF). CR refers to an intervention in 
which the total daily amount of calories provided to an animal or organism is limited 
to a certain percentage of the animals’ normal daily intake. ADF regimens involve a 
“feast day” on which food is consumed ad libitum that alternates with a “fast day” on 
which food is withheld. Fasting is abstinence of all food with ad libitum access to water. 
Although studies investigating the effect of DR in humans on lifespan are lacking there 
are reports which suggest that DR might be of benefit in humans as well. In addition, 
long-term interventions (e.g., months, years) are not amendable in the clinical setting. 
The overall aim of this thesis was to examine whether the beneficial effects of long-term 
DR could be induced by short-term nutritional interventions. Furthermore, the feasibil-
ity of DR in the clinical setting was investigated.
In chapter 2 we reviewed the literature on short-term DR interventions and protection 
afforded against ischemia-reperfusion (I/R) injury in animal models. We concluded that 
overnight fasting as well as slightly longer periods (up to 4 days) protect against I/R. The 
effects of preoperative fasting on I/R injury were investigated, as it was suggested that 
donor nutritional status may affect outcome after liver transplantation. In addition, it 
was suggested that starvation of donors, due to prolonged stay in the intensive care unit, 
may adversely affect the transplanted liver1. In contrast to this hypothesis, fasting for 
one to four days protected rat livers from cold preservation injury and resulted in higher 
survival rates after orthotopic liver transplantation in rats2 Preoperative DR regimens 
also protected other organ systems such as brain, heart, liver, and retina against I/R 
injury in animal models. The proposed protective mechanisms of DR include upregula-
tion of cytoprotective molecules such as heat shock proteins and hemeoxygenase-13.
Overall, these animal studies suggest potential uses for DR in the clinical setting, 
however there are several drawbacks that need attention. Clinical trials have demon-
strated adverse effects of the fasted state for surgical patients4-6. In addition, randomized 
clinical trials demonstrated that preoperative administration of carbohydrate-rich drinks 
improves insulin sensitivity and increases patient well-being7-12. Furthermore, restrict-
ing preoperative dietary intake may be detrimental in already malnourished patients. 
Therefore, future research should focus on the role of specific macronutrient compo-
nents and DR mimetics or agents that may impinge on (some) of the pathways induced 
by DR. However, to pharmaceutically mimic the effects of DR, the mechanisms by 
which DR exerts is beneficial effects need to be defined.
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In chapter 3 we sought to elucidate the mechanisms of protection induced by fasting 
against hepatic I/R injury in mice. Mice were fasted for 72 hours or fed ad libitum 
prior to 75 minutes of partial (70%) hepatic ischemia, followed by 6 and 24 hours of 
reperfusion. It was found that fasting decreased hepatocellular I/R injury. In addition, 
baseline mRNA expression levels of hemeoxygenase-1 and the mitochondrial anti-
oxidants superoxide dismutase-2 glutathione peroxidase-1 and glutathione reductase 
were significantly upregulated in livers from 72 hours fasted animals when compared 
to ad libitum fed animals. Six hours after reperfusion, expression levels of these genes 
were also significantly higher compared to control mice. After reperfusion p-selectin 
and interleukin-6 were significantly reduced in the fasted mice, and superoxide radi-
cal generation and neutrophil influx were significantly attenuated in the fasted group 
compared to the ad libitum fed group. We conclude that the protective effect of short-
term fasting against hepatic I/R injury is induced by increased baseline expression of 
mitochondrial antioxidant enzymes and the stress response gene heme-oxygenase-1 
(HO-1).
It is known that steroids have anti-inflammatory properties and that they are capable of 
improving the outcome after liver transplantation. In chapter 4 we hypothesized that 
the protection imposed by fasting is mediated by increased levels of corticosterone, 
induced by the stress of food deprivation. C57BL/6 mice were fasted for 1, 2, or 3 
days after which serum corticosterone levels were determined. Fasting significantly 
increased serum corticosterone levels. To prevent corticosterone production, mice 
underwent a bilateral adrenalectomy (ADX) or sham operation ten days prior to fasting 
and subsequent renal I/R injury. Mice subjected to ADX exhibited a higher mortality 
rate after renal I/R injury compared with sham-operated mice. However, ADX mice 
subjected to sham I/R injury demonstrated similar high mortality rates as ADX mice that 
underwent renal I/R injury. Therefore, these experiments did not address our hypothesis 
that the protection afforded by fasting is due to increased corticosterone levels, but 
showed that mice without adrenal glands do not withstand subsequent surgery. We 
therefore designed a new set of experiments. Mifepristone, a glucocorticoid receptor 
antagonist, blocks the downstream signaling of the glucocorticoid receptor. The use 
of mifepristone enables controlled studies on the effects of corticosterone on renal I/R 
injury without the need for a bilateral ADX. Mifepristone was administered daily during 
the 3-day fast, prior to renal I/R injury, while control mice received PBS at the same 
time-points. The mifepristone regimen did not abolish the protection afforded by fasting 
on renal I/R injury. Survival rates and kidney function were similar in both groups. 
Therefore, our results indicate that fasting-induced protection against renal I/R injury is 
mediated by corticosterone/glucocorticoid receptor-independent pathways. In chapter 
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3 we demonstrated that fasting increases baseline expression levels of mitochondrial 
antioxidant enzymes and the stress response gene HO-1. We showed that mifepristone 
treatment did not interfere with the upregulation of antioxidant defense systems. It 
would be of interest to investigate whether an agent that exactly mimicks the kinet-
ics of corticosterone production during fasting is able to increase the expression of 
cytoprotective genes, for instance by corticosteroid administration.
Next, we investigated the role of ghrelin in the protection against renal I/R injury. In 
chapter 5 C57BL/6 mice were fasted for one, two, or three days after which acylated 
ghrelin levels were determined. Fasting significantly increased acylated ghrelin levels 
in serum. To mimic the increased ghrelin levels induced by fasting, ad libitum fed 
mice were injected with acylated ghrelin or PBS prior to renal I/R injury. In contrary, 
to block the effects of fasting induced ghrelin production mice were injected with a 
growth hormone secretagogue receptor antagonist13 or a vehiculum prior to renal I/R 
injury. Administration of acylated ghrelin or ghrelin receptor blockade did not affect 
renal function after I/R injury. However, it has been shown that treatment with acylated 
ghrelin improves renal function after I/R injury in a similar model14. These conflicting 
results can be explained by the time-point of administration as we administered acyl-
ated ghrelin prior to renal I/R injury, while Takeda et al.14 administered ghrelin both 
before and after I/R injury. Although we cannot exclude a protective effect of ghrelin 
treatment on renal I/R injury, our data demonstrate that increased levels of acylated 
ghrelin induced by fasting and ghrelin receptor signaling do not mediate its protection 
against renal I/R injury.
In chapter 6 the therapeutic use of dietary restriction is extended. For most patients 
with colorectal malignancies surgical resection is the cornerstone of any potentially 
curative treatment. Surgical trauma results in systemic inflammation as reflected by 
cytokine release15,16 and in postoperative cellular immunosuppression17. There is emerg-
ing evidence suggesting that these surgery-induced processes facilitate development 
and outgrowth of tumor metastases18. Postoperative inflammatory responses facilitate 
metastasis formation of circulating tumorcells by increasing the expression of adhesion 
molecules. We have shown that two weeks of dietary restriction reduces the expression 
of adhesion molecules and protects against surgically induced inflammation. DR might 
therefore beneficially interfere with surgery-induced inflammation and subsequent 
adhesion of circulating tumorcells. BALB/c mice were subjected to two weeks of 30% 
dietary restriction prior to inoculation with tumor cells in the liver. Hepatic tumor load 
was scored after ten days as a percentage (tumor surface/total liver surface) on H&E 
stained sections. We found that DR reduces hepatic tumor load and mRNA expression 
of E-selectin. Furthermore serum obtained from DR mice reduced in vitro adhesion of 
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C26 colon carcinoma cells to human vascular endothelial cells. Although we do not 
show a direct correlation, it has been demonstrated that E-selectin plays an crucial role 
in the process of liver metastasis formation in the murine BALB/c-C26 colon carcinoma 
model as direct blockage of E-selectin was associated with lower numbers of liver 
metastasis19. The question remains why DR lowers E-selectin expression. We recently 
reported that DR robustly down regulates the production of proinflammatory cytokines 
and adhesion molecules in models of renal and hepatic ischemia-reperfusion injury20. 
In addition DR induced the expression of cytoprotective and anti-oxidant genes, leading 
to a reduced formation of reactive oxygen species20. As surgical trauma causes oxida-
tive stress21,22, the increased protection against oxidative stress and the subsequently 
reduced inflammatory response induced by DR, may explain why E-selectin expression 
is reduced.
So far, therapeutic effects of short-term preoperative dietary restriction have been ob-
served in animal models only. Therefore, in chapter 7 we describe a pilot study which 
investigates whether a relatively mild preoperative DR regimen is feasible in the clinical 
setting and explored the effects of DR in surgical patients. Live kidney donors were 
randomized between preoperative DR and ad libitum food intake. Seventeen partici-
pants were instructed to follow a 30% calorie-restricted diet, followed by one day of 
water-only fasting prior to surgery. Thirteen participants were allowed to eat ad libitum 
preoperatively. We show that modest preoperative DR is feasible in the clinical setting 
and has no measurable effect on postoperative well-being, ability to perform daily tasks 
and complication rates of live kidney donors. We performed this study in live kidney 
donors since they were eager to participate and very committed, which likely benefits 
the accurate reporting of food intake. Although compliance was measured subjectively 
and is difficult to assess with objective measurements, compliance with the diet was 
high (94%) in this motivated group.
We hypothesized that a preoperative diet in live kidney donors would enhance the 
resistance of the kidney against ischemia and reperfusion injury, leading to better graft 
function in the recipient. To assess the effect of preoperative DR on renal transplant 
function, we measured graft function on the first postoperative day by means of re-
nography and during the first month by serum creatinine levels in the recipient. We 
found no effects of DR on renal graft function. We acknowledge that this study is a pilot 
study and not sufficiently powered to draw definite conclusions about the relationship 
between preoperative DR and renal transplant function. As our diet failed to dem-
onstrate beneficial effects on postoperative graft function, longer and more extensive 
dietary regimens may be needed. This preoperative diet may set the stage for future 
work aiming at inducing protection against surgical trauma and I/R injury by dietary 
interventions.
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In chapter 8 we investigated the effect of preoperative DR on the postoperative immune 
response in the patients described in chapter 7. We hypothesized that short-term DR in 
humans reduces the acute phase response following a well defined surgical trauma. Be-
fore and after surgery, leukocyte numbers and serum cytokine levels were determined. 
Whole blood was stimulated with lipopolysaccharide (LPS) and cytokine production 
was determined. Leukocyte numbers are known to increase after surgical trauma and 
peak on the first postoperative day23. The peak in total leukocytes on postoperative day 
one was significantly lower in the DR group when compared to the control group. 
However, as a mixed model analysis over all time-points was not significantly different 
between both groups, this should be interpreted as a trend. The acute phase response, 
as reflected by increased IL-6 and CRP serum levels, was not attenuated by DR. Fur-
thermore, IL-8 serum levels were significantly higher in the DR group over the first 
postoperative days. A slight increase in IL-8 may desensitize against the proinflamma-
tory effects of subsequent high IL-8 levels24. Mice overproducing IL-8 exhibit decreased 
exudation of neutrophils into body cavities in response to acute inflammatory stimuli25. 
We therefore speculate that the preoperative rise in IL-8 levels by DR reduces its subse-
quent pro-inflammatory effect in the postoperative period. Stimulation of preoperative 
whole blood samples showed that dietary restriction itself did not influence the reactiv-
ity to LPS. In postoperative samples, TNF-α levels were significantly lower after LPS 
stimulation in the DR group, when compared to the stimulated preoperative samples. 
Since TNF-α is important in the acute phase response, this observation supports our 
hypothesis that DR attenuates the postoperative inflammatory response. Overall, these 
data suggest that a relatively short nutritional intervention induces beneficial changes 
in the acute phase response after a mild surgical intervention. Therefore, our data war-
rants further clinical studies to investigate the relevant dietary conditions and patient 
populations which might benefit from them.
fuTuRE PERsPECTivEs
Translation of the results of preoperative DR from animal studies to the clinical setting 
poses a challenge. We have demonstrated the feasibility of a preoperative diet consist-
ing of three days 30% DR and one day of fasting in humans. In literature periods much 
longer than two weeks of 30% DR in humans have been reported26, but not prior to 
surgery. Surgical patients may be malnourished and may not tolerate and/or respond 
to DR similarly as healthy animals or humans. Therefore, future research should not 
be limited to healthy animals, but investigate the effect of preoperative DR in mouse 
models of cancer or other pathologies such as hepatic steatosis. Steatotic livers are 
susceptible to I/R injury, and may be protected by preoperative DR. In addition, it 
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allows to investigate the effect of DR and chemotherapy on tumor growth. Further 
research should also focus on the role of specific macronutrient components in the 
protection induced by DR.
A diet consisting of protein restriction without a reduction in calories has been 
shown to increase maximum longevity in rats and mice27. Although the magnitude of 
these changes is around 30–40% of that of DR, neither carbohydrate28 nor lipid restric-
tion29,30 exerted these effects. Restriction of proteins could therefore be another way 
to induce the beneficial effects seen after DR and overcome the problem of reducing 
calorie intake. We have recently performed experiments in mice showing that a protein 
free diet protected against both renal and hepatic I/R injury. Future experiments will be 
designed to investigate the role of preoperative restriction of essential aminoacids such 
as methionine, as it has been demonstrated that restriction of this essential aminoacids 
increases lifespan as well31.
As mentioned earlier, the use of DR mimetics may be a way to overcome the problems 
associated with DR in surgical patients. A DR mimetic can be defined as any pharmaco-
logical intervention that produces beneficial effects of DR without causing or requiring 
a significant reduction in calorie intake. One compound that has received considerable 
attention as DR mimetic is resveratrol, a naturally-occurring polyphenol found in red 
wine. Resveratrol induces, at doses that can be readily achieved in humans, genomic 
changes which resemble many of the genetic alterations induced by DR32. Resveratrol 
treatment decreases hepatic I/R injury by significantly increasing glutathione reductase, 
Cu/Zn-superoxide dismutase, and catalase activities33. Furthermore, evidence support-
ing the use of resveratrol in the treatment of malignancies is emerging. Resveratrol 
exerted cytotoxic effects on neuroblastoma cells and on the human cholangiocarci-
noma SK-ChA-1 cell line34. In addition, resveratrol treatment suppressed the growth 
rate of subcutaneous neuroblastomas35. It has been demonstrated that the anticancer 
activity of this compound is mainly due to induction of apoptosis36. However, studies 
investigating the effect of resveratrol on life-span have conflicting results.
We were unable to demonstrate major beneficial effects of preoperative DR in the 
clinical setting. For future trials the following topics need to be considered. The ability 
of a diet to induce a protective response may have been insufficient, as the magnitude 
of the diet was not comparable to three days of fasting in mice. Increasing the length 
and severity of the DR regimen, or altering the macronutrient composition are potential 
avenues to proceed preoperative DR in humans. Furthermore, the laparoscopic donor 
nephrectomy in our study was a relatively mild surgical intervention which was fol-
lowed by a fast and uneventful recovery, without major complications. The relatively 
mild surgical trauma induced by laparoscopic nephrectomy was reflected by low levels 
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of both CRP and IL-6 which makes a measureble effect of DR unlikely. This raises 
the question if live kidney donors and the mild surgery-induced trauma are a suitable 
population to study our hypothesis. Preoperative dietary modifications might be more 
beneficial in patients undergoing more extensive surgery. In addition, live donor grafts 
are the grafts least likely to benefit from DR due to the already very good results. How-
ever, the results are not uniformly successful. One of the factors independently associ-
ated with poorer graft survival of kidneys from live donors is a donor age older than 59 
years37. Experimental studies show that older kidneys are more susceptible to ischemia 
and reperfusion injury and that DR protects old kidneys against ischemia-reperfusion 
injury38,39,40. The power to demonstrate a difference in renal function between DR and 
control grafts in our study may have been intrinsically limited, since we have included 
donors from all ages instead of limiting the study to “older” donors.
The beneficial effects of DR may not be limited to transplant patients, but could be 
extended to patients who have suffered spinal cord injury or are diagnosed with 
malignant disease. Plunet et al.41 showed that DR is also be effective when applied 
after surgical induction of cervical spinal cord injury in rats. DR resulted in a 50% 
reduction in lesion volume, improved regeneration, and improved behavioral recovery. 
As the onset of I/R injury due to trauma is unpredictable and therefore not amenable to 
planned nutritional interventions, this is particularly interesting.
It has been shown that preoperative fasting in mice protects normal cells against the 
toxic side effects of chemotherapy, whereas tumor cells were more sensitive to the 
therapy. This enabled the administration of very high doses of chemotherapy, without 
the side effects as normally seen with this regimen12. These data are supported by the 
case history of ten patients who voluntarily fasted prior to different chemotherapy 
regimens and reported fewer side effects42.
For the near future, it is necessary to strengthen and confirm our findings that preopera-
tive DR induces protection against oxidative damage, by applying DR in a large animal 
model. Pigs resemble the human situation and future experiments should determine 
whether preoperative DR also induces its beneficial effects against I/R injury in a pig 
model. If DR works in both mice and pigs, the likelihood of DR working in humans 
increases. Hereafter, research should focus on identifying the underlying mechanisms 
that induce protection on one hand and the optimal macronutrient composition to pro-
tect against I/R injury on the other. Microarray analysis can be used to investigate DR 
mechanisms as these analyses identify differences in gene expression patterns between 
DR and control livers. There is a group of candidate genes which could play a pivotal 
role in the effects of DR. In 2000, Lin et al43 proposed that sirtuins, homologues of the 
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yeast Sir2 protein, are critical mediators of the effects of DR. They mimicked calorie 
restriction in yeast by physiological or genetic means and showed a substantial exten-
sion in life-span. This extension was not observed in strains mutant for SIR2. It would be 
interesting to investigate if sirtuins play a role in inducing protection against I/R injury.
In conclusion, preoperative DR is a promising non-invasive strategy with therapeutic 
benefits in various experimental settings. Future research is needed to specify the role 
of DR or its mimetics in the clinical setting.
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Aan het begin van de twintigste eeuw ontdekte men dat calorische restrictie (CR), het 
reduceren van de dagelijkse inname van calorieën zonder tekorten aan vitaminen en 
mineralen te veroorzaken, levensverlengend werkt. Dit fenomeen is beschreven bij vele 
verschillende diersoorten, waaronder primaten. Zowel de gemiddelde als de maximale 
levensduur bleek bij deze dieren toe te nemen. Daarnaast bleek CR te leiden tot minder 
schade geïnduceerd door vrije zuurstofradicalen, zowel in vitro als in vivo1. Er zijn ver-
schillende vormen van CR die deze gunstige effecten kunnen induceren. Allereerst kan 
men de dagelijkse hoeveelheid aan calorieën beperken tot een bepaald percentage van 
de normale dagelijkse inname. Daarnaast kan men om de dag vasten. Hierbij wordt de 
periode van vasten gevolgd door eenzelfde periode waarin men onbeperkt mag eten, 
de totale inname van calorieën hoeft hierbij niet verminderd te zijn. Hoewel er tot op 
heden geen onderzoek is gedaan naar de effecten van CR op levensverlenging van de 
mens, zijn er aanwijzingen dat CR ook in mensen werkt. De bevolking van Okinawa 
(Japan) consumeert gemiddeld 20% minder calorieën per dag en staan bekend om hun 
hoge levensverwachting en lage risico op ouderdomsziekten2.
In dit proefschrift onderzochten wij of een kortdurend dieet bescherming kan indu-
ceren tegen oxidatieve schade (door vrije zuurstofradicalen) bij proefdieren. Bovendien 
werd de mogelijkheid bestudeerd om een CR-schema toe te passen op mensen.
hoofdstuk 2 biedt de uitkomsten van een literatuurstudie naar de effecten van het 
kortdurend diëten op de bescherming tegen vrije zuurstof radicalen. Vrije zuurstofra-
dicalen spelen een belangrijke, nadelige rol bij orgaan transplantaties. Gedurende een 
orgaantransplantatie is er een periode van ischemie en vervolgens recirculatie van het 
donororgaan. Tijdens de ischemische periode is het orgaan losgekoppeld van de bloed-
circulatie waardoor er zuurstofgebrek ontstaat. Na de implantatie van het orgaan in de 
ontvanger vindt er recirculatie (reperfusie) van bloed plaats. Direct na reperfusie moet 
de stofwisseling in het orgaan zich herstellen, waardoor er kortdurend een relatieve 
overvloed aan zuurstof aanwezig is, wat leidt tot de vorming van schadelijke vrije zuur-
stofradicalen. Dit noemen we ischemie en reperfusie (I/R) schade. In de jaren negentig 
ontstond het idee dat de voedingstoestand van een donor een belangrijke invloed heeft 
op de weerstand van het donororgaan tegen I/R schade3. Men dacht dat het orgaan van 
een ondervoedde donor slechter bestand was tegen I/R schade. Uit onze literatuurstudie 
bleek echter dat enkele dagen vasten in een ratmodel voorafgaand aan een orthotope 
levertransplantatie, leidde tot betere resultaten. Het “gevaste” orgaan was beter bestand 
tegen I/R schade. Dit kan mogelijk veroorzaakt worden door veranderingen in het he-
moxygenase-1 (HO-1) systeem. Niet alleen de lever, maar ook de hersenen, het hart en 
de retina bleek men te kunnen beschermen tegen I/R-schade door kortdurende diëten.
Voordat deze voedingsinterventies toegepast kunnen worden in de humane situ-
atie, is het belangrijk om enkele kanttekeningen te plaatsen. Er zijn onderzoeken die 
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beschrijven dat het nadelig is voor patiënten om nuchter te zijn voor een operatie4-6. 
Daarnaast zijn er gerandomiseerde studies die laten zien dat het innemen van een 
koolhydraatrijke drank voor de operatie leidt tot betere insulinegevoeligheid en welbe-
vinden na een operatie7-12. Tevens is het onbekend of een pre-operatief dieet veilig kan 
worden toegepast in ondervoedde patiënten. Vervolgonderzoek naar de bijdrage van 
verschillende voedingscomponenten aan het beschermende effect is daarom nodig. 
Wellicht kan men slechts één voedingscomponent weglaten en op die manier, zonder 
calorische restrictie, dezelfde bescherming induceren. Daarnaast zou het wenselijk 
zijn om met een medicijn het effect van een preoperatief dieet te induceren. Hiervoor 
is het belangrijk om te weten via welke mechanismen een preoperatief dieet beschermt 
tegen I/R-schade.
In hoofdstuk 3 onderzochten we in een diermodel de mechanismen die ten grondslag 
liggen aan de door vasten geïnduceerde bescherming tegen I/R-schade van de lever. 
Om dit te onderzoeken werden muizen gedurende drie dagen te vasten gezet of nor-
maal gevoerd voorafgaand aan de inductie van I/R-schade in de lever. Vervolgens werd 
gedurende 75 minuten de bloedstroom naar 70% van de lever onderbroken waarna 
reperfusie plaatsvond. Zes en 24 uur later onderzochten we de lever. Pre-operatief 
vasten leidde tot een vermindering van I/R-geïnduceerde leverschade. Daarnaast was 
er na vasten sprake van een toegenomen expressie van verschillende beschermende 
genen, zoals HO-1 en enkele mitochondriale antioxidanten (superoxide dismutase-2, 
glutathione peroxidase-1 en glutathione reductase), in vergelijking met de controle-
groep. Dit verschil bleef bestaan tot zes uur na reperfusie. Naast deze toegenomen 
hoeveelheid van beschermende genen, was er bij de dieren die gevast hadden ook 
sprake van een mildere inflammatoire respons (P-selectine en interleukine 6), minder 
infiltratie van ontstekingscellen en minder radicaalvorming. Wij concluderen dat de 
toegenomen expressie van HO-1 en antioxidanten door het dieet veroorzaakt zijn 
en een belangrijke rol spelen in het mechanisme van de beschermende werking van 
vasten. Echter, het is niet duidelijk welke processen ten grondslag liggen aan deze 
verhoogde expressie.
Het is bekend dat steroïden ontsteking kunnen remmen en dat het gebruik ervan een 
gunstige werking heeft op de uitkomst van een levertransplantatie. Wij veronderstelden 
in hoofdstuk 4 dat de beschermende werking van vasten geïnduceerd wordt door 
een toename in corticosteron (CS) spiegels, ten gevolge van de stress van het vasten. 
Muizen werden te vasten gezet gedurende één, twee of drie dagen, waarna wij de con-
centratie van CS in het bloed bepaalden. Vasten leidde tot een significante stijging van 
CS. Aangezien CS wordt geproduceerd door de bijnieren werden vervolgens, om de 
toename van CS tijdens vasten te voorkomen, de bijnieren verwijderd (adrenalectomie, 
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ADX). Tien dagen hierna induceerden wij renale I/R-schade en we bestudeerden de 
overleving. Nier I/R schade werd geïnduceerd door het plaatsten van een klem gedu-
rende 37 minuten op de bloedtoevoer naar de nier. Er was sprake van een toegenomen 
mortaliteit in de ADX groep vergeleken met de controlegroep (geen ADX). Echter, 
indien we tien dagen na de ADX een sham I/R procedure toepasten was de mortaliteit 
identiek. Concluderend bleek dit model ongeschikt voor het testen van de hypothese.
Mifepristone, een glucocorticoid receptorantagonist, blokkeert de receptor waar CS 
aan bindt. Door het toedienen van mifepristone konden we onderzoeken of vasten 
beschermt tegen I/R schade wanneer het effect van CS geblokkeerd wordt. Gedurende 
de drie dagen vasten dienden wij mifepristone toe, waarna I/R schade van de nier werd 
geïnduceerd. Nierfunctie en overleving waren gelijk in de groep die mifepristone kreeg 
vergeleken met de controlegroep. Wij concludeerden dat CS geen rol speelt in de be-
scherming tegen renale I/R schade, geïnduceerd door vasten. Omdat wij in hoofdstuk 3 
lieten zien dat een verhoging van HO-1 expressie door vasten wellicht een belangrijke 
rol speelt in het induceren van bescherming, onderzochten wij of mifepristone dit ef-
fect teniet kan doen. Dit bleek niet het geval.
Een ander hormoon dat mogelijk een rol speelt in de beschermende werking van 
vasten tegen I/R schade is ghreline. In hoofdstuk 5 onderzochten wij of ghreline een 
rol speelt in deze bescherming. C57BL/6 muizen werden gevast voor een, twee of 
drie dagen waarna geacyleerd ghreline (ac-Gr) niveaus werden gemeten in het plasma. 
Vasten leidde tot een significante stijging van deze niveaus. Ook hebben wij ad libitum 
gevoedde muizen geïnjecteerd met ac-Gr gedurende drie dagen alvorens I/R schade 
in de nieren te induceren. Het toedienen van ac-Gr aan gevoedde muizen leidde niet 
tot bescherming tegen nierschade. De onderzoeksgroep van Takeda et al.13 toonde dit 
wel aan, maar zij gaven ook ac-Gr na de operatie. Tot slot hebben wij gevaste muizen 
behandeld met ghrelinereceptorblokkade14 om het effect van ghreline te neutraliseren 
voor I/R schade van de nier. Het blokkeren van de ghrelinereceptor had geen effect op 
de nierfunctie na I/R schade. Hoewel wij een beschermende werking van ghreline op 
renale I/R schade niet kunnen uitsluiten, suggereren onze resultaten dat ghreline geen 
rol speelt in het kader van het pre-operatief vasten en de bescherming tegen I/R schade 
van de nier.
In hoofdstuk 6 hebben wij een mogelijke uitbreiding van de toepassing van CR on-
derzocht. Voor veel patiënten met een colorectale maligniteit is een operatie de be-
langrijkste behandelmogelijkheid. Echter, een operatie leidt tot een ontstekingsreactie 
gekenmerkt door het vrijkomen van proinflammatoire cytokinen15-16 en cellulaire im-
muunsuppressie17. Er is steeds meer bewijs dat deze processen de vorming van metasta-
sen kunnen bevorderen18. Deze postoperatieve inflammatie vergemakkelijkt tumorcel 
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adhesie aan het endotheel door de expressie van adhesiemoleculen op het endotheel te 
verhogen. In eerdere experimenten hebben wij aangetoond dat een pre-operatief dieet 
de expressie van deze adhesiemoleculen vermindert en beschermt tegen chirurgische 
inflammatie. Wij stelden de hypothese dat pre-operatieve CR de post-operatieve ont-
stekingsreactie vermindert en hierdoor de aanhechting van circulerende tumorcellen 
aan endotheel vermindert. BALB/c muizen werden twee weken op een dieet gezet 
bestaande uit 30% minder calorieën, alvorens ze te injecteren met tumorcellen. Deze 
tumorcellen werden in de milt gespoten zodat zij uiteindelijk via de bloedbaan in 
de lever tot uitzaaiingen uitgroeien. Tien dagen hierna bepaalden wij de hoeveelheid 
tumor in de lever van de twee groepen; met en zonder CR. Er bleek minder tumor in 
de lever aanwezig te zijn van muizen die voor de operatie op dieet waren gezet. Ook 
vonden wij minder expressie van het adhesie molecuul E-selectine in de levers van 
CR muizen. Dit adhesiemolecuul komt voornamelijk voor op endotheel cellen van 
bloedvaten. Tevens hebben wij aangetoond dat het serum van muizen die twee weken 
op dieet hebben gestaan, ertoe leidt dat er in vitro minder adhesie is van tumorcellen 
aan endotheelcellen. Hoewel wij geen direct bewijs leveren dat een dieet leidt tot 
minder tumor cel adhesie in de lever door een verlaagde E-selectine expressie, is er 
wel een directe relatie aangetoond in de literatuur die onze hypothese ondersteund19. 
De vraag blijft echter, waarom leidt CR tot een verlaging van de expressie van adhesie-
moleculen? Recent hebben wij aangetoond dat CR leidt tot een verminderde productie 
van inflammatoire cytokinen en adhesiemoleculen in modellen van I/R schade in nier 
en lever. Daarnaast hebben wij aangetoond dat CR tot een verhoging leidt van enkele 
enzymen (o.a. HO-1), die beschermen tegen vrije zuurstofradicalen20. Andere hebben 
laten zien dat chirurgische schade ook tot de vorming van vrije zuurstofradicalen21-22 
leidt en dat deze mede verantwoordelijk kunnen zijn voor het ontstaan van de ontste-
kingsreactie. Concluderend leidt de beschermende werking van CR tegen oxidatieve 
schade mogelijk tot een reductie van de ontstekingsreactie en daardoor ook tot minder 
expressie van adhesiemoleculen.
Tot op heden is het merendeel van de gunstige effecten van CR aangetoond in diermo-
dellen. In hoofdstuk 7 onderzochten wij of een mild preoperatief CR dieet haalbaar is 
in de klinische setting en wat de effecten ervan zijn in het kader van een niertransplan-
tatie. Hiervoor zijn levende nierdonoren gerandomiseerd tussen een pre-operatief dieet 
of vrije voedingskeuze voor de operatie. Zeventien mensen kwamen in aanmerking 
voor een preoperatief dieet dat vier dagen voor de operatie begon. Drie dagen voor de 
operatie werd de calorische inname verminderd met 30%, en 24 uur voor de operatie 
mocht men alleen water drinken. Dertien patiënten mochten die vier dagen zelf kiezen 
wat en hoeveel ze aten. De resultaten van deze studie laten zien dat het gebruikte 
dieet logistiek haalbaar is zonder dat het welzijn en de dagelijkse werkzaamheden 
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van deze nierdonoren wordt benadeeld. Een van de moeilijkheden in de kliniek is te 
zorgen dat mensen zich aan hun dieet houden. Aangezien de door ons onderzochte 
groep bestond uit mensen die vrijwillig een nier afstaan, beschikten wij over zeer ge-
motiveerde personen. In onze proefdiermodellen vonden wij dat CR de nier beschermt 
tegen I/R schade. Analoog hieraan verwachtten wij dat de nieren van CR-donoren een 
betere nierfunctie zouden hebben dan nieren van gewonen donoren. Om dit te testen 
hebben wij van alle nieren die getransplanteerd zijn op dag één na de transplantatie 
de nierfunctie gemeten door middel van nierscans en gedurende één maand de nier-
functie bepaald. Wij hebben in vergelijking met de gewone organen geen verschil in 
transplantaatfunctie gevonden. Concluderend stellen wij dat het dieet haalbaar is in de 
klinische setting. Verder onderzoek moet gericht worden op de duur en samenstelling 
van een dieet dat bij mensen vergelijkbare effecten geeft als in dieren. Daarnaast dient 
men de achterliggende mechanismen te bestuderen, die leiden tot bescherming. Wan-
neer deze bekend zijn zou men een mimeticum kunnen ontwikkelen die het diëten in 
de humane situatie onnodig maakt.
In hoofdstuk 8 zijn we nader ingegaan op de effecten van een pre-operatief dieet 
bij post-operatieve inflammatie, in de levende nierdonoren zoals beschreven in het 
vorige hoofdstuk. Wij veronderstelden dat een pre-operatief dieet de post-operatieve 
ontstekingsreactie zou verminderen. Voor en na de operatie zijn het aantal en het soort 
witte bloedcellen bepaald evenals de productie van cytokinen en de waarde van C-
reactive protein (CRP). Volbloed van voor en van na de operatie is gestimuleerd met 
lipopolysaccharide en de hoeveelheid geproduceerde cytokinen is hierin bepaald. We 
vonden een duidelijke trend tot minder stijging van het leukocytenaantal na de operatie 
in de dieetgroep. Het is bekend dat het aantal leukocyten na de operatie stijgt en dat de 
piek hiervan op dag 1 na de operatie ligt23. Deze piek was significant lager in de dieet-
groep, echter een analyse van alle tijdspunten was niet significant. Interleukine-6 (een 
belangrijk proinflammatoir cytokine) en CRP waarden waren niet beïnvloed door het 
dieet. Interleukine-8 (IL-8) waarden waren echter wel significant hoger in de dieetgroep 
voor de operatie en erna. Een kleine stijging in IL-8 waarden kan beschermen tegen 
een grotere stijging van IL-8 waarden daarna24. Muizen die altijd een overproductie van 
IL-8 hebben, recruteren minder wittebloedcellen op de plaats van een ontsteking25. Wij 
veronderstellen dat de hogere IL-8 waarden in onze dieetpatiënten beschermden tegen 
de hogere waarden na de operatie. Stimulatie van pre-operatief bloed liet zien dat het 
dieet de reactiviteit van het bloed op een inflammatoire stimulus niet beïnvloedde. 
In post-operatief verkregen bloed vonden we wel een verschil. Tumor necrose factor 
alpha (TNF-α, proinflammatoir cytokine) productie lager was in bloed van dieetpa-
tiënten ten opzichte van de controlegroep. Dit ondersteunt onze hypothese dat een 
pre-operatief dieet de post-operatieve inflammatie kan verminderen. Met deze studie 
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hebben wij aangetoond dat een relatief mild pre-operatief dieet effect kan hebben op 
post-operatieve inflammatie. In toekomstige klinische studies zal er moeten worden 
onderzocht wat de optimale vorm van het dieet is en voor welke patiënten groepen het 
inzetbaar kan zijn.
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Dankwoord
Promoveren doe je niet alleen, maar samen met de hulp, de steun en de gezelligheid 
van vele anderen. Ik wil dan ook iedereen bedanken die heeft bijgedragen aan deze 
mooie tijd en het tot stand komen van mijn proefschrift. Een aantal mensen wil ik in 
het bijzonder danken.
Mijn promotor, prof. dr. J.N.M. IJzermans, beste Jan, ik kan me nog goed herinneren 
hoe gefascineerd ik was door het onderwerp “calorische restrictie” en dat ik mij ver-
eerd voelde dat ik op dat project werd aangesteld (ondanks dat jij mij de tweede Sonja 
Bakker noemde). Ik wil je vooral bedanken voor de vrijheid die ik heb gekregen bij het 
uitvoeren van het promotie-onderzoek en het enthousiasme waarmee u mijn promotie-
onderzoek heeft begeleid. Ik ben er trots op dat ik naast de competentie “wetenschap” 
nu ook “medisch handelen” van u mag leren.
Mijn co-promotor, dr. R.W.F. de Bruin, beste Ron, als er iemand is die dit proefschrift 
net zo goed kent als ik, dan ben jij het wel. Ik wil je bedanken voor je oneindige geduld 
bij het bespreken van nieuwe experimenten en voor het corrigeren van de artikelen. 
Ook dank ik je voor de bemoedigende en relativerende woorden op de momenten 
dat ik ze nodig had, zoals bij het wachten op contractverlenging, bij de afgewezen 
artikelen en na mislukte experimenten.
Graag dank ik prof.dr. J.H.J. Hoeijmakers, prof.dr. H. Hooijkaas en prof.dr. R.G.J. Wes-
tendorp voor het beoordelen van mijn proefschrift en deelname in de oppositie. Tevens 
gaat mijn hartelijke dank uit naar de overige leden van de promotiecommissie: prof. dr. 
J.J.B. van Lanschot, prof. dr. A.J. van der Lelij en prof. dr. H.J. Metselaar.
Dr. W.A. Dik, beste Wim, de samenwerking tussen de afdeling chirurgie en de afdeling 
immunologie was van onschatbare waarde voor mijn onderzoek. Bedankt voor je frisse 
kijk op de experimenten en voor je kritische commentaar op de artikelen. Leuk dat je 
in mijn commissie wilt plaatsnemen.
Mijn collega’s van het Laboratorium voor Experimentele Chirurgie wil ik bedanken 
voor de ontzettend leuke tijd en voor de hulp bij het uitvoeren van de experimenten. 
Sandra, ik zou niet weten wat ik (en het hele lab!) zonder je zou moeten. Als er iemand 
het overzicht heeft van werkelijk alles op het lab, dan ben jij het wel. Marielle, bedankt 
voor het samenwerken, veel succes met het afronden van jouw proefschrift, je bent 
er bijna! Dr. H.P. Roest, Henk, bedankt voor je hulp bij al mijn computerproblemen. 
Dr. J.R. Mitchell, dear Jay, thank you for your help at the beginning of the project. Jan 
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Willem, wat was het fijn om samen in het schuitje te zitten dat “tumormodel” heet. 
Gelukkig is plan A nu bijna een feit, daarna volgt plan B. Ik zal je helpen waar ik kan. 
Maxl, dankzij jou heb ik vele DJ’s leren kennen en leuke feestjes meegemaakt. Ook 
heb ik me rot gelachen om weer het zoveelste filmpje van internet. Nu ben jij aan zet, 
succes met het afronden van je boekje. Sushimita, Sander en Tanja veel succes met 
jullie onderzoeken, als ik ergens mee kan helpen dan hoor ik het wel.
Daarnaast ben ik de afdeling Immunologie heel veel dank verschuldigd. Conny, Den-
nis, Jeroen, Marja, Marten en Romana, ik kan wel stellen dat het zonder jullie hulp niet 
gelukt was! De samenwerking tussen de chirurgie en de endocrinologie heeft geleid tot 
het ontstaan van hoofdstuk vijf. Patrick en Martin; bedankt. Ook het uitvoeren van de 
klinische studie was een grote logistieke uitdaging die niet gelukt zou zijn zonder hulp 
van de chirurgen, de operatieassistenten en de verpleegkundigen van afdeling 9-zuid. 
Bedankt voor het meedenken en het verzamelen van de weefselbiopten. Marijke Tim-
memans wil ik speciaal bedanken. Met veel geduld en precisie heb jij geholpen bij het 
berekenen en samenstellen van de diëten. We weten beiden wat voor klus dat is ge-
weest. Tevens wil ik de collega’s van het Laboratorium voor Experimentele Chirurgische 
Oncologie, dr. T.L.M. ten hagen, dr. Ann L.B. Seynhaeve, Dr. Gerben A. Koning, Asha, 
Li Li, Bilyana, Gisela, Joost, Cindy, Debby en Thomas bedanken voor de samenwerking. 
Ook heb ik veel hulp gekregen van de medewerkers het EDC, Kim, Kim, Jolanda, Ed en 
vele anderen. Bedankt dat jullie in het weekend mijn muizen op dieet wilden zetten. 
Wat hebben we gelachen op “melige maandag”, “wicked wednesday” en de andere 
dagen van de week.
Mede-onderzoekers van het “lab zonder daglicht”, lief Z-gebouw en buitengewesten, 
het aantal (arts-)onderzoekers is teveel om op te noemen, maar daardoor was het des te 
gezelliger. De vele lunches, congressen en borrels hebben significant bijgedragen aan 
de lol tijdens mijn onderzoekstijd. Dit geldt ook voor de arts-assistenten uit de regio 
Rotterdam en de collegae van het laboratorium voor de experimentele chirurgie van 
het AMC.
Lieve vrienden, bedankt voor jullie interesse in mijn promotie onderzoek, maar vooral 
bedankt voor al die gezelligheid die niets met onderzoek te maken had.
Dan zijn er nog twee personen voor wie de taak van “hulp bieden” er nog niet op zit: 
mijn paranimfen. Brechtje, de vele kopjes koffie in de koffiebar hebben zeker bijge-
dragen aan het afronden van mijn proefschrift. Maar wat ik nog meer waardeer, is dat 
je naast mede-onderzoeker, een goede vriendin bent geworden. Welkom in Roterdam. 
Tim, mijn allereerste artikel heb ik samen met jou geschreven, dat zegt genoeg.
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Lieve Sacha, wat lief dat je mijn omslag wilde ontwerpen terwijl je druk bezig bent met 
afstuderen. Ik ben ontzettend trots op je en hoop dat we in de toekomst nog eens een 
gecombineerd projectje kunnen starten, sanitatie in Afrika misschien? Kus.
Pap en mam, creativiteit (“hoe zou die kleur op die muur staan?”), logisch nadenken 
(“in elkaar zetten van IKEA meubelen, verbouwingen in huis) en doorzettingsvermogen 
(“Pretoria”), zijn eigenschappen die ik van jullie heb geleerd en die heel waardevol 
waren bij mij promotie-onderzoek. De combinatie van “ik heb een idee en het moet 
nu gebeuren” (mam) en “ik heb een idee dat ik eerst tot in de puntjes voorbereid” (pap) 
was heel handig in het wetenschappelijke onderzoek. Door jullie liefde, steun en en-
thousiasme heb ik alle kans gekregen om mezelf te ontplooien, dikke knuffel van mij.
Lieve Wilmar, Ik heb al in jouw dankwoord mogen staan en nu is het jouw beurt om 
in mijn dankwoord te staan. Ruim twee jaar geleden ben je zelf gepromoveerd en al 
jouw ervaring kwam mij goed van pas. Vele avonden heb je naar mij geluisterd en heb 
je meegedacht. Hierdoor heb ik van vele losse experimenten toch nog artikelen kunnen 
maken en heb ik dit promotieboekje kunnen voltooien. Vaak viste je er een inconsi-
stentie uit of wees me op die ene cruciale controlegroep die nog ontbrak. Daarnaast 
zorg jij ervoor dat mijn leven uit veel meer bestaat dan werken alleen, zoals lekker eten 
(zelfgemaakt!), genieten van een Argentijns wijntje, tennissen, reizen, kitesurfen en nog 
veel meer. Vooralsnog spring jij met kiten (veel?) hoger dan ik, maar ik blijf oefenen. 
Wil je mij dan ook nog de back-roll leren? Of we nu mijn boekje af is veel meer vrije 
tijd gaan krijgen weet ik niet, maar wat ik wel weet is dat ik gek op je ben, love you!
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W de Graaf, S Hausler, M Heger, TM van Ginhoven, G van Cappellen, RJ Bennink, 
GA Kullak-Ublick, R Hesselmann, TM van Gulik, B Stieger: Transporters involved in 
the hepatic uptake of 99mTc-mebrofenin and indocyanine green. Accepted Journal of 
hepatology
TM van Ginhoven, CM Moues, L Dawson, KM Han, J Koning. Neurogene shock na 
operatieve correctie van een aneurysma spurium bij een patiënt met perifeer vaatlijden. 
Nederlands Tijdschrift voor Heelkunde. 2008;7:272-275
T Schepers, EM van Lieshout, TM van Ginhoven, MJ Heetveld, P Patka. Current concepts 
in the treatment of intra-articular calcaneal fractures: results of a nationwide survey. Int 
Orthop. 2008 32:711-5
TM van Ginhoven, T Schepers, H Obertop, CHJ van Eijck. Delayed closure of complex 
duodenal injuries by a foley ballon catheter duodenostomy. Digestive surgery 2006; 
23:150-153
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PhD Portfolio
Name PhD student:  Tessa Malaika van 
Ginhoven
Erasmus MC Department: Surgery
Research School: Molecular Medicine
PhD period: 01-07-2007 tot 01-07-2010
Promotor(s): Prof.dr. J.N.M. IJzermans
 Dr. R.W.F. de Bruin
1. PhD training
year workload 
(ECTs)
General courses
Laboratory animal science
Classical Methods for Data-analysis
Good Clinical Practice
2008
2009
2007
5.7
5.7
1.5
Presentations conferences
National conferences
National conferences
International conferences
National conferences
International conferences
National conferences
International conferences
2007
2008
2008
2009
2009
2010
2010
1.0
3.0
1.0
3.0
3.0
2.0
1.0
2. Teaching
year workload 
(ECTs)
lecturing
Teaching (operating room nurses in training) 2007 0.3
supervising practicals and excursions, Tutoring
Supervising anatomy practicals (Medical students)
Supervising first aid examinations (Medical students)
Supervising first aid examinations (Medical students)
2008
2009
2010
0.2
0.2
0.2
supervising Master’s theses
Bachelor thesis (Nutrition and dietetics)
Bachelor thesis (Higher Laboratory education)
Master thesis (Medicine)
2007
2008
2010
5.0
5.0
5.0
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Curriculum vitae
Tessa Malaika van Ginhoven werd op 13 december 1980 geboren te Dar es Salaam, 
Tanzania. In 1999 slaagde zij cum laude voor het VWO-eindexamen aan het St. Stanis-
las college te Delft. Hierdoor kon zij zonder loting beginnen aan de studie geneeskunde 
(Erasmus Universiteit, Rotterdam). Tijdens haar studie werkte zij als practicumassistent 
voor de afdeling anatomie. Alvorens aan haar co-schappen te beginnen, heeft zij en-
kele maanden onderzoek gedaan naar de bijwerkingen van een anti-malaria medicijn 
aan de Travel Clinic (Dr. D. Overbosch). Haar keuze-co-schap chirurgie volgde zij in 
het Reinier de Graaf Gasthuis te Delft (Dr. L. Stassen).
Na het behalen van haar artsexamen (cum laude), heeft zij een jaar als ANIOS chirurgie 
gewerkt in het Reinier de Graaf Gasthuis (Dr. L.P.S Stassen). In deze periode is naast 
het enthousiasme voor wetenschappelijk onderzoek, ook een passie voor kitesurfen 
ontstaan. Na de perioden in Delft heeft zij drie maanden als ANIOS op de afdeling 
chirurgie van het Erasmus MC gewerkt (Prof.dr. J.N.M. IJzermans) alvorens zij begon 
aan haar promotieonderzoek bij de afdeling experimentele chirurgie (Prof. dr. J.N.M. 
IJzermans, Dr. R.W.F. de Bruin). In dezelfde periode heeft zij haar zwarte band tae 
kwon do behaald.
Sinds1 juli 2010 is zij in opleiding tot chirurg in het Erasmus MC te Rotterdam (Oplei-
der: Prof.dr. J.N.M. IJzermans). Vanaf 1 juli 2012 zal zij haar opleiding voortzetten in 
de Reinier de Graaf Groep te Delft (Opleider: Dr. M. van der Elst).
